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Abstract
Classical immunoglobulin transgenic (Ig-Tg) mouse models such as the MD4 anti-
hen egg lysozyme (-HEL) Ig-Tg line have been used extensively to study B cell
responses in tolerance and immunity. This thesis describes a new generation of
gene-targeted mice (designated SWHEL mice) whereby the VH10 Ig variable gene
encoding the HyHEL-10 specificity of the original anti-HEL Ig-Tg mouse was
targeted to the Ig heavy chain locus. B cells in the SWHEL mouse are therefore
capable of undergoing class switch recombination (CSR) and somatic
hypermutation (SHM), representing a major advance on the original MD4 mouse
model. SWHEL mice were found to not only contain a large population of HEL-
specific (HEL+) B cells but also a significant population of non-HEL-binding (HEL-)
B cells generated by VH gene replacement. HEL+ SWHEL B cells were found to
belong to the B2 lineage and displayed high levels of surface IgM. Nevertheless,
they matured normally and colonised the primary B cell follicle and marginal zone
(MZ) of the spleen. The SWHEL model thus provided an opportunity to re-examine
some of the original observations made in the MD4 system and also to extend
these observations, particularly with regard to the regulation of CSR by self-
reactive B cells. As expected, analysis of SWHEL B cells exposed to high avidity
membrane-bound HEL revealed that they underwent clonal deletion in the bone
marrow (BM). More interestingly, analysis of HEL+ B cells exposed to low avidity
soluble HEL revealed that they were able to emigrate from the BM to the spleen as
anergic B cells. However, unlike anergic MD4 B cells, anergic SWHEL B cells were
reduced in frequency, displayed an immature B cell phenotype, were excluded
from the follicle and had a reduced lifespan. Direct measurement of B cell antigen
xviii
receptor (BCR) occupancy by HEL and the frequency of HEL- competitor B cells
was combined with mixed BM irradiation chimeras to demonstrate unequivocally
that the difference in phenotype and fate of HEL+ B cells in the two systems was
due solely to competition from HEL- B cells. In addition, the SWHEL model of B cell
self-tolerance was used to show that while self-reactive B cells were hypo-
responsive to BCR stimulation, BCR-independent signals delivered via anti-CD40
plus IL-4 or lipopolysaccharide could trigger them to undergo CSR and secretion
of potentially pathogenic isotype-switched autoantibodies. Finally, the SWHEL
model was used to study the responses of adoptively transferred follicular (Fo) and
MZ B cells to in vivo activation with HEL conjugated to sheep red blood cells (HEL-
SRBC). These studies revealed that both HEL+ MZ and Fo B cells were capable of
mounting a robust T cell-dependent IgG1 antibody response to HEL-SRBC.
However, HEL+ MZ B cells did not efficiently localise to the T cell-B cell border
following antigen engagement and preferentially migrated to the bridging channels
and red pulp. In contrast, HEL+ Fo B cells rapidly localised to the T cell-B cell
border and subsequently colonised numerous germinal centres. As a result, the
rate and pattern of SHM differed between HEL+ Fo and MZ B cells, with more
frequent mutations and preferential targeting of mutations to the second
complementarity-determining region in the former compared to the latter. Together
these data illustrate the value of the SWHEL model and its potential to greatly
advance the current understanding of B cell responses in tolerance and immunity.
INTRODUCTION
Chapter 1
Chapter 1. Introduction
1
1.1. Preamble
The genetic manipulation of mice has transformed our understanding of B cell
biology. Transgenic (Tg) and gene-targeted mice developed over the last 15-20
years have provided numerous insights into the physiology of B cells and their
roles in infection and immunity. Some of the key factors that regulate B cell
development and activation, and the genetic lesions that break down these
controls to cause autoimmune diseases have been elucidated using
immunoglobulin- (Ig-) Tg mice. For example, the mechanisms of central and
peripheral B cell tolerance were first identified using double Tg mice that
expressed both the Ig transgene and its cognate antigen. This type of model,
combined with the recent characterisation of defined subsets of mature peripheral
B cells and their functional heterogeneity, has given impetus to further delineation
of the exact roles of these B cell subsets in tolerance and immunity. The above
notwithstanding, the inability of B cells from classical Ig-Tg models to undergo
efficient class switch recombination (CSR) and somatic hypermutation (SHM) has
exposed critical gaps in our understanding of these processes. Thus, to
investigate these and some other outstanding issues in B cell biology, we have
developed the SWHEL mouse model to study B cell responses to self and foreign
antigen. This thesis presents the initial characterisation of these mice and their use
in investigating antigen-specific self-tolerance and T cell-dependent B cell
activation in vivo.
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Figure 1.1. Stepwise model of early B cell development. B cells arise from CD43+ CD93+
(AA4.1+) CD24+ (HSA+) HSCs in the BM and proceed through distinct developmental stages.
Early lymphoid progenitors are dependent on Flt3 ligand, c-Kit and IL-7 to provide growth and
differentiation signals. Commitment to B cell lineage in pro-B cells is marked by expression of
B220 and surrogate light chain (SLC) and induction of Rag1/2. V(D)J recombination of the Ig
heavy chain results in expression of the pre-BCR and a rapid proliferative burst in large pre-B
cells. Small pre-B cells that are CD43- downregulate SLC and re-express Rag1/2. Ig light chain
rearrangement and expression of a functional BCR (IgM) by immature B cells then allows them
to exit the BM as B220+ CD93+ CD24hi CD19+ IgM+ cells.
Adapted from (Hardy & Hayakawa 2000).
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1.2. Early B cell development
1.2.1. Cytokine requirements for early B cell development
Mature B cells are characterised by expression of the B cell receptor (BCR)
for antigen on their cell surface. In the mouse, B cells are also identified by the
expression of B220, the B cell-specific 220-kDa splice variant of CD45 (Coffman
1982). They are generated from pluripotent haematopoietic stem cells (HSCs) in
the adult bone marrow (BM) (Fig. 1.1; and reviewed in (Hardy and Hayakawa
2001)). B cell progenitors express CD43 and AA4.1 (CD93) and are initially
dependent on cytokines for proliferation, differentiation and survival. Stromal cells
that secrete stem cell factor, Flt3 ligand and IL-7 support the growth and
differentiation of these progenitor cells during this cytokine-dependent phase. For
example, activation of the tyrosine kinase receptor c-Kit by stem cell factor
promotes the survival of HSCs (Domen and Weissman 2000). Progression to the
common lymphoid progenitor (CLP) stage and their subsequent differentiation into
pro- and pre-B cells is dependent on Flt3 ligand (McKenna et al. 2000; Sitnicka et
al. 2002). Further differentiation of CLPs to pro-B cells in mice requires IL-7
signalling via the γ common chain (γc) (Carvalho et al. 2001; Miller et al. 2002) that
is shared between the multi-chain receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-
21 (reviewed in (Leonard 2001)). Following this early differentiation stage,
developing B cells become less dependent on cytokine signalling and more
dependent on signalling via the pre-BCR and BCR complex.
1.2.2. Transcriptional control of early B cell development
Several key transcription factors control the lineage decisions that ultimately
lead to the generation of mature B cells (Fig. 1.2; and reviewed by (Busslinger
Notch1
PU.1low
Ikaros
PU.1high
E2A EBF Pax5HSC CLP pro-B
cell
myeloid
progenitor
pro-T
cell
Id2
pro-NK
cell
Id2
pro-DC
cell
Figure 1.2. Transcriptional regulation of early B cell development. Key transcription factors that
determine B cell lineage commitment are shown. These factors promote B cell development by
upregulation of genes that are necessary for growth and differentiation and for the assembly of
a functional BCR. They also act to cross-repress genes that allow differentiation of myeloid and
other lymphoid cell lineages.
Reproduced from (Busslinger 2004).
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2004)). The Ikaros family of zinc-finger transcription factors promotes the
development of CLPs by repression of key myeloid genes and activation of the c-
kit and flt3 genes (Nichogiannopoulou et al. 1999). The Ets transcription factor
PU.1 (Spi-1) acts in concert with Ikaros by regulating the expression of cytokine
receptors, such as IL-7Rα, that are necessary for the proliferation, survival and
differentiation of HSCs (DeKoter et al. 2002). Commitment of CLPs to the B cell
lineage depends on E2A, early B cell factor (EBF) and Pax5. E2A and EBF are
basic helix-loop-helix E proteins that co-ordinately activate B cell-specific genes
including Rag1, Rag2, Igα, Igβ, λ5, VpreB, CD19 and Pax5 (Bain et al. 1994; Lin
and Grosschedl 1995). Thus, E2A and EBF initiate V(D)J recombination of the Ig
heavy chain locus in pro-B cells at the DH-JH segments by inducing Rag1 and
Rag2 (Romanow et al. 2000). The transcription factor Pax5, which encodes B cell-
specific activator protein (BSAP), represses B lineage-inappropriate genes such
as Notch1 required for T cell differentiation (Souabni et al. 2002), and activates B
cell-specific genes such as BLNK, Igα and CD19 that are required for pre-BCR
signalling (Nutt et al. 1999; Schebesta et al. 2002). Pax5 therefore acts
downstream of E2A and EBF and is critical for B lineage commitment. E proteins
can be sequestered into inactive heterodimers by inhibitors of differentiation (Id)
proteins that lack the basic region required for DNA binding. Therefore Id2 can
block E2A function and repress B cell differentiation (Spits et al. 2000; Becker-
Herman et al. 2002). Similarly, Notch1 can antagonise E2A but the molecular
mechanism for this interaction has not been fully elucidated (Ordentlich et al.
1998). Finally, interferon regulatory factor 4 (IRF4) and interferon regulatory factor
8 (IRF8) repress surrogate light chain (SLC) expression to terminate pre-BCR
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signalling in large pre-B cells and initiate conventional light chain gene
rearrangement in small pre-B cells (Lu et al. 2003).
1.2.3. Generation of the primary B cell repertoire
The Clonal Selection theory elaborated by Burnet mandated a mechanism
for generation of diversity that was unprecedented at the time (Burnet 1959).
Notwithstanding, Dreyer and Bennett had proposed such a mechanism involving
DNA rearrangement in 1965, well before the advent of molecular biology and the
independent discovery of V(D)J recombination by the Tonegawa and Leder
laboratories in 1978 (reviewed in (Jung and Alt 2004)).
It is now established that the principle mechanism by which a diverse
primary B cell repertoire is created is by the random reassortment of multiple VH,
DH and JH Ig gene segments (Brack et al. 1978; Seidman et al. 1978). This
combinatorial diversity requires creation of DNA double-stranded breaks (DSBs)
by the V(D)J recombinases Rag1 and Rag2 (Schatz et al. 1989; Oettinger et al.
1990). Rag1- and Rag2-deficient mice have severe combined immunodeficiency
(SCID) due to failure to assemble functional antigen receptors on T and B cells,
confirming the essential roles of these enzymes in lymphopoiesis (Mombaerts et
al. 1992; Shinkai et al. 1992). Rag binds recombination signal sequences (RSS)
that flank the VH, DH and JH gene segments to cleave DNA and initiate the DSB.
The RSS consist of a conserved heptamer (CACAGTG) and nonamer
(ACAAAAACC) separated by a non-conserved 12- or 23-bp spacer (Max et al.
1979; Sakano et al. 1979). Efficient recombination occurs when a 12-bp one-turn
RSS forms a hybrid "stem-loop" or hairpin with a 23-bp two-turn RSS (the "12/23
rule") and this directs recombination initially of DH-JH and then of VH-DHJH gene
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segments (Early et al. 1980). This ordered rearrangement of the Ig heavy chain
(Spanopoulou et al. 1994) also allows for feedback regulation whereby a µ heavy
chain generated from one allele inhibits further VH to DHJH rearrangement (Alt et al.
1984), thus ensuring allelic exclusion of Ig expression.
In addition to combinatorial diversity, the Rag-mediated cleavage of DNA to
create DSBs and their repair by non-homologous end joining (NHEJ) requires
insertion of short palindromic sequences by fill-in DNA polymerases (P-regions)
(Lafaille et al. 1989). The junctions between DH-JH and VH-DHJH segments are also
susceptible to non-templated nucleotide additions (N-regions) catalysed by the
enzyme terminal deoxynucleotidyl transferase (TdT) (Gilfillan et al. 1993; Komori
et al. 1993). This greatly increases the junctional diversity and extends the
theoretical diversity of the B cell repertoire to >108 (Klinman and Linton 1988).
Finally, an unexpected mechanism for further diversification of the primary
repertoire was recently described (Mao et al. 2004). This involved the enzyme
activation-induced cytidine deaminase (AID), which is required for CSR and SHM
(Muramatsu et al. 2000; Revy et al. 2000). Although SHM is normally associated
with antibody diversification in the context of a T cell-dependent (TD) immune
response (Section 1.4.3), AID-induced mutations in hotspots in the Ig variable
region in immature B cells was found to be T-independent (TI) (Mao et al. 2004).
1.2.4. BCR signalling and early B cell development
Developing B cells must prove that they are capable of assembling a
functional (non-self-reactive) BCR to progress past key checkpoints. The first
checkpoint occurs at the large pre-B cell stage where productive rearrangement of
the µ heavy chain locus results in expression of the pre-BCR complex comprising
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the µ heavy chain associated with the pseudo light chain proteins VpreB and λ5
and the signalling subunits Igα and Igβ. Pre-BCR expression results in transient
downregulation of Rag1/2 (Grawunder et al. 1995) and rapid clonal expansion
(Hardy et al. 1991). This positive selection step is evident in µMT mice that carry a
stop codon at the 5' end of the first transmembrane exon of the µ heavy chain.
Mature B cells are absent from these mice as they cannot express the pre-BCR
and consequently are arrested at the large pre-B cell stage (Kitamura et al. 1991).
Similarly, ablation of components of the pre-BCR signalling complex, such as λ5
(Kitamura et al. 1992) and Igα (Gong and Nussenzweig 1996), also blocks B cell
development at the large pre-B cell stage.
The next checkpoint occurs at the immature to mature B cell stage where κ
light chain rearrangement and its productive association with µ heavy chain results
in expression of surface BCR. Functional light chain rearrangement is required for
immature B cell export to the periphery as demonstrated by mice with targeted
disruption of the κ light chain locus (Chen et al. 1993; Takeda et al. 1993; Zou et
al. 1993).  Moreover, mice deficient in both κ and λ light chains are blocked at the
small pre-B cell stage and consequently lack peripheral mature B1 and B2 cells
(Zou et al. 2003). The small pre-B to immature B cell checkpoint is also critical for
those mechanisms of central tolerance that screen the newly generated BCR for
self-reactivity (Fig. 1.3). This negative selection step is discussed further in Section
1.4.1.
Even though BCR ligation can lead to functional silencing of immature B
cells, some form of "tonic" signalling via surface IgM is undoubtedly required for
continued B cell survival (reviewed in (Monroe 2004)). However, this signal is
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Figure 1.3. BCR signalling and early B cell development. (A) Developing B2 cells are screened
for the ability to assemble a functional BCR that precludes self-reactivity. Pre-B cells that have
rearranged the µ heavy chain are positively selected to rapidly proliferate. Immature B cells that
have rearranged the κ light chain are negatively selected for self-reactivity. Thus, high affinity
membrane-bound antigen induces clonal deletion, low affinity membrane-bound antigen induces
light chain receptor editing and soluble antigen induces clonal anergy in self-reactive immature
B cells. Nevertheless, some form of “tonic” BCR signal is required as immature B cells that do
not express IgM are unable to exit the BM. (B) In contrast, pre-BCR signalling induces pre-B
cells in the foetal liver to exit the cell cycle rather than divide and together with the absence of
N-regions this favours germline Ig variable genes that associate with certain light chains form a
restricted repertoire that is “hardwired” for polyreactivity against self/natural ligands.
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ligand-independent and does not require BCR ligation by cognate antigen as was
shown by the creation of mice expressing Igα/Igβ signalling complexes that lacked
transmembrane regions and ectodomains. These truncated Igα/Igβ complexes are
therefore unable to interact with extracellular ligands. Nevertheless, their
attachment to the inner leaflet of the plasma membrane is sufficient to rescue B
cell development in Rag2-/- and µMT mice that fail to express pre-BCR and are
arrested at the pro-B to large pre-B cell transition (Bannish et al. 2001). The role of
"tonic" BCR signalling in mature B cell survival is discussed in Section 1.3.4.
1.2.5. B1 versus B2 cells
BCR signalling also plays a key role in the development of B1 cells (Fig.
1.3; and reviewed in (Hayakawa and Hardy 2000; Martin and Kearney 2001)). B1
cells reside predominantly in the peritoneal cavity but are also found in the spleen
where they comprise 5% of the total B cell pool. They can be divided into CD5+
B1a cells and CD5- B1b cells (Berland and Wortis 2002). B1 cells are generated in
the foetal liver and comprise a long-lived self-replenishing population of B cells
(Hao and Rajewsky 2001) responsible for the spontaneous secretion of protective
IgM "natural" antibodies (Boes et al. 1998; Ochsenbein et al. 1999; Baumgarth et
al. 2000).
B1 cells have a limited antibody repertoire "hardwired" by usage of
distinctive germline genes in combination with particular light chains (Hardy and
Hayakawa 2001). There is evidence that this restricted repertoire may in fact be
imprinted during foetal lymphopoiesis. For example, the predominance of
homology-directed recombination (Feeney 1992) and lack of TdT expression by
developing B cells in the foetal liver (Li et al. 1993) greatly limits the
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foetal/neonatal heavy chain variable gene repertoire. Indeed, enforced expression
of TdT was shown not only to be sufficient to increase junctional diversity but also
to deplete protective anti-phosphorylcholine B1 cells from the B cell repertoire of
TdT Tg mice (Benedict and Kearney 1999). Furthermore, pre-BCR signalling that
occurs in the BM has the opposite effect in the foetal liver, as association of the µ
heavy chain with SLC during foetal lymphopoiesis results in pre-B cells exiting the
cell cycle rather than undergoing a proliferative burst (Wasserman et al. 1998).
This paradoxical selection against SLC indicates a possible preference for unusual
light chain variable regions that might complement the Ig heavy chain to produce a
restricted range of "hardwired" antibody specificities.
Strong BCR signals triggered by self/natural ligands are thought to lead to
positive selection of developing B cells into the B1 pool (Arnold et al. 1994;
Hayakawa et al. 1999; Hayakawa et al. 2003). Consistent with this, genetic lesions
that weaken BCR signal strength are associated with a decreased frequency of B1
cells. For example, mice deficient for components of the BCR signalling complex
such as CD19 (Engel et al. 1995; Rickert et al. 1995), CD21 (Ahearn et al. 1996),
BLNK (Xu et al. 2000), p85α regulatory (Fruman et al. 1999; Suzuki et al. 1999)
and p110δ catalytic subunit of phosphatidylinositol 3-kinase (PI3K) (Clayton et al.
2002) and Btk (Khan et al. 1995) all have reduced numbers of B1 cells.
Conversely, CD19 transgenic mice have hyper-responsive BCRs and enriched B1
cell populations (Engel et al. 1995; Sato et al. 1996). Finally, the Rajewsky
laboratory replaced the Igh locus by targeted insertion of the Epstein-Barr virus
(EBV) latent membrane protein 2A (LMP2A) to prove unequivocally that BCR
signal strength and not specificity determined the fate of mature B cells (Casola et
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al. 2004). LMP2A contains immunoreceptor tyrosine-based activation motifs
(ITAMs) homologous to the Igα/Igβ heterodimer and can substitute for BCR
signalling (Fruehling and Longnecker 1997). In VHLMP2A mice, strong constitutive
LMP2A signalling promoted B1 cell development and abolished the B2 cell
compartment (Casola et al. 2004).
Nevertheless, relatively little is known about how signals from the BCR that
promote the development of B1 cells during foetal lymphopoiesis differ from those
that normally result in functional silencing of developing B2 cells in the adult BM.
The role of BCR signalling in B2 cell development is considered in the next
section.
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Figure 1.4. Distinct peripheral B cell subsets as defined by cell surface phenotype, lifespan and
response to BCR cross-linking. Transitional B cells are recognised by expression of the C1q-like
receptor CD93 recognised by the 493 and AA4.1 mAbs and sensitivity to anti-IgM induced
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1.3. Peripheral B cell maturation
1.3.1. Immature (transitional) B cells in the spleen
Immature B cells emigrate from the BM to the spleen where they complete
their maturation to become long-lived mature follicular (Fo) or marginal zone (MZ)
B cells. The surface phenotype and functional properties of these cells are
summarised in Fig.1.4. Although 2 × 107 immature B cells are produced per day in
the adult BM (Osmond 1991), only 2-3 × 106 cells actually reach the spleen (Rolink
et al. 1998), and of these cells only 20-50% will enter the mature B cell pool
(Rolink et al. 1998; Allman et al. 2001). In the spleen, immature B cells comprise
10-15% of the total B cell pool (Allman et al. 1992). The phenotype of immature B
cells was previously described as IgMhi IgDlo B220lo CD19+ B cells that had a short
half-life (t1/2 = 2-4 days; (Forster and Rajewsky 1990)) and sensitivity to anti-IgM
induced apoptosis (reviewed in (Nossal 1983)). The latter characteristic
recapitulates their continued susceptibility to mechanisms of negative selection
that normally operate in the BM ((Carsetti et al. 1995); and Section 1.2.4.).
Subsequently, these cells were shown to express high levels of the heat-stable
antigen (HSA, also designated CD24) compared to mature B cells that are HSAint
(Allman et al. 1992).
The term "transitional B cells" was first coined by Carsetti to describe recent
BM emigrants to the spleen in transition to a more mature B cell phenotype
(Carsetti et al. 1995). Later work in the same laboratory subdivided them into two
groups based on surface phenotype and proliferative capacity (Loder et al. 1999).
Thus, transitional 1 (T1) B cells found in the BM, peripheral blood and spleen were
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IgMhi IgDlo CD21lo CD23lo non-cycling cells whereas transitional 2 (T2) B cells
found only in the spleen were IgMhi IgDhi CD21hi CD23hi cycling cells that give rise
to Fo and MZ B cells. Many laboratories have since questioned the validity of
these subpopulations, particularly given the heterogenous nature of the splenic B
cell pool and the lack of a reliable marker of immaturity to clearly distinguish T2
from MZ B cells in this study. Indeed by the authors' own admission, the gates
used to define T2 B cells for the cell cycle analysis contained MZ B cells (Loder et
al. 1999). Furthermore, the Rawlings laboratory reported that T2 cells as defined
by the Carsetti group proliferated in response to BCR engagement (Su and
Rawlings 2002); this result is consistent with them being a mature rather than an
immature B cell population.
The more definitive studies by Allman and colleagues using the 493 mAb
have since clarified the surface phenotype and functional properties of transitional
B cells (Allman et al. 2001). Both the 493 (Rolink et al. 1998) and AA4.1 (Petrenko
et al. 1999) mAbs recognise the CD93 antigen normally expressed by HSCs that
is identical to the C1q-like receptor (C1qRp) present on all myeloid lineage cells as
well as some lymphoid cells (Steinberger et al. 2002). To avoid confusion, the term
CD93+ will be used hereafter to refer to CD93-expressing cells that stain with
either the 493 or AA4.1 mAb. Using these mAbs Allman and colleagues were able
to distinguish transitional B cells from Fo and MZ B cells by their continued
expression of CD93. Such CD93+ B cells can be further resolved into three, rather
than two, distinct subsets based on the expression of IgM and CD23. Accordingly,
T1 B cells were found to be CD93+ IgMhi CD23neg, T2 B cells AA4.1+ IgMhi CD23hi,
and T3 B cells CD93+ IgMlo CD23hi (Allman et al. 2001). T1, T2 and T3 B cells did
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not proliferate in response to IgM cross-linking and had a rapid turn over (t1/2 = 2-4
days), consistent with previous descriptions of immature B cells. However, they
were all unequivocally shown to be non-cycling, in contradistinction to the cycling
T2 population described by the Carsetti group (Loder et al. 1999). Henceforth, the
terms T1, T2 and T3 will be used to describe subgroups of bona fide transitional B
cells as defined by Allman (Allman et al. 2001).
1.3.2. Mature B cell compartments in the spleen
The mature long-lived B cell pool in the spleen consists of Fo (70-80% of
splenic B cells) and MZ B cells (5-10% of splenic B cells) (Hardy and Hayakawa
2001). These two distinct peripheral B cell subsets differ significantly in cell
surface phenotype, anatomical localisation and functional properties. Non-
recirculating mature B cells resident in the splenic MZ are IgMhi, IgDlo, CD21hi,
CD23lo (Gray et al. 1984; Waldschmidt et al. 1988) and express high levels of the
non-classical major histocompatibility complex (MHC) molecule CD1d (Amano et
al. 1998; Makowska et al. 1999). By contrast, recirculating mature B cells that
colonise the primary follicle are IgMlo-hi, IgDhi, CD21int, CD23hi (Gray et al. 1984;
Waldschmidt et al. 1988) and express lower levels of CD1d (Amano et al. 1998;
Makowska et al. 1999).
The lifespan of B cells and their homeostasis have been intensively studied
since the early 1970s (Sprent and Miller 1972; Sprent and Basten 1973). The half-
life of mature B cells has thus been estimated by different methods to vary from a
few days (Rozing and Benner 1976; Freitas et al. 1982; Heyman et al. 1989) to 6-
10 weeks (Forster and Rajewsky 1990; Fulcher and Basten 1997).  Elegant
studies whereby B cell influx from the BM was blocked by Cre-inducible
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inactivation of Rag2 have since estimated that Fo B cells have a half-life of 4.5
months and that MZ B cells (similar to peritoneal cavity B1 cells) may be
maintained by self-renewal (Hao and Rajewsky 2001). However, it is possible that
the recorded half-life of Fo B cells was prolonged in this study due to the absence
of newly generated competitor B cells since earlier investigations in intact mice
(Forster and Rajewsky 1990) suggested significantly shorter half-life of ~2 months.
Similarly, the slow turnover of MZ B cells may represent homeostatic proliferation
to fill empty lymphoid compartments (Cabatingan et al. 2002) that were created by
the investigators. Nevertheless, the fact that MZ B cells are slowly cycling probably
explains why the Carsetti group's "T2" cells that included MZ B cells were
mistakenly claimed to be proliferating (Section 1.3.1).
The exact lineage relationships between T1, T2, T3, Fo and MZ B cells
remain unclear despite the recent advances in the characterisation of peripheral B
cell subsets. For example, a number of investigators have claimed that MZ B cells
can arise directly from Fo B cells (Kumararatne and MacLennan 1981; Dammers
et al. 1999; Vinuesa et al. 2003). However, these studies were largely performed
in a rat model and involved either the creation of lymphocyte-deficient animals (by
irradiation or chemotherapy) or adoptive transfer into lymphocyte-deficient hosts.
Therefore, the model depicted in Fig. 1.5 is not intended to reveal exact lineage
relationships nor the identity of the precursors of Fo and MZ B cells.
1.3.3. Transcription factors required for Fo versus MZ cell fate decision
There are a number of factors responsible for determining the fate of
peripheral B cells (Table 1.1). One of these is the Notch family of
receptor/transcription factors that regulates cell fate decisions by both promotion
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and cross-repression of B cell differentiation at various stages of ontogeny.
Conditional knockout of Notch2 (Saito et al. 2003) and RSS-binding protein-J
(RBP-J) (Tanigaki et al. 2002), a key mediator of Notch signalling, results in loss of
MZ B cells with a concomitant increase in Fo B cells. On the other hand, foetal
liver chimeras made from mice deficient for Msx2-interacting nuclear target protein
(MINT), which negatively regulates Notch signalling, displayed the opposite
phenotype with a relative increase in MZ B cells and a concomitant decrease in Fo
B cells (Kuroda et al. 2003). Together these data indicate that Notch2 signalling
directs differentiation of transitional B cells into MZ B cells and suppresses their
differentiation into Fo B cells (Fig. 1.5). However, the actual Notch2 ligand and the
cell that expresses it remain to be elucidated.
1.3.4. Requirements for Fo and MZ compartmentalisation
The segregation of Fo and MZ B cells into their respective anatomical
compartments in the spleen requires precise regulation of their trafficking and
retention by chemotactic factors and adhesion molecules, respectively (reviewed
in (Cyster et al. 2002)). The chemokine CXCL13 (also known as BLC and BCA1)
(Gunn et al. 1998) and its receptor CXCR5 (also known as BLR1) (Forster et al.
1996) are indispensable for the development of peripheral lymph nodes and
Peyer's patches and the establishment of normal follicular architecture (Ansel et
al. 2000). B cells from mice deficient for either CXCL13 or CXCR5 are unable to
colonise follicles in the spleen and lymph nodes and fail to upregulate LTα1β2 or
induce LTβR+ stromal cells to increase CXCL13 secretion (Ansel et al. 2000).
Indeed, CXCL13 expression is reduced 20-fold in ltα-/- and 3- to 4-fold in tnf-/- mice
(Ngo et al. 1999). Splenic and lymph node architecture is markedly disorganised in
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ltα-/- (De Togni et al. 1994; Matsumoto et al. 1996) and tnf-/- (Matsumoto et al.
1996; Pasparakis et al. 1996; Korner et al. 1997) mice. Therefore it is likely that
the development of secondary lymphoid organs and normal follicular architecture
is dependent on TNF/TNFR1 and LTα1β2/LTβR via a CXCL13-driven positive
feedback loop.
Lymphocyte chemotaxis is not only required for B cell entry into the splenic
follicle but also for their subsequent compartmentalisation. For example, in vivo
treatment with pertussis toxin displaced MZ B cells into the circulation, indicating a
role for G-coupled receptor signalling in their positioning (Lo et al. 2003). This is
consistent with the absence of MZ B cells in mice deficient for the tyrosine kinase
Pyk2 (Guinamard et al. 2000). Pyk2 is activated by chemokines and integrins and
is involved in cell migration and adhesion. MZ B cells are also absent in mice
deficient for the Rho family guanosine exchange factor (GEF) Rac2 (Croker et al.
2002) and the CDM family protein Dock2 (Fukui et al. 2001), which acts upstream
of Rac to regulate cytoskeletal organisation. Similarly, MZ B cells are absent in
mice deficient for the Rho family GEF Lsc, which directly links activation of G-
protein coupled receptors to actin polymerisation in T and B cells (Girkontaite et al.
2001).
These data indicated that chemotactic factors are critical for MZ B cell
localisation but their role could not be attributed to any of the recognised
chemokines known to signal via G-protein coupled chemokine receptors (Lu and
Cyster 2002). The discovery of the "missing" chemotactic factor came from the
recognition that the immunosuppressive drug FTY720 causes MZ B cells to
relocalise into follicles (Cinamon et al. 2004). FTY720 targets G-protein coupled
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sphingosine-1-phosphate (S1P) receptors (Chiba et al. 1998; Brinkmann et al.
2002; Mandala et al. 2002) thereby preventing lymphocyte egress from the thymus
and peripheral lymphoid organs (Matloubian et al. 2004). S1P is a
lysophospholipid that is abundant in the peripheral blood where it is mainly derived
from circulating platelets (Yatomi et al. 1995). MZ B cells express high levels of
S1P receptors 1 and 3 (S1P1 and S1P3, respectively) and treatment with FTY720
downregulates S1P1 but not S1P3 (Cinamon et al. 2004). Peripheral B cell
maturation is normal in mice deficient for S1P1 but CD21hiCD23intCD1dhi B cells fail
to colonise the splenic MZ (Cinamon et al. 2004). Interestingly, CXCL13-deficient
B cells treated with FTY720 or B cells doubly deficient for CXCL13 and S1P1 are
not displaced from the MZ indicating that S1P1 counteracts CXCL13-induced
migration into the follicle (Cinamon et al. 2004).
Correct positioning of MZ B cells in the spleen is maintained by the
mechanism of integrin-mediated retention (Lu and Cyster 2002). MZ B cells
express high levels of the integrins αLβ2 (also known as leucocyte functioning
antigen-1 or LFA-1) and α4β1 (also known as very late antigen-4 or VLA-4), which
bind to the ligands intercellular adhesion molecule-1 (ICAM-1) and vascular cell
adhesion molecule-1 (VCAM-1), respectively. B cells, by virtue of their expression
of LTα1β2, are able to directly induce LTβR+ stromal cells to express these ligands
and thereby facilitate their retention in the MZ. Thus, LTα1β2 is not only critical in
the development of secondary lymphoid tissue but it is also required for the
development of MZ B cells and their compartmentalisation within the spleen (Lu
and Cyster 2002).
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1.3.5. BCR signalling and peripheral B cell maturation
"Tonic" BCR signals distinct from antigen-induced BCR activation are
required for the survival of mature as well as immature B cells (Section 1.2.4). This
was elegantly shown in the Rajewsky laboratory by Cre-mediated deletion of a
gene-targeted Ig variable gene (Lam et al. 1997). In vivo ablation of surface
immunoglobulin in these mice resulted in rapid death of mature B cells. The
apoptosis of B cells lacking surface BCR was delayed but not prevented by
constitutive expression of the anti-apoptotic gene bcl-2. This work was extended
by inducible inactivation of ITAMs in the cytoplasmic tail of Igα resulting in loss of
BCR signalling but not surface BCR expression (Kraus et al. 2004). Under these
circumstances, the survival of mature B cells was also markedly reduced (t1/2 = 3-6
days) (Kraus et al. 2004). Hence, while strong BCR cross-linking results in the
death of immature B cells, some level of "tonic" BCR signalling is required for the
survival of mature B cells.
The nature of the "tonic" BCR signals remains unresolved but may involve
activation of members of the nuclear factor κB (NF-κB) family of transcription
factors. B cells constitutively express all five NF-κB members at all stages of
development (Liou et al. 1994) and intact NF-κB signalling is essential for
maintenance of mature peripheral B cells, particularly the MZ subset (Franzoso et
al. 1997; Bendall et al. 1999; Grossmann et al. 2000; Kaisho et al. 2001;
Pasparakis et al. 2002). NF-κB can be activated by a number of distinct
extracellular signals including engagement of the BCR, TNF superfamily ligands
(such as CD40L and BAFF; see Section 1.3.6) and Toll-like receptors (TLRs)
(reviewed in (Ruland and Mak 2003)). BCR-mediated NF-κB activation is
Table 1.2. Ig transgenic models of B cell tolerance.
ReferencesAntigenIg transgene Outcome
Goodnow, 1988Soluble HEL TgIgHEL anti-HEL Clonal anergy
Hartley, 1991Membrane-bound HEL TgIgHEL anti-HEL Central deletion
Nemazee, 1989Endogenous H-2Kk,b3-83µ anti-H-2Kk,b Central deletion
Russell, 1991Liver-specific H-2Kb Tg3-83µδ anti-H-2Kk,b Peripheral deletion
Erikson, 1991Native dsDNAVH3H9 anti-DNA Central deletion
Radic, 1993Native dsDNAVH3H9 anti-DNA Receptor editing
Tiegs, 1993Endogenous H-2Kk,b3-83µδ anti-H-2Kk,b Receptor editing
Lang, 1996H-2bm3 and KdDk (low affinity)3-83µδ anti-H-2Kk,b Receptor editing
Brombacher, 1991Endogenous CD8.2Anti-CD8.2 Deletion and/or anergy
Okamoto, 1992Endogenous RBCsH3 x L1 anti-RBC Deletion and/or anergy
Erikson, 1991Native ssDNAVH3H9 anti-DNA Clonal anergy
Gay, 1993Native dsDNAVH3H9 x Vκ4 anti-DNA Receptor editing
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dependent on Bcl10 but the mature B cell compartment was initially reported to be
normal in Bcl10-deficient mice (Ruland et al. 2001). Remarkably, a second line of
Bcl10-deficient mice generated by a different laboratory showed that normal
maturation and function of peripheral B1 and B2 cells was dependent on Bcl10
(Xue et al. 2003). Therefore it is still unclear whether the constitutive activation of
NF-κB survival signals is mediated by BCR and/or some other signal (such as
BAFF - see Section 1.3.6).
BCR signalling not only maintains the peripheral B cell pool but also
influences the fate of mature B cells. Low affinity polyreactive B cells were found to
be highly enriched in the MZ compartment of VH81x and M167 Ig-Tg mice (Chen
et al. 1997; Martin and Kearney 2000). This prompted Kearney to argue that BCR
specificity for self-antigens positively selected B cells into the MZ compartment
(Martin and Kearney 2000; Bendelac et al. 2001). However, there is little direct
evidence for BCR specificity as a primary determinant of the fate of Fo versus MZ
B cells as low affinity environmental antigens may also trigger the BCR in these Ig-
Tg B cells. It would therefore be interesting to see if peripheral B cell maturation is
biased towards the Fo or MZ B cell pathway in other Ig-Tg models, particularly
those where potential cross-reactivity with environmental antigens is eliminated.
Several pieces of evidence indicate that BCR signal strength can determine
the fate of mature B cell (Fig. 1.5; and Table 1.1). For example, mice deficient for
CD19 (Makowska et al. 1999; Martin and Kearney 2000), p85α regulatory subunit
(Suzuki et al. 1999) and p110δ catalytic subunit of PI3K (Clayton et al. 2002;
Okkenhaug et al. 2002) have relatively weak BCR signal strength but reduced
numbers of MZ B cells. In contrast, mice deficient for the phosphatidylinositol 3-
Chapter 1. Introduction
19
phosphatase phosphatase and tensin homologue (Pten) (Anzelon et al. 2003;
Suzuki et al. 2003) have relatively strong BCR signal strength and increased
numbers of MZ B cells. However, this generalisation does not apply to the zinc-
finger protein Aiolos that negatively regulates Btk. Aiolos-deficient B cells have
strong BCR signal strength but decreased MZ B cells (Cariappa et al. 2001).
These complex genetic lesions exert diverse effects on the BCR signal making it
difficult to reconcile them all in a simplistic model of maturation based on BCR
signal strength such as proposed by Pillai (Pillai et al. 2004).
1.3.6. BAFF signalling and peripheral B cell maturation
In 1999, several groups independently cloned a TNF family ligand that
promoted B cell survival, which was named BAFF (Schneider et al. 1999), BLys
(Moore et al. 1999), TALL-1 (Shu et al. 1999), THANK (Mukhopadhyay et al. 1999)
and zTNF4 (Gross et al. 2000) (reviewed in (Mackay et al. 2003)). Henceforth, the
term BAFF will be used to avoid confusion. BAFF exists as a trimer and can be
cleaved from the plasma membrane by furin-type proteases with release of soluble
BAFF (Schneider et al. 1999). The major source of BAFF required for peripheral B
cell homeostasis is radiation-resistant stromal cells (Gorelik et al. 2003). However,
myeloid cells such as monocytes/macrophages (Moore et al. 1999; Nardelli et al.
2001), dendritic cells (DCs) (Balazs et al. 2002; Litinskiy et al. 2002) and
neutrophils (Scapini et al. 2003) can also be stimulated to produce BAFF;
presumably, this inducible production of BAFF is important for antigen-driven
humoral immune responses (Avery et al. 2003; Rahman et al. 2003; O'Connor et
al. 2004) but not for B cell maturation and homeostasis.
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BAFF binds to three receptors: B cell maturation antigen (BCMA);
transmembrane activator and cAML interactor (TACI); and BAFF-R (otherwise
known as B cell maturation defect or Bcmd, and BLySR3 or BR3). A proliferation-
inducing ligand (APRIL), another TNF family ligand, also binds to BCMA and TACI
but BAFF is the unique ligand for BAFF-R. Expression of BAFF receptors and
therefore BAFF-responsiveness is tightly regulated during B cell development (Fig.
1.4). Thus, T1 B cells that have recently emigrated from the BM express BCMA
but not BAFF-R. Acquisition of BAFF-R and downmodulation of BCMA marks the
T1 to T2 B cell transition (Hsu et al. 2002). Hence, BAFF enhances the survival of
T2, T3 and mature B cells via BAFF-R but has no effect on T1 cells via BCMA
(Hsu et al. 2002). The indispensable role of BAFF/BAFF-R in peripheral B cell
maturation and survival is evident in mice deficient either for BAFF (Gross et al.
2001) or BAFF-R signalling (Schiemann et al. 2001; Thompson et al. 2001). In
these models, there is a block in T1 to T2 progression and absence of late
transitional (T2 and T3) and mature B cells.
In contrast, mice that overexpress BAFF develop peripheral
lymphadenopathy and splenomegaly as a consequence of B cell hyperplasia due
to an excess of Fo and particularly MZ B cells (Mackay et al. 1999; Khare et al.
2000). Further, there is intense elevation of serum immunoglobulins (Igs) that is
typically associated with false positive serological tests for anti-nuclear antibodies
(ANA) (Hollingsworth et al. 1996), rheumatoid factor (RhF) (Borretzen et al. 1996)
and anti-double-stranded DNA antibodies (anti-dsDNA) (Smeenk et al. 1996). This
finding has led to the assertion that excess BAFF promotes systemic
autoantibody-mediated autoimmune disease (Mackay et al. 1999; Khare et al.
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2000). Unfortunately, the proteinuria reported in the both BAFF Tg mice was not
diagnostic of immune-mediated glomerulonephritis as the histology shows non-
specific staining of the tubule as well as glomeruli that is typically seen in patients
with elevated serum Igs such as those with multiple myeloma (Jenis and
Lowenthal 1977). Consequently, these data do not provide sufficient evidence to
support the claim that BAFF Tg mice develop any form of autoimmunity.
Table 1.1. Selected knockout and transgenic mice with perturbations in the peripheral B2 cell
pool.
ReferencesProposed mechanismModel Outcome
Guinamard, 2000Altered traffickingPyk2-/- Absent MZ B cells
Fukui, 2001Altered traffickingDock2-/- Decrease MZ B cells
Girkontaite, 2001Altered traffickingLsc-/- Decrease MZ B cells
Makowska, 1999
Martin, 2000
Altered BCR signallingCD19-/- Absent MZ B cells
Anzelon, 2003
Suzuki, 2003
Altered BCR signallingPtenCD19/Cre Increase MZ B cells
Wang, 1998
Cariappa, 2001
Altered BCR signallingAiolos-/- Slight increase Fo B cells
Decrease MZ B cells
Matloubian, 2004
Cinamon, 2004
Altered traffickingS1P1-/- Failure of splenic B cell
compartmentalisation
Schiemann, 2001Absent BAFF-R signalBaff-/- Absent peripheral B2 cells
Thompson, 2001Absent BAFF-R signalBaffr-/- Absent peripheral B2 cells
Mackay, 1999
Batten, 2000
Increase BAFF-R signalBaff-Tg Increase peripheral B2 cells
Marked increase MZ B cells
Grech, 2004Increase NF-κB2
processing
Traf2Mx/Cre Marked increase MZ B cells
Tanigaki, 2002Decrease Notch2 signalRBP-JMx/Cre Increase Fo B cells
Absent MZ B cells
Saito, 2003Decrease Notch2 signalNotch2Mx/Cre Increase Fo B cells
Absent MZ B cells
Kuroda, 2003Increase Notch2 signalMINT-/- Decrease Fo B cells
Increase MZ B cells
Casola, 2004Strong BCR signalVHLMP2A Absent peripheral B2 cells
Casola, 2004Weak BCR signalDHLMP2A Absent peripheral B1 cells
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1.4. B cell self-tolerance
1.4.1. Ig-Tg models of B cell self-tolerance
The stochastic recombination of multiple gene segments to generate the
primary B cell repertoire created the problem of dealing with self-reactive Ig genes
that would inevitably emerge. Burnet resolved this by proposing that lymphocytes
that encounter antigen in utero are programmed to undergo clonal deletion (Burnet
1959). Lederberg recognised that lymphocytes continue to be generated post-
natally and modified Burnet's original hypothesis by suggesting that the
developmental stage of the lymphocyte and not of the animal determined whether
antigen encounter resulted in clonal selection or deletion (Lederberg 1959). In
agreement with this, developing B cells have been shown to be highly sensitive to
anti-IgM induced apoptosis in vivo (Lawton and Cooper 1974). This sensitivity was
subsequently confirmed by a large number of in vitro studies (reviewed in (Nossal
1983)). However, it was not until the creation of Ig-Tg mice by the Basten and
Nemazee laboratories that this tolerance checkpoint was directly observed for the
first time (Table 1.2; and reviewed in (Goodnow 1992)).
The original Ig-Tg model of self-tolerance utilised the Ig variable gene
derived from the HyHEL-10 hybridoma to create mice with a predominantly
monoclonal population of anti-HEL B cells (Goodnow et al. 1988). By crossing
these with Tg mice expressing soluble HEL (sHEL) as a neo-self-antigen, it was
shown that self-reactive B cells were functionally silenced before they leave the
BM. This state of anergy was characterised by downregulation of surface IgM,
hypo-responsiveness to antigenic stimulation and failure to secrete serum
autoantibodies (Goodnow et al. 1988). Clonal anergy has since been confirmed in
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a number of other Ig-Tg models. For example, VH3H9 B cells expressing anti-DNA
Ig heavy chain are anergic towards native single stranded DNA (ssDNA) (Erikson
et al. 1991).
This demonstration of clonal anergy to low avidity (soluble) self-antigen was
followed by the description of another classical Ig-Tg model whereby B cells
expressing BCRs directed against the class I MHC molecules H-2Kk and H-2Kb
(Nemazee and Burki 1989). Anti-H-2Kk,b B cells developing in mice expressing H-
2Kk or H-2Kb were eliminated in the BM thereby providing the first demonstration in
vivo of clonal deletion that had been predicted earlier by Burnet (Burnet 1959) and
Lederberg (Lederberg 1959). Clonal deletion of immature B cells exposed to high
avidity membrane-bound antigen was also subsequently shown for anti-CD8.2
(Brombacher et al. 1991), anti-double stranded DNA (anti-dsDNA ) (Erikson et al.
1991), anti-membrane HEL (anti-mHEL) (Hartley et al. 1991) and anti-RBC
(Okamoto et al. 1992) B cells.
Analysis of VH3H9 mice generated by the Weigert laboratory revealed that
antibodies secreted by hybridomas derived from these mice did not bind dsDNA
and that the sequences of light chains which associated with the Tg anti-DNA
heavy chain was biased against DNA-binding κ light chains (Radic et al. 1993). By
crossing VH3H9 mice with mice expressing the Vκ4 light chain from the original
anti-dsDNA hybridoma, Weigert and colleagues were able to provide more direct
evidence for what has since been termed light chain receptor editing (Gay et al.
1993). In the resulting VH3H9 × Vκ4 mice, B cells expressed the anti-DNA heavy
chain but not the anti-DNA light chain (Gay et al. 1993). At the same time
Nemazee's group showed that IgM+ immature B cells in the BM of anti-H2Kk,b mice
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continued to express Rag and underwent further light chain rearrangement to alter
their BCR specificity (Tiegs et al. 1993). Nemazee has postulated that low affinity
membrane-bound ligands preferentially induce receptor editing whereas high
affinity membrane-bound ligands induce clonal deletion (Lang et al. 1996).
However, failure to edit the light chain, for example in Rag2-deficient mice, would
also result in clonal deletion in the BM (Xu et al. 1998).
Taken together, these Ig-Tg models established a hierarchy of fates for self-
reactive B cells based on the strength of the tolerogenic BCR signal (Fig. 1.3; and
(Goodnow et al. 1995)).
1.4.2. Peripheral deletion of self-reactive B cells
The export into the periphery of immature self-reactive B cells that have
escaped clonal deletion and receptor editing implied that peripheral mechanisms
must also exist to reinforce B cell self-tolerance (Fig. 1.6). For example, even
though self-reactive anti-HEL B cells are anergic they are still able to proliferate in
response to stimulation with lipopolysaccharide (LPS) (Goodnow et al. 1988) and
T cell membranes containing CD40L (Eris et al. 1994). Therefore peripheral
tolerance mechanisms are required to prevent the maturation and inadvertent
activation of these cells.
 Not surprisingly, immature (transitional) B cells in the spleen continue to be
subject to negative selection as shown by their apoptotic response to IgM cross-
linking (Allman et al. 1992; Carsetti et al. 1995; Allman et al. 2001; Su and
Rawlings 2002). This continued susceptibility to deletion in the periphery is a
natural extension of the apoptotic response of immature B cells in the BM (Nossal
1983). Hence, liver-specific expression of the H-2Kb antigen under the
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metallothionein promoter resulted in peripheral deletion of high avidity self-reactive
anti-H-2Kk,b B cells in the liver (Russell et al. 1991).
1.4.3. Follicular exclusion and interclonal competition
In contrast to the above, low avidity self-reactive B cells are eliminated from
the periphery by more indirect means. In the original sHEL double Tg model,
immature self-reactive B cells that reached the periphery fail to colonise the MZ of
the spleen but are able to enter the follicle and matured into Fo B cells (Mason et
al. 1992). However, in the presence of competition from a polyclonal (non-self-
reactive) repertoire, the migration of self-reactive B cells is further restricted
resulting in their failure to colonise the primary B cell follicle (Cyster et al. 1994;
Cyster and Goodnow 1995; Ekland et al. 2004). Migration of these self-reactive B
cells is arrested at the T-B border where they are rapidly eliminated (Cyster et al.
1994). Consequently, they have a reduced half-life of 2-4 days (Fulcher and
Basten 1994; Cyster and Goodnow 1995) similar to that of immature B cells
(Forster and Rajewsky 1990; Fulcher and Basten 1997; Allman et al. 2001).
Therefore, in the presence of interclonal competition, self-reactive B cells fail to
enter the follicle or complete their peripheral maturation programme.
There has been longstanding controversy over the mechanism of follicular
exclusion (Cyster et al. 1994; Cyster and Goodnow 1995; Fulcher et al. 1996;
Cook et al. 1997). Specifically, it was argued that the presence of competing B
cells reduced the frequency of self-reactive HEL+ B cells and thereby increased
the concentration of available HEL (Fulcher et al. 1996; Cook et al. 1997). In other
words, follicular exclusion and competitive peripheral elimination of self-reactive B
cells could have arisen from more intense BCR signalling rather than physiological
Figure 1.6. Peripheral fate of immature self-reactive B cells. Immature self-reactive B cells
(green) are functionally inactivated on exit from the BM. (1) The migration of these anergic B
cells are restricted such that they cluster at the border between the primary B cell follicle and T
cell-rich periarteriolar lymphatic sheath (PALS). (2) Hence, they are eliminated from the margin-
al zone. (3) In the presence of competition from a diverse polyclonal repertoire they are also
excluded from the primary follicle. As a result the maturation of self-reactive B cells is arrested
at the immature T1 transitional stage and their lifespan is shortened leading to their peripheral
elimination. In contrast, non-self-reactive B cells (blue) are that exit the BM are able to colonise
the follicle and mature normally.
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competition for migratory and survival signals. Hence, the phenotype of peripheral
self-reactive B cells (mature versus immature) and the basis of their follicular
exclusion (interclonal competition versus receptor occupancy) remain to be
resolved (Fig. 1.6; Chapter 4).
1.4.4. BCR signalling defects in anergic B cells
Initial studies of self-reactive (but mature) anti-HEL B cells identified the key
features of anergy i.e. downregulation of surface IgM (Goodnow et al. 1988) and
inactivation of BCR signalling (Cooke et al. 1994; Eris et al. 1994; Healy et al.
1997). Subsequent studies by Goodnow and colleagues established the major
biochemical differences in signalling between acute ("immunogenic") and chronic
("tolerogenic") antigenic stimulation. Thus, BCR stimulation of naïve B cells
induced large biphasic calcium spikes and activated nuclear signals via NF-AT,
ERK, NF-κB and JNK. In contrast, BCR stimulation of self-reactive B cells induced
small calcium fluxes and only activated NF-AT and ERK nuclear signals (Healy et
al. 1997). These biochemical differences are consistent with differences in the
transcriptome of activated naïve compared to self-reactive B cells (reviewed in
(Glynne et al. 2000)).
1.4.5. CD4+ TH cell-mediated killing of self-reactive B cells
A major defect in BCR signalling by self-reactive B cells is the failure to
upregulate expression of the co-stimulatory molecule CD86 (B7.2) (Cooke et al.
1994; Eris et al. 1994; Ho et al. 1994). As a result, anergic B cells can present
captured or constitutively expressed antigen but are unable to provide CD28-
dependent co-stimulation to CD4+ T helper (TH) cells (Cooke et al. 1994; Eris et al.
1994; Ho et al. 1994). Under these circumstances, previously activated CD4+ T
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cells although capable of upregulating expression of CD40L and CD95L, fail to
secrete cytokines such as IL-2 and IL-4 (Ho et al. 1994). Thus anergic self-reactive
B cells do not receive adequate cytokine-dependent proliferative and survival
signals and are eliminated by CD95L displayed on activated CD4+ T cells
(Rathmell et al. 1995; Rathmell et al. 1996). This CD4+ T cell-mediated killing
provides a final peripheral checkpoint to prevent the inadvertent activation of self-
reactive B cells at the T-B border following antigen exposure and their subsequent
recruitment into the germinal centre (GC) response (Section 1.5). Accordingly,
constitutive expression of CD86 can rescue self-reactive anergic B cells from
CD95-mediated deletion and induce autoantibody secretion (Rathmell et al. 1998).
1.4.6. Regulation of CSR and Ig secretion by self-reactive B cells
In contrast to the BCR-mediated responses such as activation and
tolerance, relatively little is known about the responses of self-reactive B cells to
BCR-independent stimuli. Studies have shown that anergic B cells can respond
normally to LPS (Goodnow et al. 1989) and CD40 stimulation (Eris et al. 1994).
However, these early investigations were performed in the original anti-HEL
double-Tg system in which the majority of self-reactive B cells had a mature
phenotype. Thus, studies of BCR-independent activation of immature self-reactive
B cells (which may be more representative of self-reactive B cells generated within
a diverse polyclonal repertoire) are still lacking. Moreover, the anergic B cells used
for examining signal transduction were unable to undergo SHM or to switch from
IgM to downstream isotypes since they only carried Cµ and Cδ heavy chains
(Goodnow et al. 1988). Hence, it was not possible to study the regulation of either
CSR or SHM in these mice. This is particularly relevant as most pathogenic
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human autoantibodies are of the switched IgG isotype (George and Shoenfeld
1996; Peng et al. 2002). Indeed, the onset of autoimmune diseases such as
systemic lupus erythematosus (SLE) is associated with class switching from IgM
to IgG and affinity maturation from low affinity anti-ssDNA to high affinity anti-
dsDNA antibodies (Smeenk et al. 1996). Likewise the onset of glomerulonephritis
in murine models of SLE is associated with switching from secretion of IgM to IgG
autoantibodies (Steward and Hay 1976; Papoian et al. 1977; Panosian-Sahakian
et al. 1989; Tillman et al. 1992; Peng et al. 2002). Therefore the lack of knowledge
regarding the regulation of CSR by self-reactive B cells continues to be a critical
gap in the understanding of peripheral B cell self-tolerance and its breakdown in
autoimmune diseases.
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1.5. B cell activation
1.5.1. In vitro responses by naïve mature B cells
The responses of naïve mature B cells to stimulation with antigen and
polyclonal activation have been discussed together with responses of self-reactive
mature B cells in the previous sections. In addition, the Hodgkin laboratory has
provided some useful insights into the regulation of B cell differentiation in vitro.
They purified small, dense naïve splenic B cells and labelled them with the
intracellular and membrane dye 5-(and 6-) carboxyfluorescein diacetate
succinimidyl ester (CFSE) to track cell division (Lyons and Parish 1994) following
in vitro stimulation with various T cell-derived (e.g. CD40L, IL-4) (Hodgkin et al.
1996; Hasbold et al. 1998) and T-independent (e.g. LPS) signals (Deenick et al.
1999). These studies revealed that Ig class switching was linked to cell division
such that the probability of a cell switching to a particular isotype increased with
the division number (Hodgkin et al. 1996; Hasbold et al. 1998; Deenick et al.
1999). Likewise, the differentiation of activated B cells into syndecan-1+ antibody
secreting cells (ASCs) appeared to be regulated in a division-dependent manner
(Hodgkin et al. 1996; Hasbold et al. 2004). These in vitro systems have now been
used to examine the regulation of human B cell activation in health and disease
(Tangye et al. 2002) as well as to characterise the intrinsic differences between
human naïve and memory B cells (Tangye et al. 2003; Tangye et al. 2003). Thus,
these in vitro systems provide a useful framework with which to study the
regulation of CSR by naïve and self-reactive B cells (Chapter 4).
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1.5.2. TD versus TI-2 immune responses
Antibody affinity maturation is a hallmark of the adaptive immune response
(reviewed in (Rajewsky 1996)). In the B cell compartment, this is achieved in GCs
by the TD processes of SHM and clonal selection (reviewed in (MacLennan
1994)). Although rudimentary GCs can be generated in the absence of T cells (de
Vinuesa et al. 2000; Lentz and Manser 2001) they rapidly involute after 5 days due
to a massive wave of apoptosis leading to impaired SHM (Toyama et al. 2002). In
contrast, SHM (and CSR) occur efficiently in TD GCs and are critically dependent
on the enzyme AID (Muramatsu et al. 2000; Revy et al. 2000). AID was initially
identified by cDNA subtraction as the switch factor responsible for conversion of
IgM to IgA in the CH12F3-2 lymphoma cell line and is highly expressed in GC B
cells (Muramatsu et al. 1999). Induced overexpression of AID causes constitutive
switching from IgM to IgA and both CSR and SHM are abrogated in mice deficient
for AID (Muramatsu et al. 2000). Likewise, mutations in human AID causes an
autosomal recessive form of hyper-IgM syndrome characterised by
lymphadenopathy due to the presence of enlarged GCs containing numerous
activated B cells (Revy et al. 2000).
The current understanding of TD and TI responses has come largely from
studies of the immune response to the hapten (4-hydroxy-3-nitrophenylated)acetyl
(NP). The TD response to NP occurs within three distinct anatomical
compartments in the rat (Liu et al. 1991) and mouse spleen (Jacob et al. 1991a;
Jacob and Kelsoe 1992). Thus, at different points in the response, hapten-specific
B cell blasts are found in foci at the boundary between the primary B cell follicle
and T cell-rich periarteriolar lymphatic sheath (PALS), in clusters around follicular
Figure 1.7. Classical T-dependent immune response. (1) Naïve B cells in the primary follicle
migrate to the border between the follicle and T cell-rich periartiolar lymphatic sheath (PALS)
upon antigen engagement to seek T cell help. (2) Activated B cells then migrate into the inner
follicle to establish germinal centres (GCs) where they proliferate as centroblasts in the dark
zone adjacent to the T cell area. Centrocytes undergo affinity maturation in the light zone distal
to the T cell area. (3) Long-lived plasma cells produced by the GC reaction and migrate via the
bridging channels and red pulp to the bone marrow. (4) Memory B cells produced by the GC
reaction migrate to the marginal zone. (5) In addition, naïve B cells in the marginal zone have
been proposed to rapidly respond to blood-borne antigen and generate short-lived plasma cells
in the extrafollicular proliferative foci.
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dendritic cells (FDCs) in GCs, and in extrafollicular proliferative foci (EPF) located
in the bridging channels. These are illustrated in Figs. 1.7 and 1.8 and discussed
further below.
1.5.3. CD4+ T cell help is provided at the T-B border
Several groups have independently observed the rapid migration of
activated B cells to the T-B border of the spleen following antigen engagement (Liu
et al. 1988; Cyster and Goodnow 1995; Fulcher et al. 1996). The Jenkins
laboratory used anti-HEL Ig-Tg B cells and anti-OVA T cell antigen receptor-
(TCR-) Tg T cells to show that in the lymph node this migration resulted in cognate
interactions between activated B and CD4+ TH cells (Garside et al. 1998). After
receipt of T cell help, activated B cells undergo CD40L-dependent B cell
proliferation and GC formation (Garside et al. 1998). CD40L is a TNF family
member that was cloned as the ligand for CD40 in 1992 (Armitage et al. 1992;
Hollenbaugh et al. 1992). It is upregulated on activated T cells (Armitage et al.
1992; Hollenbaugh et al. 1992) and mutations in human CD40L cause X-linked
hyper-IgM syndrome characterised by the absence of GCs and defective Ig
isotype switching (Allen et al. 1993; Aruffo et al. 1993; DiSanto et al. 1993;
Fuleihan et al. 1993; Korthauer et al. 1993). This phenotype has been
recapitulated in mice deficient for CD40L (Xu et al. 1994). Activated B cells at the
T-B border must express the CD28 ligands CD80 (B7.1) and CD86 to completely
activate CD4+ TH cells to proliferate and secrete cytokines such as IL-2 and IL-4
(McKnight et al. 1994; Seder et al. 1994). Not surprisingly, GC formation is also
impaired in mice deficient for CD28 (Ferguson et al. 1996) and CD80/CD86
(Borriello et al. 1997).
Dark zone
Extrafollicular sites
Light zone
IL-4
IL-21
Immune
complexes
Centrocyte
Follicular TH cell
ICOS
ICOSL
CD40
Naïve B cell
BCR
Antigen
Activated
B cell
CD80/
CD86
CD95
Activated
TH cell
CD40L
CD95L
IL-2, IL-4
Naïve TH cell
CD28
TCRMHCII
PALS Follicle
rapid
proliferation
Centroblast
IDC
SHM
Mutated BCR
R.I.P.
R.I.P.
Affinity
maturation
CD95-mediated killing
Anergic B cell
Memory B cell
Plasma cell
CSR
FDC
Germinal centre
CD80/
CD86
CD40
CD28
proliferation T-B border
Figure 1.8. Textbook GC reactions. Naïve TH cells proliferate and upregulate expression of
CD40L and CD95L after priming by interdigitating dendritic cells (IDCs) in the T cell zone. Naïve
B cells upregulate the co-stimulatory molecules CD80/CD86 and migrate to the T-B border to
seek T cell help after antigen engagement. At the outer PALS they co-stimulate activated TH
cells via CD28 to secrete cytokines such as IL-2 and IL-4. Failure of anergic self-reactive B cells
to express CD80/CD86 results in their CD95-mediated killing at this site. Activated B cells
undergo proliferation and CSR in response to CD40L and then migrate to the inner follicle and
establish the GC. The GC is polarised into a dark zone containing proliferating centroblasts and
a light zone containing non-dividing centrocytes, follicular dendritic cells (FDCs) and specialised
follicular TH (TFH ) cells. These TFH cells express ICOS and secrete cytokines such as IL-10 and
IL-21 to support Ig production. SHM is thought to occur in centroblasts and clonal selection in
centrocytes which compete for antigen retained in immune complexes and displayed on FDCs.
In this way, self-reactive and low affinity clones also undergo CD95-mediated elimination. After
iterative rounds of division, hypermutation and selection, high affinity clones are generated and
selected to either terminally differentiate into plasma cells or enter the memory B cell pool.
Adapted from (Manser 2004).
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1.5.4. SHM and affinity maturation occurs in GCs
The GC serves three important functions in the TD response as the site of:
(1) clonal expansion where antigen-specific B cells proliferate (Jacob et al. 1991a;
Liu et al. 1991); (2) clonal selection where high affinity mutants are positively
selected to undergo iterative rounds of cell division (Berek et al. 1991; Jacob et al.
1991a; Jacob et al. 1991b); and (3) clonal deletion where self-reactive B cells are
eliminated (Han et al. 1995; Pulendran et al. 1995; Shokat and Goodnow 1995).
These functions are compartmentalised in the dark zone located proximal to the
PALS and the light zone located distal to the PALS (reviewed in (MacLennan
1994)). The dark zone contains centroblasts that rapidly proliferate and
hypermutate their Ig variable genes and the light zone contains centrocytes that
compete with each other for growth and survival signals from TH cells and FDCs.
Thus the GC reaction requires complex coordinated interactions ("cross-talk")
between activated TH, FDCs and B cells.
GCs contain a unique population of CXCR5+ CCR7- CD4+ TH cells that
homes to the follicle rather than the T cell zone (Breitfeld et al. 2000; Schaerli et al.
2000; Kim et al. 2001). These follicular TH cells (TFH) were first identified in human
tonsils but similar populations of specialised effector CD4+ T cells have now been
detected in murine GCs as well (Campbell et al. 2001; Smith et al. 2004). They
express the CD28 homologue inducible co-stimulator (ICOS) and in humans
secrete cytokines such as IL-10, which are needed to support Ig production by B
cells (Breitfeld et al. 2000; Kim et al. 2001). Moreover, TFH cells express increased
levels of mRNA for IL-21 (Chtanova et al. 2004), another cytokine capable of
inducing differentiation of B cells into ASCs (Ozaki et al. 2002; Pene et al. 2004).
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In mice deficient for both IL-4 and IL-21 GC formation and Ig production are
impaired (Ozaki et al. 2002). ICOS expression is induced upon T cell activation
(Hutloff et al. 1999; Yoshinaga et al. 1999; Coyle et al. 2000) and T cells
selectively deficient for ICOS are unable to contribute to GC formation (McAdam et
al. 2001; Tafuri et al. 2001), isotype switching and Ig secretion (Dong et al. 2001;
McAdam et al. 2001; Tafuri et al. 2001). Humans with homozygous loss of ICOS
similarly have impaired GC development and hypogammaglobulinemia
(Grimbacher et al. 2003). Thus, while the activation of naïve T cells in the PALS is
CD28-dependent, the maintenance of effector TFH cells in GCs is ICOS-dependent
and CD28-independent (Schweitzer and Sharpe 1998). Intriguingly, GCs are also
absent in mice deficient for the cytoplasmic adaptor protein SLAM-associated
protein (SAP) (Crotty et al. 2003), which is encoded by the gene SH2D1A (also
known as DSHP). Mutation in the human SH2D1A gene results in X-linked
lymphoproliferative disease, which is characterised by fulminant EBV infection,
hypogammaglobulinaemia and B cell lymphoma (Coffey et al. 1998; Nichols et al.
1998; Sayos et al. 1998).
Centrocytes in the light zone of the GC cluster closely around FDCs, which
appear to rescue GC B cells from apoptosis (Lindhout et al. 1993). In mice
deficient for LTα1β2/LTβR and TNF/TNFR1 signalling FDCs are absent and GCs
fail to develop (reviewed in (Fu and Chaplin 1999)). FDCs form an extensive
network in the light zone that traps and retains antigen in immune complexes
(reviewed in (Tew et al. 1990)). They express the low affinity Fc receptor for IgG
FcγRIIB (CD16) (Qin et al. 2000) as well as the receptors for complement
components C3b/C4b (Cr1 or CD35) and iC3b/C3d,g (Cr2 or CD21) (Liu et al.
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1997; Fang et al. 1998). Opsonised antigen can therefore be trapped either via
FcγRIIB or Cr1/Cr2. Consistent with this, both FcγRIIB- (Qin et al. 2000) and Cr2-
deficient mice (Ahearn et al. 1996; Molina et al. 1996) have impaired TD
responses and make a poor B cell memory response to recall antigen, particularly
in the case of cr2-/- mice (Barrington et al. 2002).
GC B cells, particularly centrocytes, are highly susceptible to apoptosis in
vitro (Liu et al. 1989). They have decreased expression of anti-apoptotic genes
such as bcl2 (Liu et al. 1991; Nunez et al. 1991) and increased expression of pro-
apoptotic genes such as c-myc, p53 and bax (Martinez-Valdez et al. 1996).
Indeed, overexpression of Bcl2 can rescue GC B cells from apoptosis (Smith et al.
1994) and lead to impaired negative selection of memory B cells (Smith et al.
2000). Moreover, GC B cells express high levels of CD95 (Liu et al. 1995; Smith et
al. 1995) rendering them susceptible to CD95-mediated killing by activated TH cells
((Rathmell et al. 1995); and Section 1.4.4). CD95-induced apoptosis can be
prevented by antigen engagement (Rothstein et al. 1995) but not TH cell-derived
signals such as CD40L (Garrone et al. 1995; Schattner et al. 1995) thereby
providing a mechanism for the elimination of low affinity GC B cells that are less
able to compete for antigen. Conversely lpr/lpr mice with defective CD95 signalling
(Watanabe-Fukunaga et al. 1992) accumulate memory B cells that are heavily
mutated but do not carry the canonical Trp33/Gly99 substitutions of VH186.2
responsible for increasing the affinity of the anti-NP response by 10- to 100-fold
(Takahashi et al. 2001). Indeed, Shlomchik and colleagues have shown that when
SHM occurs outside GCs in the bridging channels in autoimmune-prone MRL/lpr
Table 1.3. Selected genetic lesions that affect normal GC structure and function in the mouse.
ReferencesProposed mechanismModel Outcome
Matsumoto, 1996Lack FDCsLtα−/− Absent GCs
Pasparakis, 1996Lack FDCsTnf−/− Absent GCs
Xu, 1994Defective T cell helpCd40l−/− Absent GCs
Ferguson, 1996Defective T cell helpCd28−/− Impaired GC formation
Muramatsu, 2000Defective CSR and SHMAid−/− Enlarged GCs
Borriello, 1997Defective T cell helpCd80−/−Cd86−/− Absent GCs
Dong, 2001
McAdam, 2001
Tafuri, 2001
Defective T cell helpIcos−/− Absent GCs
Takhashi, 2001Defective CD95-mediated killinglpr/lpr Impaired negative selection
Dent, 1997
Fukuda, 1997
Loss of Blimp-1 repressionBcl6−/− Absent GCs
Kuwahara, 2004Defective B cell proliferation in
response to anti-CD40
Ganp−/− Delayed GC formation
Impaired SHM
Matsumoto, 1996Lack FDCsTnfr1−/− Absent GCs
Molina, 1996
Ahearn, 1996
Failure to trap antigen on FDCsCr2−/− Poor memory response
Qin, 2000Failure to trap antigen on FDCsFcγrIIb−/− Poor memory response
Smith, 2000Defective centrocyte apoptosisBcl2 Tg Impaired negative selection
Crotty, 2003Defective T cell helpSap−/− Absent GCs
Allen, 2004Loss of dark/light zone polarisationCxcr4−/− Absent GCs
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mice this safeguard is bypassed and self-tolerance breaks down (William et al.
2002).
In addition to the above, several other genes have been shown to be
indispensable for normal GC structure and function (Table 1.3). The gene bcl6
encodes a ubiquitous transcriptional repressor that is highly expressed in GC B
and T cells but not plasma cells (PCs) (Cattoretti et al. 1995; Onizuka et al. 1995).
B cells deficient for Bcl6 cannot participate in the GC reaction (Dent et al. 1997;
Fukuda et al. 1997; Ye et al. 1997) nor undergo SHM (Toyama et al. 2002). One
target of Bcl6 is the B lymphocyte-induced maturation protein (Blimp-1) encoded
by prdm1, and it is likely that Bcl6 sustains the GC reaction by repression of Blimp-
1-induced terminal B cell differentiation (Shaffer et al. 2000; Tunyaplin et al. 2004).
Centrocytes also selectively express the GC-associated nuclear protein (GANP)
that is induced following stimulation with anti-µ and anti-CD40 (Kuwahara et al.
2000). GANP contains an RNA primase domain and MCM3-binding region, which
implicates it in the "licensing" of DNA replication. Consistent with this, GANP-
deficient B cells have impaired proliferative responses to anti-CD40 stimulation
and are associated with delayed GC formation as well as defective SHM
(Kuwahara et al. 2004).
1.5.5. Ig secretion by PCs in the EPF and BM
PCs are found in the red pulp of the spleen and medullary cords of lymph
nodes shortly after immunisation whereas they appear in the BM much later in the
TD response (Benner et al. 1981). The lifespan of PCs present in peripheral
lymphoid tissues is considerably shorter than those in the BM (Ho et al. 1986;
Manz et al. 1997). Thus short-lived PCs found in EPF have predominantly
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Figure 1.9. Transcriptional control of terminal B cell differentiation. In naïve B cells, Pax5 is
needed to maintain expression of B cell lineage markers such as CD19, Igα and BLNK and
repress expression of J chain, IgH and XBP-1. GC B cells express c-myc and Bcl6 which
represses prdm1, the gene for Blimp-1. High affinity BCR signals degrade Bcl6 and lifts prdm1
repression in PCs. In turn, this represses Pax5 to allow expression of XBP-1 and other genes
necessary for Ig secretion. Cytokines such as IL-6 and IL-10 can also induce prdm1 expression
via STAT3 and XBP-1 expression directly. In memory B cells, Bcl6 and prdm1 is extinguished
but Pax5 continues to be expressed.
Adapted from (Calame 2003).
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unmutated Ig variable genes (Jacob and Kelsoe 1992) whereas long-lived PCs in
the BM are characterised by the presence of highly mutated Ig variable genes
indicating that they have undergone affinity maturation in GCs (Smith et al. 1997;
Takahashi et al. 1998). Ahmed and colleagues have unequivocally characterised
these long-lived PCs as radioresistant ASCs with a lifespan of more than 1 year, in
contrast to the short-lived PCs that are continuously replenished by memory B
cells activated by persisting antigen (Slifka et al. 1998).
Terminal differentiation into PCs is regulated by a number of transcription
factors (Fig. 1.9; and reviewed in (Lin et al. 2003)). The "master regulator" is
thought to be the transcriptional repressor Blimp-1 encoded by prdm1 (Turner et
al. 1994). BCR signalling results in MAPK-dependent phosphorylation,
ubiquitination and proteasomal degradation of Bcl6 (Niu et al. 1998). As a result
Bcl6-dependent repression of Blimp-1 is relieved as the GC reaction proceeds and
high affinity mutants are generated. In turn, Blimp-1 represses c-myc (Lin et al.
1997) and has also been proposed to repress Pax5 (Lin et al. 2003). Repression
of c-myc allows PCs to exit the cell cycle and promotes their resistance to
apoptosis. Pax5 is required to maintain B cell lineage identity (Section 1.2.2) and
block Ig secretion by repression of J chain, IgH and X box binding protein-1 (XBP-
1) (Lin et al. 2002). XBP-1 itself is indispensable for the terminal differentiation of B
cells into PCs (Reimold et al. 2001). It belongs to a family of unfolded protein
response (UPR) transcription factors that protect the cell from the stress of
misfolded proteins (such as Igs) in the endoplasmic reticulum (Iwakoshi et al.
2003; Shaffer et al. 2004). XBP-1 acts downstream of Blimp-1 (Shaffer et al. 2004)
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and is induced by signals involved in PC differentiation such as CD40L plus IL-4
and LPS (Iwakoshi et al. 2003).
1.5.6. Chemokine requirements for TD antibody responses
It is apparent from the above that the immune response demands the co-
ordinated trafficking of lymphocytes between distinct anatomical compartments
(Figs. 1.7 and 1.8). Extensive work from the Cyster laboratory has shown that
migration of B cells is dependent on the balance in responsiveness to chemokines
expressed in the primary B cell follicle (CXCL13), T cell area (ELC or CCL19, SLC
or CCL21) and red pulp/BM (SDF-1 or CXCL12) (reviewed in (Cyster et al. 2002)).
In particular, antigen engagement causes B cells to migrate from the follicle to the
T-B border in response to upregulated expression of CCR7 and increased
responsiveness to CCL19 and CCL21 (Reif et al. 2002; Ekland et al. 2004).
Interestingly chronic BCR stimulation of anergic B cells also results in their
migration to the T-B border. However, unlike naïve B cells, anergic B cells are
arrested at the outer PALS and fail to migrate into the inner follicle to establish
GCs (Section 1.4.2). The exclusion of anergic B cells from the follicle is thought to
occur because they are less responsive to CXCL13 due to their lower expression
of CXCR5 (Seo et al. 2002; Ekland et al. 2004). After receipt of T cell help
activated B cells migrate into the inner follicle where they form GCs (Jacob et al.
1991a; Liu et al. 1991). Hence, GC B cells express lower levels of CCR7 and
slightly higher levels of CXCR5 than naïve B cells (Allen et al. 2004). Remarkably,
centrocytes can be distinguished from centroblasts on the basis of higher
expression of CXCR4 on the latter cell population (Allen et al. 2004). CXCL12, the
ligand for CXCR4, is expressed in the dark zone and polarisation of GCs into dark
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and light zones is abolished in cxcr4-/- mice (Allen et al. 2004). Once formed,
terminally differentiated PCs acquire the ability to leave the white pulp as a result
of downregulation of CXCR5 and CCR7 whence they migrate to the red pulp and
BM in response to upregulation of CXCR4 (Hargreaves et al. 2001).
1.5.7. Functional heterogeneity in peripheral B cell subsets
Functional heterogeneity in the responses of peripheral B cell subsets was
first described in the 1980s in the pioneering studies of the rat spleen by
MacLennan and colleagues (Kumararatne et al. 1981; Kumararatne and
MacLennan 1981; Gray et al. 1985; Lane et al. 1986). They defined the surface
phenotype of non-recirculating naïve B cells that resided in the rat MZ as IgMhi
CD21/35hi B cells (Kumararatne et al. 1981; Kumararatne and MacLennan 1981;
Gray et al. 1985) and showed that they were responsible for the bulk of the
antibody response to the TI-2 antigen 2,4-dinitrophenylated hydroxyethyl starch
(Gray et al. 1985; Lane et al. 1986). In contrast, these MZ B cells did not
contribute significantly to the antibody response to the same hapten NP when it
was conjugated to haemocyanin as a TD antigen (Lane et al. 1986). This scenario
were extended 15 years later by the observation that Pyk2-deficient mice that lack
MZ B cells failed to mount effective TI-2 responses (Guinamard et al. 2000).
Kearney's group subsequently showed that anti-phosphorylcholine B cells
enriched in the MZ of M167 Ig-Tg mice rapidly proliferated and differentiated into
plasmablasts in EPF when challenged with TI-2 antigen (Martin et al. 2001). The
splenic MZ is separated from the primary follicle by the marginal sinus (reviewed in
(Kraal 1992)). The latter is lined by a discontinuous endothelial cell layer, which
allows blood to be directly filtered through the MZ. Thus B cells residing there are
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ideally situated to monitor for the presence of blood-borne pathogens enriched
with TI-2 antigens. It is therefore not surprising that, in addition to naïve B cells,
somatically mutated memory B cells have also been found in the MZ of rats (Liu et
al. 1988; Liu et al. 1991) and humans (Dunn-Walters et al. 1995; Tangye et al.
1998).
The in vitro responses of Fo and MZ B cells to polyclonal stimulation have
been extensively studied in the Kearney laboratory in order to explain the
compartmentalisation of TI-2 responses to the MZ. Thus, MZ B cells have been
shown to proliferate more rapidly and generate ASCs more efficiently than Fo B
cells in response to polyclonal activation with anti-IgM, anti-CD40 plus IL-4, and
LPS (Oliver et al. 1997; Oliver et al. 1999). Further studies revealed that the more
sustained calcium flux of MZ compared to Fo B cells in response to anti-IgM cross-
linking was not due to intrinsic differences in BCR signalling but rather contingent
to their higher levels of IgM (Li et al. 2001). Interestingly, the cells used in the first
in vitro comparison of Fo and MZ B cell responses were purified on the basis of
staining for IgM (and CD23) and this almost certainly would have induced
occupancy and downregulation of the BCR (Snapper et al. 1993). Consequently,
no significant difference was detected in proliferation of Fo versus MZ B cells
following stimulation with unconjugated and dextran- or Sepharose-conjugated
anti-IgM and anti-IgD antibodies (to simulate a TI-2 antigen).
Kearney's group also demonstrated higher levels of expression of class II
MHC and the co-stimulatory molecules CD80 and CD86 on MZ compared to Fo B
cells (Oliver et al. 1999). As a result, following activation in vitro (Oliver et al. 1999)
or in vivo (Attanavanich and Kearney 2004) MZ B cells were more effective than
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Fo B cells in stimulating thymidine uptake and cytokine secretion by naïve CD4+ T
cells. However, these in vitro results only translated into a modest 2- to 3-fold
increase in T cell expansion in vivo (Attanavanich and Kearney 2004).
Nevertheless, these data do suggest that MZ B cells are not only specialised for
TI-2 responses but may also be able to bridge the gap between the innate and
adaptive immune system (Martin and Kearney 2000; Martin and Kearney 2002).
Indeed, MZ B cells can respond to protein as well as polysaccharide antigens
(MacLennan and Liu 1991). Moreover, MZ B cells express high levels of CD1d
(Amano et al. 1998; Makowska et al. 1999) and theoretically could also promote
the early recruitment of CD1d-restricted NKT cells that rapidly secrete IL-4 and IL-
13 (Schofield et al. 1999; Akbari et al. 2003) in the TD immune response.
To investigate the relative ability of MZ B cells to mount TD responses in
vivo, a recent study was performed in which purified Fo or MZ B cells were
challenged with the hapten NP coupled to chicken gamma globulin (NP-CGG)
following transfer into lymphocyte-deficient scid/scid mice (Song and Cerny 2003).
In this system, MZ B cells were the major source of primary ASCs, formed GCs
albeit with delayed kinetics, underwent SHM and generated memory B cells. In
normal TD responses, however, responding cells are required to navigate the
secondary lymphoid tissues following highly regulated chemotactic cues in order to
establish effective T-B cell collaboration and subsequent GC formation (Section
1.4.4). Since scid/scid mice lack normal secondary lymphoid structure and the
normal excess of non-responding lymphocytes, the relative efficiency of Fo and
MZ B cells in mounting TD responses within an intact immune system remains to
be determined (Chapter 5).
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1.6. Project outline
The aims of this project are to characterise a new line of Ig-gene targeted
mice (designated SWHEL mice) and to develop a new model to study B cell self-
tolerance and B cell activation in vivo. SWHEL B cells carry the anti-HEL specificity
encoded by the HyHEL-10 Ig heavy and light chains. The SWHEL model therefore
takes advantage of the large body of literature accumulated over the last 15 years
using the classical anti-HEL Ig-Tg model and at the same time has the potential to
extend our understanding of B cell biology. For example, the ability of SWHEL B
cells to undergo CSR and SHM mandates a re-examination of the self-tolerance
mechanisms that were originally described in the anti-HEL double Tg model. In
particular, the physiological basis of follicular exclusion remains to be clarified.
Moreover, a detailed study of the regulation of CSR by peripheral self-reactive B
cells has yet to be performed. Finally, the availability of a large cohort of HEL-
specific B cells that can be easily tracked in vivo makes it possible to follow the
critical events in B cell activation such as CSR and SHM during the course of the
response. The SWHEL model therefore provides an opportunity, amongst other
things, to compare the in vivo TD responses of Fo and MZ B cells within an intact
immune system.
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Figure 2.1. The antigen binding site for HEL on the HyHEL-10 mAb. (A) Space filling model of
HEL in blue with the atoms in contact with the the HyHEL-10 mAb in green. (B) Cartoon model
depicting the crystal structure of the HEL-HyHEL-10 antigen-antibody complex. HEL ((rotated
90°) is shown in blue, the HyHEL-10 heavy chain in dark red and the HyHEL-10 light chain in
light red. HEL atoms in contact with HyHEL-10 are shown in green. HyHEL-10 atoms in contact
with HEL are shown in yellow. (C) The table to the right lists the amino acid residues in the
HyHEL-10 heavy chain in direct contact with the corresponding residue on HEL. Models were
made using RasMac v2.6.
Based on (Padlan et al. 1989).
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2.1. Mice
2.1.1. HEL and anti-HEL Ig-Tg mice
Unless otherwise indicated all Tg and gene-targeted mice were
maintained on a pure inbred C57BL/6 background at the Centenary Institute
Animal Facility. The high affinity HyHEL-10 anti-HEL mAb is encoded by the
somatically mutated VH36-60DJH3 heavy chain (VH10) and Vκ23Jκ2 light chain (Vκ10-
κ) variable region genes (Smith-Gill et al. 1982). The crystal structure for HEL-
HyHEL-10 antigen-antibody complex has been solved (Padlan et al. 1989) and
this, together with the contact residues on HEL for HyHEL-10 is shown in Fig.
2.1. HyHEL-10 has a Ka of 4.5 × 1010 M-1 (Lavoie et al. 1992). In MD4 Ig-Tg
mice separate VH10-µδ heavy chain and Vκ10-κ light chain transgenes encoding
anti-HEL IgM and IgD antibodies are co-integrated into the genome (Goodnow
et al. 1988). MD2 Ig-Tg mice carry only the VH10-µδ heavy chain transgene
(Hartley and Goodnow 1994) and LC2 Ig-Tg mice (produced by DNX Inc.) carry
only the Vκ10-κ light chain light chain transgene.
KLK3 Tg mice express mHEL under the H-2Kb promoter (Hartley et al.
1991). ML5 Tg mice express sHEL under the control of the mouse
metallothionein-1 promoter (Goodnow et al. 1988), whilst AL3 Tg mice express
sHEL from the mouse albumin promoter (Adelstein et al. 1991). ML5 mice
secrete intermediate levels (10-20 ng/mL) of sHEL (Goodnow et al. 1988). Male
and female AL3 mice secrete high (80 and 160 ng/mL, respectively) levels of
sHEL (Cook et al. 1997). To maximise the differences in sHEL secreted
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Figure 2.2. Generation of SWHEL mice by Dr. Robert Brink. (A) Endogenous IgH locus showing
the position of the upper (U) screening primer in JH3 and lower (L) screening primer downstream
of the intronic enhancer (EH). (B) Targeting construct indicating the 5' and 3' homology arms and
the inverted loxP-neor-loxP cassette and VH10 gene replacing DQ52 and all four JH segments in
the endogenous IgH locus. (C) Targeted IgH locus (VH10tar) after homologous recombination.
Due to deletion of JH4, amplification of the targeted locus results in a shorter PCR product than
that from the endogenous heavy chain gene (1.8 vs. 2.3 kb). (D) PCR screening of DNA from
G418-resistant ES cell clones obtained after transfection with the targeting construct. A single
homologous recombinant heterozygote is indicated by the asterisk. (E) PCR screening of DNA
from mice derived from homologous recombinant ES cells. Heterozygous (VH10tar+/-) mice were
mated and DNA from peripheral blood leucocytes of the resulting litter was PCR amplified with
the primers described above.
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between the ML5 and AL3 lines only female MD4 × AL3 mice and BM chimeras
produced using female AL3 recipients were analysed.
2.1.2. SWHEL Ig-Tg mice
Gene-targeted VH10tar mice were produced and maintained on a C57BL/6
background by Dr. Robert Brink at the Centenary Institute and described in
detail in (Phan et al. 2003). The targeting construct and the position of the
primers used for the polymerase chain reaction (PCR) to screen for the
presence of the targeted allele are shown in Fig. 2.2. VH10tar mice carrying the
neomycin resistance (neor) cassette flanked by inverted loxP sites were crossed
with LC2 Tg mice to create the SWHEL (VH10tar+/- × LC2) mice that were used for
the initial phenotypic characterisations described in Chapter 3 and 4.
Subsequently, the neor cassette upstream of the VH10 exon was deleted from
the SWHEL germline by crossing with Zp3-cre Tg mice (Lewandoski et al. 1997)
(Jackson Laboratories, Bar Harbour). SWHEL mice in which the neor cassette
had been deleted were used for the experiments described in Chapter 5.
2.1.3. Wild type and other gene-targeted mice
Wild type (WT) BALB/c (IgHa allotype), BALB/c-nu (athymic), C57BL/6
(CD45.2+) and congenic C57BL/6-SJL.Ptpca (CD45.1+) mice were purchased
from the Animal Resources Centre (Canning Vale, Western Australia). cd40-/-
mice on C57BL/6 background (Kawabe et al. 1994) were purchased from
Jackson Laboratories. il-4-/- mice on C57BL/6 background (Kuhn et al. 1991)
were a kind gift of Dr. Barbara Fazekas de St. Groth (Centenary Institute,
Sydney).
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Table 2.1. Reagents and mAb’s used for FACS®, ELISA and ELISPOT.
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Mutant mice were either phenotyped by fluorescence activated cell
sorting (FACS®) by Michelle Amesbury (MD4, MD2 × LC2, and CD40-/- lines) or
genotyped by PCR amplification of DNA isolated from peripheral blood
leucocytes by Sandra Gardam, Tyani Chan and Chris Brownlee (VH10tar, LC2,
ML5, AL3 and KLK3 lines).
2.1.4. F1 crosses for analysis of Ig heavy chain allotype expression
SWHEL mice were generated on a C57BL/6 background and therefore
express the IgHb allotype. BALB/c mice were crossed with C57BL/6 and SWHEL
mice and the F1 progeny analysed by FACS®  for Ig heavy chain allotype
expression by HEL-binding (HEL+) and non-HEL-binding (HEL-) B cells.
2.1.5. Generation of irradiation BM chimeras
To generate BM chimeras, 10-16 weeks-old recipient mice were lethally
irradiated with 950 rads of γ-rays using a Gammacell® 40 Exactor Caesium137
irradiator (Nordion International Inc.). BM cells were harvested from the long
bones (tibias and femurs) of donor mice and resuspended in 10FR medium
(see Section 2.2.1) at a concentration of 108 cells/mL. 2 × 107 BM cells in 200
µL of medium were injected via the lateral tail vein 6-8 hours later to rescue the
irradiated recipients. To generate mixed BM chimeras, the recipient mice
(C57BL/6, ML5 or AL3) were reconstituted with a mixture of BM from C57BL/6,
SWHEL and MD4 mice in a ratio of 2:23:75, respectively. Chimeras were
sacrificed after 2-3 months and serum samples collected for measurement of
serum anti-HEL Igs by enzyme-linked immunosorbent assay (ELISA) and
splenocytes analysed by FACS® analysis and histology.
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2.2. In vitro studies
2.2.1. Medium and buffers for in vitro studies
10FR
RPMI 1640 (Life Technologies) 900 mL
Foetal Calf Serum (FCS) (Life Technologies) 100 mL
Hepes pH 7.4 (Sigma) 10 mM
60 µg/mL Penicillin + 100 µg/mL Streptomycin (Sigma) 1 mL
L-glutamine (Sigma) 2 mM
2-β-mercapto-ethanol (2-ME) (Sigma) 2 mM
ACK red cell lysis buffer
Potassium bicarbonate, KHCO3 (Sigma) 10 mM
Ammonium chloride, NH4Cl (Sigma) 150 mM
Ethylene diamine tetra-acetic acid (EDTA) (Sigma) 0.1 mM
pH 7.3
B cell medium (BCM)
10FR 1 000 mL
Sodium pyruvate (Sigma) 1 mM
Non-essential amino acids (Sigma) 0.1 mM
Cytotoxicity medium (CTM)
RPMI 1640 1 000 mL
1M Hepes pH 7.4 10 mL
Bovine Serum Albumin (BSA) (ICN Biomedicals Inc.) 3 g
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NPP buffer
Triple distilled water  (TDW) 1 L
Sodium bicarbonate, NaHCO3 2.93 g
Sodium carbonate, NaCO3 1.59 g
Sodium azide 0.2 g
Magnesium chloride, MgCl2 0.095 g
2.2.2. B cell purification
Small dense naïve splenic B cells were purified for in vitro stimulation as
described (Hodgkin and Kehry 1996). All live cell counts were done on a
Neubauer haemocytometer (Hirschmann Em Techolor) using Trypan blue
exclusion. Spleens were harvested in 10 mL 10FR and single cell suspensions
prepared by passage through a 70 µm Nylon cell strainer (BD Biosciences).
Splenocytes were washed in 10FR by centrifugation at 1 500 rpm at 4°C for 5
minutes in a Megafuge 2.0R centrifuge (Heraeus Sepatech GmbH). The cells
were resuspended in 5 mL ACK red cell lysis buffer and allowed to stand at
room temperature for 5 minutes to lyse red blood cells (RBCs). 2 mL FCS was
gently underlaid and the intact cells pelleted by centrifugation. Splenocytes
were then washed in 10FR, resuspended in 10 mL RPMI 1640 medium
containing 2% FCS and incubated for 30 minutes at 37°C on a plastic tissue
culture dish to deplete adherent cells (monocytes, macrophages and
neutrophils). Non-adherent cells were then washed and resuspended at a
concentration of 107 cells/mL in CTM. T cells were opsonised by incubation for
30 minutes on ice with anti-CD4- (RL172), anti-CD8- (31M) and anti-Thy1- (30-
H12) specific hybridoma supernatants. Unbound antibodies were removed by
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washing in CTM and the T cells lysed by incubation for 30 minutes in a 37°C
water bath with 20 mg of sterile Cedarlane Low-tox® Guinea Pig Complement
(Cedarlane Laboratories Ltd.) in 5 mL CTM. The remaining cells were washed
in 10 mL BCM, resuspended at a concentration of 107 cells/mL and 2-4 mL
loaded on to an ice-cold Percoll (Amersham Biosciences) density gradient
column containing 2 mL layers of 80%, 65% and 50% Percoll in PBS. The
column was centrifuged at 4°C for 25 minutes at 2 500 rpm with no brake to
separate dead cells and low density debris (at the top of the column), large
activated and MZ B cells (at the 50/65% density interface), small dense naïve
Fo and immature B cells (at the 65/80% density interface) and residual RBCs
(at the bottom of the column). Small dense naïve B cells were then recovered
and washed with BCM.
For FACS® analysis, B cells were isolated as above except that T cells
were depleted by immunomagnetic bead separation using anti-Thy1.2
Dynabeads® (Dynal Biotech) instead of complement-mediated T cell lysis. 108
Dynabeads® were resuspended in 10 mL PBS/10% FCS, concentrated on a
Dynal MPC® magnetic particle concentrator (Dynal® Biotech) for 2 minutes and
the supernatant poured off. Splenocytes were washed and 4 × 107 cells
resuspended in 10 mL PBS/10% FCS and added to 108 concentrated anti-
Thy1.2 Dynabeads® to give an expected bead:T cell ratio of 10:1 (assuming
that 25% of the splenocytes are T cells). The cells and beads were thoroughly
mixed by inverting the tube and incubated on ice for 30 minutes on a STR6
rocking platform (Bibby Sterilin Ltd). T cells bound to the anti-Thy1.2
Dynabeads® were depleted by attachment to a Dynal MPC® for 2 minutes and
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the unbound cells decanted into a plastic tube. This step was repeated twice
and consistently yielded B cells with >95% purity as determined by FACS®
analysis.
2.2.3. CFSE labelling
Isolated cells were labelled with the intracellular and membrane dye
CFSE (Molecular Probes) according to the method described by Lyons and
Parish (Lyons and Parish 1994). CFSE was prepared and stored at -70°C in 10
µL aliquots of 5 mM CFSE in dimethyl sulfoxide (DMSO). The aliquots were
thawed and resuspended in 10 mL PBS/0.1% BSA immediately before use.
Cells were washed in PBS/0.1% BSA and thoroughly resuspended in 5 µM
CFSE in PBS/0.1% BSA at 107 cells/mL. The tube was incubated for 10 minutes
in a 37°C water bath and vortexed for 10 seconds every 2 minutes.
Unincorporated CFSE was quenched by addition of 10 mL ice-cold BCM.
CFSE-labelled cells were then washed twice in BCM.
2.2.4. In vitro B cell stimulation
Purified small dense naïve B cells were CFSE-labelled as above and
cultured for 3-5 days at 37°C in vitro to examine their ability to proliferate,
isotype switch and secrete antibodies. To simulate T cell-derived signals 105
cells were cultured in 1 mL BCM in 24-well MULTIWELL™ tissue culture plates
(Becton Dickinson Labware) and activated with either 5 µg/mL of agonistic anti-
CD40 mAb (HM40-3, BD Biosciences) or CD40L prepared from Sf9 insect cell
line transfected with a baculovirus vector containing CD40L (kindly provided by
Dr. Marilyn Kehry, Boehringer Ingelheim) plus 10 ng/mL recombinant murine IL-
4 (Sigma-Aldrich). To simulate T-independent signals 105 cells were cultured in
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1 mL BCM and activated with 2.5 µg/mL of LPS (Sigma-Aldrich). Culture
supernatant was collected to measure anti-HEL Igs by ELISA and cells were
harvested for FACS® analysis. Before harvesting, 105 CaliBRITE™ beads (BD
Biosciences) were added to each well. These beads have low forward light
scatter (FSC) and high side light scatter (SSC) allowing them to be easily
distinguished from live cells and dead cell debris on the FACSCalibur™. The
ratio of CaliBRITE™ beads to live cells can therefore be used to determine the
original number of cells in each well. The ability of B cells to respond to antigen
engagement was tested by culturing 106 freshly isolated splenocytes overnight
at 37°C in 1 mL BCM with or without 500 ng of filter-sterilised HEL (Sigma).
2.2.5. ELISA and ELISPOT assays
The amount of anti-HEL Ig in sera from various immunised and
unimmunised mice and in the culture supernatant of in vitro B cell cultures were
measured by indirect ELISA based on the method described (Goodnow et al.
1988). 96-well polystyrene Maxisorp™ plates (Nunc) were coated overnight at
4°C with 60 µL of NPP buffer containing HEL at 10 µg/mL. Plates were washed
3 × with 300 µL 0.05% Tween 20/PBS in a M96V microplate washer (Titertek
Plus) and blocked with 100 µL of either 1% BSA/PBS or 5% skim milk
powder/PBS for 1 hour at 37°C. Serial 2-fold dilutions of sera or culture
supernatants in 50 µL 0.1% BSA/PBS were added in duplicate to the wells
together with the appropriate Ig isotype standards and incubated for 1 hour at
37°C. Standards expressing the HyHEL-10 specificity in association with each
Ig heavy chain isotype were produced by Sandra Gardam and have been
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described elsewhere (Phan et al. 2003). Bound antibody was detected with
isotype specific mAb in 50 µL 0.1% BSA/1% skim milk powder/PBS.
Streptavidin-alkaline phosphatase (SA-AP)  (Roche Diagnostics) in 50 µL 0.1%
BSA/PBS was added and visualised with 1 mg/mL of substrate p-nitrophenyl
phosphate (ICN Biomedicals Inc.) in 100 µL NPP buffer. The absorbance at 405
nm was read on a Multiskan® MCC/340 microplate reader (Fisher Scientific
Thermo Labsystems). A standard curve was constructed and the concentration
of serum anti-HEL Ig determined from the absorbance of dilutions that fell within
the dynamic range of the curve.
Enzyme-linked immunosorbent spot assay (ELISPOT) for the detection
of anti-HEL ASCs was based on the method described (Sedgwick and Holt
1986). 96-well MultiScreen™ filter separation plates containing mixed cellulose
ester membranes (Millipore®) were coated overnight at 4°C with 1 µg/mL HEL
in 100 µL NPP buffer or NPP buffer alone (background control). Plates were
washed in PBS ×  3 and blocked for 1 hour at 37°C with 5% skim milk
powder/PBS. Cells were then serially diluted across the plate in 100 µL BCM
and incubated at 37°C for 6-8 hours. Plates were washed with PBS × 3 and with
0.05% Tween 20/PBS × 3 and blocked with 1% BSA/0.05% Tween 20/PBS for
1 hour at 37°C before overnight incubation at 4°C with biotinylated anti-IgG1
mAb in 100 µL 0.1% BSA/0.05% Tween 20/PBS. Plates were washed with
0.05% Tween/PBS and bound mAb revealed by SA-AP. Positive ELISPOTs
were visualised with 5-bromo-4-chloro-3-imidolyl phosphate/nitroblue
tetrazolium (Sigma) and counted by indirect light microscopy.
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2.3. FACS® analysis and sorting
2.3.1. Reagents for FACS® analysis and sorting
All wash and staining steps for FACS® analysis were carried out in PBA
(PBS/1% BSA/0.01% azide) unless live cell FACS® sorting was required in
which case they were carried out in PBS/10% FCS. The non-competing binding
sites of the HyHEL-5, -9 and -10 hybridoma supernatants used to detect HEL-
specific BCRs have been well-characterised (Lavoie et al. 1989). Purified HEL,
HyHEL-5 and -9 mAbs were labelled with the fluorochrome Alexa Fluor® 647
(Molecular Probes) according to the manufacturer's instructions. To achieve
this, 1/10 volume of 1 M sodium bicarbonate was added to 1 mg/mL of protein
to be labelled in PBS (azide-free). 100 µL of the mixture was then added to the
reactive dye, mixed gently by inversion and allowed to stand at room
temperature for 1 hour, with mixing every 15 minutes. The completed reaction
mix was loaded drop-wise on to a spin column containing 30 kDa size-exclusion
resin and centrifuged at 4°C for 5 minutes at 2 300 rpm. Alexa Fluor® 647-
labelled protein was then stored in the dark at 4°C until use. Fc-fusion proteins
used to detect surface expression of chemokine receptors are described in
Section 2.5.5. All reagents and mAbs used for FACS® analysis are listed in
Table 2.1.
2.3.2. Method for surface and intracellular staining
Cell surface staining was performed in 96-well round bottom plates
(Greiner). Single cell suspensions of harvested spleen and BM cells were made
by passage through a 70 µm cell strainer (BD Biosciences) or repeated
Chapter 2. Materials and Methods
52
aspiration through a 25G hypodermic syringe (Terumo®), respectively. 106 cells
were stained per well in 50 µL PBA containing the relevant mAb at a pre-
determined optimal dilution. All mAbs and reagents were diluted in PBA and
microcentrifuged at 4°C for 15 minutes at maximum speed (15 000 rpm) in a
Sigma 1-15K refrigerated microcentrifuge (Sigma Laborzentrifugen GmbH)
before use to remove large molecular weight (MW) aggregates. Mouse Fc
receptors were blocked by incubation with anti-CD16/32 for 30 minutes on ice
before staining with mAbs. Staining was performed on ice in the dark for 30
minutes with frequent mixing by gentle tapping of the plate. Cells were washed
in 200 µL PBA × 3 between each staining step. HEL-specific BCRs were
detected by HEL directly conjugated to fluorescein isothiocyanate (FITC) or
Alexa Fluor® 647, or by a sandwich of HEL plus either HyHEL-5- or HyHEL-9-
biotin, -FITC or -Alexa Fluor®  647. IgG1-switched anti-HEL BCRs were
detected by anti-mouse IgG1-biotin or -phycoerythrin (-PE) mAb followed by
blocking with 10% normal mouse serum diluted in PBA (obtained by
venesection of WT C57BL/6 mice) before detection of HEL-binding. This was
required because the HyHEL-5, -9 (and -10) mAbs are BALB/c IgG1 isotype
and would otherwise be bound by the captured anti-mouse IgG1 mAbs.
Blocking with 10% normal mouse serum was also required following detection
of Fc-fusion proteins by anti-mouse IgG2a-biotin because the anti-CD45.2 mAb
used to detect donor-derived B cells was a mouse IgG2a isotype. In addition,
staining with the streptavidin (SA) conjugate was always left to the last step to
avoid non-specific binding to HEL. Stained cells were transferred to 1 mL
Titretube microtubes (Bio-Rad) for data acquisition.
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Intracellular staining was performed in 6 mL polystyrene round bottom
FACS® tubes (Becton Dickinson Labware). 107 cells were washed in PBA and
the cell pellet vortexed and fixed by drop-wise addition of 1 mL 2%
paraformaldehyde in PBS while vortexing. After 30 minutes incubation in the
dark at room temperature, the cells were permeabilised overnight at 4°C by the
addition of 1 mL PBS/0.2% Tween 20/0.2% azide. The next day the cells were
washed in PBA and 106 cells transferred to new FACS® tubes for staining to
avoid residual detergent. Staining was performed in 100 µL PBA containing the
relevant mAb (usually anti-Ig isotype) at the optimal dilution. In some cases the
cells were first surface stained before fixation to avoid denaturation of the
epitopes recognised by the mAbs (e.g. anti-syndecan-1 mAb) and also to avoid
denaturation of the fluorochromes (e.g. some PE- and APC-conjugated mAbs).
All FACS® analysis was performed with single colour compensation controls.
2.3.3. Measurement of BCR occupancy
BCR occupancy by self-antigen in double-Tg mice was measured
according to the method described (Mason et al. 1992). This method detects
endogenous sHEL bound by self-reactive BCR in vivo. Splenocytes from mice
of various genotypes were surface stained with anti-B220-PerCp and anti-HEL-
FITC (HyHEL-5) with and without prior incubation with 200 ng/mL HEL. To
calculate BCR occupancy by HEL, the geometric mean fluorescence intensity
(m.f.i.) of staining by C57BL/6 B cells was used as background control. Thus,
BCR occupancy by HEL = (m.f.i. of HEL+ B cells without exogenous HEL - m.f.i.
of C57BL/6 B cells) ÷ (m.f.i. of HEL+ B cells with exogenous HEL - m.f.i. of
C57BL/6 B cells). To avoid contamination by aerosolised HEL, staining for BCR
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occupancy was performed in a separate area of the laboratory with fresh HEL-
free PBA and ART® Self-Sealing Barrier Tips (Stratagene).
2.3.4. Data acquisition and analysis
Data from stained cells was acquired on a FACSCalibur™ dual laser flow
cytometer (BD Biosciences) and analysed with either CELLQuest™  (BD
Biosciences) or FlowJo™ software (Tree Star Inc.). The FACSCalibur™ uses a
488 nm Argon-ion laser to excite the fluorochromes in FL1 (FITC), FL2 (PE) and
FL3 (PerCp, PE-Cy5 or propidium iodide, PI) and a 635 nm Helium-Neon laser
to excite FL4 (allophycocyanin, APC or Alexa Fluor® 647). Data files typically
contained 105 live events (according to FSC and SSC) for the phenotypic
analyses described in Chapter 3 and 4, and 1-20 × 106 live events for the
adoptive transfer experiments described in Chapter 5. For the latter, FL3 was
used as an empty "dump" channel and multiple data files of the same sample
were concatenated to generate a data meta-file with enough gated events for
meaningful analysis.
Cell proliferation was tracked by the serial 2-fold dilution of CFSE with
each cell division as described (Lyons and Parish 1994). Single-colour
compensation controls included CFSE-labelled B cells that were cultured with
IL-4 alone (for in vitro experiments in Chapter 4) or CFSE-labelled B cells that
were co-transferred with mock-conjugated sheep RBC (SRBC) (for in vivo
experiments in Chapter 5). These controls were also used to establish the
position and width of the undivided cells in division 0. Gates were drawn around
each CFSE division peak and back gating ("division slicing") used to determine
the proportion of cells that had undergone isotype switching per division.
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2.3.5. FACS® sorting
Individual cell populations were purified for analysis of VH10 gene
expression (Chapter 3) and antigen-induced hypermutation (Chapter 5) and for
ELISPOTs and adoptive cell transfer experiments (Chapter 5) with the
assistance of Joseph Webster and Tara McDonald in the Centenary Institute
FACS® Facility. HEL+ and HEL- SWHEL B cells were electronically sorted on a
modified FACStarPLUS™ dual laser flow cytometer (BD Biosciences) for analysis
of VH gene expression. The FACStarPLUS™ uses an Argon laser tuned to 488 nm
to excite FL1 (FITC), FL2 (PE) and FL3 (PerCp or PI) and a Rhodamine 6G dye
laser tuned to 635 nm to excite FL4 (Texas Red®) and FL5 (APC or Alexa
Fluor® 647). PI was added to the cells just before analysis and sorting.
CD21intCD23hi Fo and CD21hiCD23lo MZ B cells were sorted on a
FACSVantage™ SE (BD Biosciences) 3-colour flow cytometer for adoptive
transfer experiments. The FACSVantage™ SE utilises an Argon laser at 488 nm
(FL1 = FITC, FL2 = PE, FL3 =PerCp, FL4 = PI), a Rhodamine 6G dye laser
tuned to 635 nm (FL5 = APC or Alexa Fluor® 647, FL6 = Texas Red®) and a
UV laser tuned to 350 nm (FL7 = DAPI or Hoechst 33342). These live cell sorts
were performed at low pressure  (16 kPa) to avoid high shear stress,
particularly as the MZ population is more sensitive than Fo population to
apoptosis ex vivo. In addition, responding B cells were sorted after challenge
with TD antigen into CD45.2hi syndecan-1lo and CD45.2lo syndecan-1hi
populations for ELISPOTs, and CD45.2+ HEL+ cells for analysis of the VH10
gene segment on the FACSVantage™ SE.
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2.4. In vivo studies
2.4.1. BrdU labelling and FACS® staining
Incorporation of the thymidine analogue 5-bromodeoxyuridine (BrdU,
Sigma) into newly synthesised DNA was used to determine the half-life of non-
self-reactive  (HEL-) and self-reactive (HEL+) B cells as previously described
(Forster and Rajewsky 1990; Fulcher and Basten 1994; Cyster and Goodnow
1995). BrdU was introduced into the drinking water at a concentration of 0.25
mg/mL with the addition of 1% glucose (Sigma). The water bottles were made
up fresh daily and wrapped in aluminium foil to protect from UV light. After three
days, BrdU-treated and control mice were sacrificed and splenocytes harvested
and 106 cells transferred to FACS® tubes for staining.
BrdU-labelled cells were then detected by intracellular staining using the
BrdU Flow Kit (BD Biosciences) according to the manufacturer's instructions.
106 cells were washed in 1 mL staining buffer, resuspended in 100 µL BD
Cytofix/Cytoperm Buffer and incubated for 30 minutes on ice. Cells were
washed in 1 mL BD Perm/Wash Buffer, resuspended in 100 µL BD Cytoperm
Plus Buffer and incubated for 10 minutes on ice following which the cells were
washed again and re-fixed in 100 µL BD Cytofix/Cytoperm Buffer for 5 minutes
on ice. Cells were then washed and resuspended in 100 µL PBS containing 30
µg DNase. After DNase treatment for 1 hour at 37°C the cells were washed and
stained with 50 µL BD Perm/Wash Buffer containing diluted anti-BrdU-FITC for
20 minutes in the dark at room temperature. Finally, cells were washed and
stained with anti-CD24-PE and HEL plus HyHEL-5-Alexa Fluor® 647 before
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data acquisition on the FACSCalibur™. Mice that had not been fed BrdU were
used as controls for the anti-BrdU-FITC staining.
2.4.2. Conjugation of HEL-SRBC
Fresh SRBCs were purchased from the Institute of Medical and
Veterinary Sciences (Adelaide, South Australia) and conjugated to HEL as
described (Kipp and Miller 1980). 5 mL of SRBC in Alsevers was washed in 50
mL sterile PBS × 3 or until the supernatant was transparent. The 2 mL pellet of
SRBCs was washed in 20 mL 0.35 M mannitol/0.1 M NaCl (conjugation buffer)
and resuspended in 9 mL conjugation buffer. 1 mL conjugation buffer with and
without 1 mg HEL was added to the SRBCs (HEL-SRBC and mock-conjugated
SRBCs, respectively) and incubated for 10 minutes on ice on a rocking
platform. 1 mL of 100 mg/mL 1-ethyl-3-(3-dimethylaminopropyl)carboiimide
hydrochloride (Sigma) was then added to cross-link HEL to SRBCs for 30
minutes on ice on a rocking platform. Once the reaction had been completed,
SRBCs were washed in PBS × 3 or until the supernatant was transparent. HEL-
SRBCs and mock-conjugated SRBCs were counted and resuspended at
109/mL PBS.
Successful conjugation was confirmed by a haemagglutination test. 106
HEL-SRBCs and mock-conjugated SRBCs were transferred to 6 wells in a 96-
well round bottom plate. Serial 2-fold dilutions of a 25 µL cocktail of HyHEL-5
plus HyHEL-9 mAbs starting at 5 µg/mL was added to each well except for the
negative control wells. Bound mAbs were aggregated with 25 µL of 1:20 dilution
of goat anti-mouse IgG (H + L) (Southern Biotechnology). Haemagglutination
typically occurred after 1-2 hours.
SourcePrimary reagent Secondary reagent Source
Table 2.2. Reagents and mAb’s for immunofluorescence microscopy.
School of Veterinary
Sciences, University
of Sydney
Polyclonal rabbit anti-
HEL antisera
Sheep anti-rabbit IgG-FITC Silenus Labs
RA3-6B2 hybridomaRat anti-B220 Goat anti-rat IgG-Texas Red® Caltag Laboratories
RA3-6B2 mAb, BDAnti-B220-biotin SA-FluoroBlue™ Biomeda
MECA-367 mAb, BDRat anti-MadCAM-1 Goat anti-rat IgG-Texas Red® Caltag Laboratories
GK1.5 mAb, BDRat anti-CD4 Goat anti-rat IgG-Texas Red® Caltag Laboratories
SigmaPNA-biotin SA-FluoroBlue™ Biomeda
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2.4.3. Adoptive transfer experiments
An adoptive transfer system was used to study the immune response of
SWHEL B cells to HEL-SRBC. For these experiments 1 or 2 × 104 HEL+ B cells
from SWHEL donors (in 50 µL 10FR) were co-transferred together with 2 or 5 ×
108 HEL-SRBC or mock-conjugated SRBC (in 200 µL PBS) into C57BL/6-
SJL.Ptprca recipients. Homozygous SWHEL mice were also crossed with
C57BL/6-SJL.Ptprca mice to produce CD45.1+ SWHEL B cells, which were then
transferred into (CD45.2+) WT C57BL/6 or i l - 4-/- recipients. In some
experiments, CD45.1+ SWHEL B cells were CFSE labelled before adoptive
transfer into WT C57BL/6 recipients to track cell division. SWHEL mice also were
crossed on to BALB/c background for 6 generations before adoptive transfer
into BALB/c, BALB/c-nu (athymic) and cd1d-/- mice.
2.4.4. Immunofluorescence microscopy
Immunohistology was based on a method previously described (Mason
et al. 1992). Spleens were embedded in Tissue-Tek®  OCT™ compound
(Sakura) and snap frozen in liquid nitrogen. Spleens were stored at -70°C until
needed for sectioning. 5-7 µm sections were cut with a Microm HM 500 cryostat
(Zeiss), transferred to Poly-Prep™  glass slides coated with poly-L-lysine
(Sigma-Aldrich) and air-dried for at least 1 hour. Slides were then fixed for 10
minutes in ice-cold acetone and air-dried for at least 1 hour. Cut sections were
stored at -20°C for subsequent staining.
The mAbs and reagents used for staining tissue sections are listed in
Table 2.2. All staining reactions were carried out in a humidified chamber at
37°C for 1 hour. To visualise the splenic localisation of naïve and self-reactive B
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cells (Chapter 4) HEL-specific BCRs were stained with 200 ng/mL HEL in PBS.
Sections were blocked with 30% normal horse serum (School of Veterinary
Sciences, University of Sydney) before detection with polyclonal rabbit anti-HEL
antisera (School of Veterinary Sciences, University of Sydney) and visualisation
with sheep anti-rabbit IgG-FITC. The marginal sinus was identified by staining
with purified anti-MadCAM-1 rat mAb plus goat anti-rat IgG-Texas Red® .
Sections were then blocked with 1% normal rat serum (Jackson
ImmunoResearch Laboratories) and stained with anti-B220-biotin followed by
SA-FluoroBlue™ to reveal the B cell follicle.
To visualise the migration of B cells to the T-B border after antigen
engagement (Chapter 5) slides were stained as above except that slides were
stained with purified anti-CD4 instead of anti-MadCAM-1 rat mAb to reveal the
T cell-rich PALS. To visualise the entry of B cells into GCs (Chapter 5) slides
were stained for HEL-specific BCRs as above. Sections were then stained with
purified anti-B220 hybridoma supernatant plus goat anti-rat IgG-Texas Red®
followed by biotinylated peanut agglutinin (PNA) plus SA-FluoroBlue™ to detect
GCs.
Fluorescent images were viewed with a Leitz DMRBE fluorescence
microscope (Leica) and high resolution gray-scale digital images acquired with
the CoolSNAP™-Pro cf Digital Kit (Media Cybernetics) which includes Image-
Pro® Plus software. Images were processed using Canvas™ 9 Professional
Edition software (ACD™ Systems of America Inc.).
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2.5. Molecular studies
2.5.1. Buffers and reagents for molecular studies
Luria-Bertani Broth (LB)
1% tryptone (Bacto Laboratories)
0.5% yeast extract (Amyl Media)
1% NaCl
LB Amp agar plates
LB
1.5% agar (MP Biomedicals Inc.)
100 µg/mL Ampicillin (Sigma)
TENS solution
10 mM Tris base (Asia Pacific Specialty Chemicals)
1 mM EDTA
0.1 mM NaOH (Sigma)
0.5% sodium dodecyl sulfate (SDS, Roche)
TE + RNase
10 mM Tris base
1 mM EDTA
20 µg/mL RNase (Sigma)
50 × TAE stock in 1L TDW
Tris base 242 g
Glacial acetic acid 57.1 mL
0.5 M EDTA (pH 8.0) 100 mL
Gene Primer
U = GTCTCTGCAGGTGAGTCCTAACTTCT
L = CAACTATCCCTCCAGCCATAGGAT
U = CAGGGCCAGCCAAAGTATTG
L = TCCAACCTCTTGTGGGACAGTT
U = AAGCCCTGCTGAGCTCAGA
L = AACTGCCAAGCGGGTAGC
U = CTGGCTGTGGAAGCAGGTTT
L = CCTGCCAGGGACTTTCTGAAT
Line Anneal Cycles
Table 2.3. Primers and PCR conditions used for screening mutant mice.
SWHEL
LC2
ML5, AL3, KLK3
Control
VH10tar*
Vκ10-κ
HEL
Shh** 63°C
63°C
63°C
63°C
30
30
30
30
* These primers are different from those used to screen ES cells.
** Shh = Sonic hedgehog
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2.5.2. DNA isolation and PCR amplification
DNA was isolated from the peripheral blood of mutant mice using the
Wizard® Genomic DNA Purification Kit (Promega) according to the
manufacturer's instructions. 300 µL of blood was collected by tail incision into
an Eppendorf tube containing 25 µL Alsevers by either Michelle Amesbury or
Sandra Gardam. Cells were pelleted by microcentrifugation at maximum speed
for 10 seconds. The plasma was discarded and RBCs were lysed by incubation
for 10 minutes at room temperature with 900 µL Cell Lysis Solution. The
remaining leucocytes were pelleted and resuspended in 300 µL Nuclei Lysis
Solution together with 1.5 µL RNase Solution and incubated at 37°C for 15
minutes. 100 µL Protein Precipitation Solution was added to each tube and
vortexed for 20 seconds. The tube was microcentrifuged for 5 minutes and the
supernatant transferred to a new tube containing 300 µL isopropanol (Merck
Pty. Ltd.), which then was mixed by gentle inversion and microcentrifuged for 2
minutes. The supernatant was discarded and the precipitated DNA
resuspended in 600 µL 70% ethanol (Merck Pty. Ltd.). Finally, the tube was
microcentrifuged for 2 minutes and the DNA pellet air-dried for 1 hour. The DNA
was rehydrated in 30 µL TDW overnight at 37°C.
Typical PCR reaction mix and protocol are shown below. All PCR
reactions were carried out in a PTC-200 DNA Engine (MJ Research).
Oligonucleotide primers (Sigma Genosys) are listed in Table 2.3. A typical PCR
screen is shown in Fig. 2.3. PCR products were visualised by 1-2% agarose gel
electrophoresis in TAE buffer. PCR screening to genotype mutant mice was
mostly performed by Sandra Gardam, Tyani Chan and Chris Brownlee.
AB
C
non-targeted IgH = 865 bp
VH10tar targeted IgH = 302 bp
VH10tar PCR
-/- +/-
Vκ10-κ PCR
-/- +/-
Sonic hedgehog = 707 bp
Vκ10-κ Tg = 405 bp
HEL PCR
-/- +/-
Sonic hedgehog = 707 bp
HEL Tg = 302 bp
Figure 2.3. Typical PCR screening reactions for wild type (left) and SWHEL x ML5 mice (right).
(A) PCR screening for the VH10tar gene. This PCR is different from that used to screen ES cells
in Fig. 2.1. (B) PCR screen for the Vκ10-κ Tg in LC2 line of mice. (C) PCR screen for the HEL
Tg in ML5 line of mice. The same Sonic hedgehog gene was amplified in (B) and (C) as an
internal control.
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PCR reaction mix
TDW 18.0 µL (15.5 µL)
10 mM dNTPs (Sigma) 0.5 µL
10 × RedTaq buffer (Taq) or 5 × Buffer B (Elongase) 2.5 µL  (5.0 µL)
Oligonucleotide primer mix 10 pmol/µL
DNA (~ 10 ng) 1.0 µL
RedTaq™ (Sigma) 1.0 µL
PCR reaction protocol
1. 94°C for 2 minutes
2. 94°C for 30 seconds
3. Anneal for 30 seconds (typically 55-65°C)
4. Extend at 72°C for 1 minute/kb DNA
5. Go to 2 × 32
6. 72°C for 10 minutes
7. End
In addition, DNA was isolated from FACS® sorted HEL+ and HEL- SWHEL
B cells to determine the integrity of the VH10 gene in HEL- B cells (Chapter 3).
This characterisation utilised SWHEL mice that still retained the inverted loxP-
neor-loxP cassette. The following primers were therefore designed to flank the
neor cassette to amplify a 450 bp fragment (designated the VH10-5' fragment) in
the presence of an intact VH10 allele: GTCTGCCTTGACTTCCCTCAGTG (in
the 5' homology arm) and GATTCGCAGCGCATCGCCTTCTA (in the neor
cassette). Similar PCR was performed using DNA isolated from the brain and
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unsorted peripheral blood leucocytes of a SWHEL mouse as a positive control
and a WT mouse as a negative control. Amplification of a 600 bp fragment in
exon 2 of the traf2 gene was performed as an internal control for these
experiments with the primers GCCTCTCCAGGAACCTTGAACCA and
GATGCTCTCTCCCAGCTGTTGCA.
2.5.3. RNA isolation and modified 5' RACE™ strategy for analysis of VH10
gene expression
Ig heavy chain gene expression was determined by isolation of
polyadenylated (polyA+) mRNA from FACS® sorted HEL+ and HEL- B cells.
Sorted cells were washed in PBS and lysed using QIAshredder™ spin columns
(QIAGEN). PolyA+ mRNA was then isolated from the flow-through using the
Oligotex™ Direct mRNA Micro Kit (QIAGEN) according to the manufacturer's
instructions.
A modified 5' rapid amplification of cDNA ends (5' RACE™, Gibco-BRL
Life Technologies) was used to generate reverse transcription- (RT-) PCR
fragments for cloning and sequencing. PolyA+ mRNA was reverse transcribed
with an oligonucleotide primer (GTTGAGGTTCAGTTCTGA) specific for the first
constant region domain of the δ heavy chain (CδH1) and the cDNA then dC
tailed with TdT. Primary PCR amplification was performed with the Unabridged
Anchor Primer that recognised the poly-dC tail and a second nested primer
(TGGCTGACTTCCAATTACT) 5' to the first CδH1 primer used for reverse
transcription. Secondary PCR amplification was performed with a Universal
Primer that anneals to the first framework-coding region (FR1)
(AGGTSMARCTGCAGSAGTCWGGCG) and a third nested CδH1-specific
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primer (GCACTCTGAGAGGAGGAACA). The final PCR product was cloned
with the TOPO TA Cloning® Kit (Invitrogen) using the plasmid vector pCR2.1®-
TOPO (Invitrogen).
Recombinant plasmids were introduced into chemically competent TOP
10F' E. coli strain cells after incubation on ice for 30 minutes by heat shock for
20 seconds at 37°C following which the bacteria were shaken in 1 mL LB broth
in a Gallenkamp orbital incubator (Sanyo) for 1 hour at 240 rpm at 37°C.
Transformed bacteria were then inoculated onto an LB Amp agar plate
containing 40 µL 100 mg/mL isopropylthio-β-D-galactoside (to induce β-
galactosidase) and 80 µL 20 mg/mL 5-bromo-4-chloro-3-indolyl-β-D-galactoside
(as a chromogenic substrate for β-galactosidase). Cultures were grown
overnight at 37°C and white colonies selected for overnight liquid cultures in 5
mL LB broth with ampicillin in an orbital incubator at 37°C. The blue colonies
present contained intact LacZ gene and therefore did not have the insert.
Plasmid DNA was isolated by "dirty preps" as follows (Sambrook et al.
1989). 1.5 mL of the overnight liquid cultures were pelleted at maximum speed
for 20 seconds on a microcentrifuge. Bacterial cells were resuspended in 300
µL TENS and vigorously vortexed to lyse the cells. 150 µL 3.0 M sodium
acetate pH 5.2 (Asia Pacific Specialty Chemicals) was added and thoroughly
mixed to precipitate protein and chromosomal DNA from the lysate. The
suspension was microcentrifuged at maximum speed for 10 minutes and
supernatant transferred to a new tube containing 1 mL ice-cold 100% ethanol to
precipitate plasmid DNA. The pellet was washed × 2 in 1 mL 70% ethanol, air-
dried for 30 minutes in a BH2000 Series biosafety cabinet (Gelman Sciences)
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and rehydrated in 30 µL TE + RNase. Plasmids were screened by EcoRI
restriction enzyme (RE) digestion and agarose gel electrophoresis for the
predicted 600 bp insert, flowing which plasmid DNA was purified using the
QIAPrep® Spin Miniprep Kit (QIAGEN) according to the manufacturer's
instructions.  The cloned fragment was then sequenced at the Sydney
University Prince Alfred Macromolecular Analysis Centre (SUPAMAC, Sydney,
NSW) using the standard sequencing reaction shown below.
Sequencing reaction
600 ng plasmid DNA
6.4 pmol primer (GGAAACAGCTATGACCATG)
16 µL TDW
Sequences were analysed by alignment with native HyHEL-10 heavy
chain sequence using DNA Strider™  (available by email from:
marck@jonas.saclay.cea.fr).
2.5.4. Analysis of the VH10 gene for antigen-induced SHM
To analyse SHM, the VH10 gene was amplified from genomic DNA
isolated from >105 CD45.2+ HEL+ cells FACS® sorted from mice given either
SWHEL Fo or MZ B cells and challenged with HEL-SRBC (Chapter 5). The VH10
gene was also amplified and sequenced from sorted naïve (unimmunised) Fo,
and MZ HEL+ B cells to control for baseline (antigen-independent) mutations.
Finally, the VH10 gene was also amplified and sequenced from genomic DNA
isolated from the brain of a SWHEL mouse to control for background PCR error
rate.
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The Wizard® Genomic DNA Purification was used to isolate DNA
following which the VH10 gene was amplified for 33 cycles at 68°C with
Elongase DNA polymerase (Gibco-BRL Life Technologies) using the following
oligonucleotide primers: GTTAAGTCTTCTGTACCTGTCGACAGC (in the 5'
leader sequence) and CCCAACTTCTCTCAGCCG (in the 3' intron). The
resulting fragment was separated by 1% agarose gel electrophoresis, excised
and purified with QIAEX® II Gel Extraction Kit (QIAGEN) according to the
manufacturer's instructions and digested with SalI and NsiI. The plasmid vector
pBlueScript® II SK (Stratagene) was digested with SalI and PstI (Roche
Diagnostics) and ligated to the digested amplicon with T4 DNA ligase (Roche
Diagnostics) overnight at 16°C. Recombinant plasmids were used to transform
Subcloning Efficiency™ DH5α™  chemically competent E. coli strain cells
(Invitrogen) according to the manufacturer's instructions. White colonies were
grown overnight and "dirty preps" of plasmid DNA screened with SalI and NotI.
Typical RE digest conditions are shown below.
RE digests for 1-2 hours at 37°C
TDW 13 µL
10 × BSA 2.5 µL
10 × RE buffer 2.5 µL
10 U/µL RE 1 1.0 µL
10 U/µL RE 2 1.0 µL
DNA 5.0 µL
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Plasmid DNA was purified from positive colonies with the QIAPrep Spin
Miniprep Kit as above and sequenced by the Australian Genome Research
Facility (AGRF, Brisbane, QLD). Mutations were detected by alignment of
sequence list files using DNA Strider™ and confirmed by examination of the
trace files using Sequencher™ 3.11 (Gene Codes). The translated protein
sequence was aligned with the HyHEL-10 sequence numbered according to
Kabat (Kabat et al. 1991) to determine the significance of mutations (silent vs.
replacement).
2.5.5. Fc-fusion proteins
Fc-fusion proteins were used to detect surface expression of chemokine
receptors. Marilyn Thien made the CCL19-Fcγ2a fusion protein for detection of
CCR7. The plasmid consisted of a modified pcDNA3 vector (Invitrogen)
encoding murine CCL19 fused at its C-terminal end to the Fc region (aa 229-
466) of the mouse γ2a constant region in which Cys at 239, 245 and 248 were
mutated to Ser to prevent interchain disulfide bonding. To produce CXCL12-
Fcγ2a, CXCL12 was cloned from C57BL/6 cDNA by nested PCR using
Platinum Pfx polymerase (Invitrogen). The cDNA was prepared by isolating
polyA+ mRNA from the spleen of a C57BL/6 mouse with the Oligotex™ Direct
mRNA Micro Kit and reverse transcription with the RevertAid™ H Minus First
Strand cDNA Synthesis (Fermentas Life Sciences). Primary PCR was
performed at an annealing temperature 55°C using the upper primer
CCATCAGCACCATGAACC and lower primer CCATCCATCGCAGCAC.
Secondary PCR was also performed at an annealing temperature of 55°C using
the upper primer AATAATGCGGCCGCCACCATGAACCCAAGTGCTGC and
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lower primer TCACCGCGGCTCAGGAGCCCTTTTAGA. The final PCR product
and vector were digested first with KspI and then NotI. Both vector and insert
were then ligated overnight at 16°C and used to transform competent E. coli
cells as described above in Section 2.5.3. Plasmid DNA was prepared from
cultured cells and screened by RE digest with BamHI for the expected 300 bp
fragment. 20 µg plasmid DNA was then used to transiently transfect Chinese
Hamster Ovary cells by incubation with 50 µL FuGENE 6 transfection reagent
(Roche Diagnostics) in serum-free RPMI for 30 minutes at room temperature.
The culture supernatant was collected after 3 and 5 days. CXCL12-Fcγ2a was
concentrated by centrifugation for 25 minutes at 4°C at 4 000 rpm using
Amicon® Ultra-15 Centrifugal Filter Devices with a 10 kDa MW cutoff
(Millipore). Concentrated Fc-fusion proteins were used at a dilution of 1:4 for
cell surface staining and compared to control Fc-fusion protein that lacked any
chemokine. Bound Fc-fusion proteins were detected by staining with anti-
mouse IgG2a mAb followed by SA-PE. Subsequently a commercial anti-
CXCR4-PE mAb became available and was used instead of CXCL12-Fcγ2a.
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3.1. Preamble
Targeting of the VH10 variable gene to the Ig heavy chain locus in SWHEL mice
potentially adds several dimensions to the previous anti-HEL Ig-Tg mouse
models. The presence of the VH10 gene in its physiological position makes it
easily accessible for both CSR and SHM. Therefore the SWHEL mouse model
has the capacity to build upon the large body of knowledge generated by the
anti-HEL Ig-Tg and extend our understanding of B cell biology. This chapter
describes the phenotypic characterisation of SWHEL mice. In particular, it
describes the B cell compartment in SWHEL mice and their ability to secrete
isotype switched anti-HEL Igs. Chapter 4 describes the use of the SWHEL model
to study B cell self-tolerance and Chapter 5 describes the use of the SWHEL
model to study in vivo B cell activation.
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Figure 3.1. Detection of HEL-binding B cells in anti-HEL Ig-Tg mice. Spleens were harvested
from 10-14-week-old mice of the indicated genotypes and cells analysed by FACS® for surface
expression of B220 and HEL-binding BCRs. Expression of both the HyHEL-10 heavy and light
chain variable genes in SWHEL (VH10tar+/- x LC2) mice is required to generate a high frequency
population of HEL+ B cells (lower boxes). In addition SWHEL mice also contained a significant
population of HEL- B cells. The frequency of HEL+ and HEL- B cells in each pseudo-colour plot
is indicated by the numbers next to each box. Values from each are representative of more than
five independent experiments.
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3.2. B cell development in SWHEL mice
3.2.1. SWHEL mice contain both HEL+ and HEL- B cells
Expression of anti-HEL BCRs in SWHEL mice was determined by FACS®
analysis of splenocytes from WT, LC2, MD2, MD2 × LC2, MD4, VH10tar+/-, SWHEL
(VH10tar+/- × LC2) and VH10tar+/+ × LC2 mice. Enumeration of total numbers of
B220+ cells revealed that spleens of SWHEL mice contained fewer B cells than
WT C57BL/6 mice (Fig. 3.1). This reduced frequency is characteristic of most
Ig-Tg mice, among them the MD4 line (Fig. 3.1; and (Goodnow et al. 1995)) and
may arise because rapid expression of the pre-rearranged Ig heavy chain
shortens the IL-7-dependent phase of growth in the BM (Section 1.2.1).
When analysis was confined to the HEL-specific B cells, 40-60% of
splenic B cells were found to be HEL+ (Fig. 3.1). Generation of significant
numbers of these cells required expression of both the HyHEL-10 heavy and
light chain variable genes as <1% of splenic B cells were HEL+ in mice that only
expressed either the heavy chain (in VH10tar+/- and MD2 Tg mice) or the light
chain (in LC2 Tg mice) (Fig. 3.1). However, the frequency of HEL+ SWHEL B cells
was significantly lower than the frequency of >90% routinely observed in MD4
mice. This difference was not due to inefficient expression of the Vκ10-κ
transgene in SWHEL mice because inheritance of the same Vκ10-κ transgene in
conjunction with the VH10-µδ transgene (in MD2 × LC2 mice) resulted in the
same high frequencies of HEL+ B cells observed in MD4 mice (Fig. 3.1). In
other words, the targeted VH10 allele was more permissive for the development
of HEL- B cells than the VH10-µδ transgene. Interestingly, homozygosity for the
WT MD4
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Figure 3.2. SWHEL and MD4 HEL+ B cells express high levels of surface IgM. Splenocytes were
stained for surface expression of B220, IgM, IgD and HEL-binding. IgM and IgD expression by
WT (top left), MD4 (top right), HEL- (bottom left) and HEL+ (bottom right) SWHEL B220+ B cells is
shown. Numbers indicate the proportion of gated B220+ B cells in the quadrants shown. Data
are representative of more than five independent experiments.
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targeted VH10 allele in VH10tar+/+ × LC2 mice was associated with the same high
frequency of HEL+ B cells seen in MD4 and MD2 × LC2 lines (Fig. 3.1). The
relative frequency of HEL- B cells increased as SWHEL mice aged (data not
shown) and for this reason all subsequent experiments were performed on
young (8-14-week-old) age-matched mice. A similar increase in the frequency
of HEL- B cells with age was observed previously in MD4 mice (Fulcher and
Basten 1994). Nevertheless, the presence of HEL- B cells in SWHEL mice
provided a useful internal control for the experiments to be described in Chapter
4 and 5.
3.2.2. HEL+ B cells express high levels of surface IgM
HEL+ SWHEL B cells were found to consistently express the IgMhi IgDlo-hi
phenotype characteristic of MD4 (Fig. 3.2) and MD2 × LC2 (data not shown) Ig-
Tg B cells. Therefore, it is unlikely that the IgMhi phenotype of HEL+ B cells in
these mice is due to transgenic overexpression as SWHEL B cells contain only
one copy of the VH10 gene under the control of physiological promoters. In
contrast, HEL- SWHEL B cells expressed variable levels of surface IgM thereby
reproducing the pattern of surface Ig present on naïve WT B cells (Fig. 3.2).
These data indicate that the unique monoclonal specificity of the HEL+ B cells is
responsible for their IgMhi phenotype, perhaps due to the absence of significant
interactions with environmental/self antigens which are associated with IgM
down-modulation (Goodnow et al. 1988).
3.2.3. HEL+ B cells belong to the B2 lineage
The impact of BCR specificity on B cell development was also reflected
by the almost complete absence of B1 lineage HEL+ B cells in SWHEL mice (Fig.
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Figure 3.3. SWHEL and MD4 HEL+ B cells are of the B2 lineage. Mice of the indicated genotypes
were sacrificed and cells were collected by peritoneal lavage and surface stained for B220, IgM,
CD5 and HEL-binding. Expression of B220 and CD5 is shown for WT (top left), MD4 (top right),
HEL- (bottom left) and HEL+ SWHEL (bottom right) cells in the lymphocyte gate that were B220+
and/or IgM+. Numbers indicate the proportion of gated B2 cells in the box shown. Peritoneal B1
cells (CD5+/- B220lo) therefore reside outside the gate shown. Data are representative of three
independent experiments.
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3.3). FACS® analysis of peritoneal exudate revealed that only 2-3% of HEL+ B
cells in the peritoneal cavity of SWHEL mice expressed the IgM+ B220lo CD5+/-
phenotype typical of B1 cells (Fig. 3.3), as was the case for B cells from MD4
(Fig. 3.3) and MD2 × LC2 (data not shown) mice. That is to say, the HEL+
SWHEL B cells belonged almost exclusively to the B2 lineage. Conversely, the
great majority of peritoneal cavity B1 cells detected in SWHEL mice were HEL-
and were present at a similar frequency to that of WT C57BL/6 mice (Fig. 3.3).
The lack of cross-reactivity of HyHEL-10 with environmental/self-antigens may
preclude the selection of HEL+ B cells into the B1 compartment, consistent with
the concept proposed by Hardy that the B1 cells are "hard-wired" for low-level
polyreactivity against self-ligands (Section 1.2.5).
3.2.4. SWHEL B cells mature normally in the spleen
HEL+ B cells matured normally despite the differences in BCR phenotype
of HEL+ and HEL- SWHEL B cells. Hence, both HEL+ and HEL- populations
contained normal proportions of immature (10-25%), Fo (70-80%) and MZ (5-
10%) B cells as defined by surface expression of CD21/35 and CD23 (Fig. 3.4)
and CD24 (data not shown). Furthermore, both HEL+ and HEL- SWHEL B cells
localised normally to the primary B cell follicle and MZ compartments in the
spleen (see Chapter 4, Fig. 4.5). In other words, peripheral B cell maturation is
normal in SWHEL mice insofar that it is not biased towards either the Fo or MZ
cell phenotype. This is in contrast to other Ig-Tg mice such as the VH81x (Chen
et al. 1997; Martin and Kearney 2000) and M-167 (Martin and Kearney 2000)
mice where there is marked expansion of transgene-expressing B cells in the
MZ compartment.
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Figure 3.4. SWHEL and MD4 HEL+ B cells have normal splenic immature, Fo and MZ subsets.
Splenocytes from mice of the indicated genotypes were harvested and stained for surface
expression of B220, CD21/35, CD23 and HEL-binding. B220+ B cells from WT (top left), MD4
(top right) and SWHEL mice (HEL-, bottom left; and HEL+, bottom right) in the immature (CD21lo
CD23-), Fo (CD21int CD23+) and MZ (CD21hi CD23-) gates are shown. Numbers represent the
proportion of cells in the gates indicated. Data is representative of five independent experiments.
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Figure 3.5. SWHEL B cells are capable of Ig isotype switching. (A) Constitutive production of
serum anti-HEL Ig’s by WT, MD4 and SWHEL mice. Serum was collected from 8-12-week-old
mice and analysed by ELISA. (B) In vitro production of anti-HEL Igs by small dense naïve B
cells isolated from 8-12-week-old mice and stimulated with either CD40L plus IL-4 or LPS. Data
are representative of at least five independent experiments.
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3.3. CSR and Ig secretion by SWHEL B cells
3.3.1. Secretion of isotype-switched anti-HEL Igs by SWHEL mice in vivo
Sera from naïve MD4 mice contain >10 µg/mL anti-HEL IgM (Fig. 3.5 A;
and (Goodnow et al. 1988)). When tested for isotype-switched Igs, MD4 mice
were also found to have low but detectable levels of anti-HEL IgG2a, IgG3 and
IgA (Fig. 3.5 A). These predominantly TI isotypes were presumably produced
by rare interchromosomal gene conversion events that have been reported in
MD4 (Christopher Parish, JCSMR; personal communication) and other Ig-Tg
models (Gerstein et al. 1990). In contrast, sera from naïve SWHEL mice
contained anti-HEL Igs of all isotypes with the exception of IgE (Fig. 3.5 A). IgE
is typically present in mouse serum at 1 000-fold lower levels than other Ig
isotypes and it is likely that the serum anti-HEL IgE level in SWHEL mice was
below the limit of detection of the indirect ELISA method.
3.3.2. Secretion of isotype-switched anti-HEL Igs by SWHEL B cells in vitro
In vitro stimulation with LPS and CD40L plus IL-4 showed that not only
were SWHEL B cells capable of secreting anti-HEL Igs of all isotypes, including
IgE (Fig. 3.5 B), but also that the isotypes corresponded to those typically
secreted by non-Tg C57BL/6 B cells under the same culture conditions. Thus,
in response to "TD stimulation" with CD40L plus IL-4 they secreted IgG1, IgE
(Fig. 3.5 B) and IgG2a (data not shown) (Hasbold et al. 1999) and in response
to "TI stimulation" with LPS they secreted IgG2b, IgG3 (Fig. 3.5 B) and IgA
(data not shown) (Deenick et al. 1999). In contrast, purified MD4 B cells
produced negligible levels of isotype-switched anti-HEL Igs (Fig. 3.5 B).
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Figure 3.6. Identification of intact and disrupted VH10 gene in HEL+ and HEL- B cells. (A)
FACS® sorting of HEL+ and HEL- B cells to >95% purity by negative gating on CD3+ NK1.1+
PI+ cells and positive gating on B220+ HEL+ or B220+ HEL- cells. Genomic DNA was prepared
from sorted cells and PCR amplified. (B) Position of the upper (U) and lower (L) PCR primers
used to specifically amplify a DNA fragment immediately 5' of the targeted IgH locus. Invasion
of the intact VH10 gene by upstream VH or VH + DH segments would delete this VH10-5' fragment.
(C) PCR amplification of the 450 bp VH10-5' fragment. Genomic DNA was isolated from the
brain of SWHEL mouse, peripheral blood leucocytes from wild type (WT) and SWHEL mice (PBL)
and HEL+ and HEL- B cells from a SWHEL mouse. A 600 bp fragment of the traf2 gene was PCR
amplified as loading control. The VH10-5' fragment is undetectable in HEL- B cells from SWHEL
mice, suggesting that these cells have undergone VH gene replacement.
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3.4. VH gene replacement
3.4.1. Origin of HEL- SWHEL B cells
Ig heavy chain allelic exclusion predicted that the majority of SWHEL B
cells should be HEL+. In fact a significant proportion of SWHEL B cells did not
express the anti-HEL specificity (Fig. 3.1). Expression of alternate non-Tg BCR
specificities has also been reported in other Ig gene-targeted mice (Chen et al.
1995; Cascalho et al. 1996). In these cases VH gene replacement had occurred
leading to replacement of the VH segment of the targeted VHDHJH exon by either
upstream VH or VH plus DH segments during early B cell development (Chen et
al. 1995). The trigger for these Rag-dependent gene conversion events was
suggested to be a cryptic RSS heptamer embedded at the 3' end of nearly all
VH gene segments (Chen et al. 1995). The next step was therefore to test
whether HEL- B cells were generated in SWHEL mice due to replacement of the
VH36-60 segment by upstream VH and/or VHDH segments.
3.4.2. Deletion of sequences 5' of the VH10 gene in HEL- B cells
To determine whether VH gene replacement had occurred, genomic DNA
was isolated from >95% pure HEL+ and HEL- B220+ B cells sorted by the
FACStarplus™ (Fig. 3.6 A). SWHEL mice that retained the inverted loxP-neor-loxP
cassette were used for these experiments. PCR primers were designed to
amplify a 450 bp DNA fragment 5' of VH10 (designated VH10-5') which was
specific for the targeted IgH allele and would be deleted in the event of VH gene
replacement at this locus (Fig. 3.6 B). Co-amplification of a 600 bp band from
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Figure 3.7. (A) Modified 5‘ RACE™ strategy for the analysis of IgH variable gene expression.
HEL+ and HEL- SWHEL B cells were FACS® sorted to >95% purity as for Fig. 3.6. PolyA+ mRNA
was isolated from the cells and the IgH variable gene reverse transcribed with a primer (CHδ1)
specific for the CδΗ1. The cDNA was dC tailed with TdT and PCR amplified with an unabridged
anchor primer that recognises the polydC tail and a nested CδΗ1-specific primer (CHδ2) 5' to the
first primer. Secondary PCR was performed with a universal primer to the FR1 coding region
and a third CδΗ1-specific primer (CHδ3). The PCR product was then cloned into the pCR® 2.1
plasmid. Positive clones were then sequenced by SUPAMAC and AGRF. (B) Nested PCR
showing the 500 bp VH-δ PCR fragment specifically in dC tailed samples. (C) The 3.9 kb pCR®
2.1 plasmid contains overhanging T bases for direct ligation of PCR products. (D) EcoRI digest
of colonies with for the 500 bp insert. Blue colonies have intact LacZ gene whereas insertion of
the PCR product in white colonies disrupts expression of LacZ. Positive white colonies were
then grown in overnight culture and plasmid DNA purified for sequencing.
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exon 2 of the traf2 gene was used as an internal control for these PCR
reactions (Fig. 3.6 C).
As would be predicted, the VH10-5' fragment was not amplified from DNA
isolated from a WT C57BL/6 mouse but was readily detected in both brain and
unsorted peripheral blood leucocytes from a SWHEL mouse (Fig. 3.6 C). The
same VH10-5' fragment was also detected in purified HEL+ B cells but was
absent from HEL- B cells, consistent with the selective occurrence of VH gene
replacement in the latter population.
3.4.3. Expression of IgH variable genes generated by VH gene replacement
in HEL- B cells
To determine whether HEL- SWHEL B cells expressed IgH variable genes
generated by VH gene replacements, HEL+ and HEL- B cells were isolated to
>95% purity from the spleen of a SWHEL by FACS® sorting and polyA+ mRNA
isolated from them. Variable region genes expressed by mature δ heavy chain
transcripts were amplified using a modified 5' RACE™ strategy (Fig. 3.7 A), the
PCR products subcloned into pCR2.1® (Fig. 3.7 B), and plasmids containing
inserts (Fig. 3.7 C) sequenced. As expected, only unaltered VH10 genes were
detected in δ heavy chain transcripts from HEL+ B cells (10/10 clones). In
contrast, less than 5% (1/21) of the clones derived from HEL- B cells contained
unaltered VH10. The single unaltered VH10 clone from the sorted HEL- B cell
population presumably derived from one of the <5% contaminating HEL+ cells
(Fig. 3.6 A). Of the remainder, nearly half (9/20) expressed hybrid variable
region genes consisting of the DH and JH3 segments from the targeted VH10
exon recombined in frame with upstream VH plus DH segments (illustrated in
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Figure 3.8. VH gene replacement in HEL- B cells in SWHEL mice. (A) The VH10 gene contains an
RSS heptamer (red triangle) embedded at the 3' end of the VH36-60 segment. This embedded
RSS differs by only one base pair (shown in bold) from the canonical “two-turn” RSS heptamer.
(B) Expression of the intact VH10 gene together with LC2 Tg results in HEL+ B cells. Replace-
ment of the VH36-60 gene segment by upstream VHDH segments leads to disruption of the VH10
gene and loss of HEL-binding. Canonical “one-turn” RSS is shown as orange and “two-turn”
RSS as yellow triangles. (C) Representative sequences from clones expressing mature δ heavy
chain transcripts obtained from sorted HEL- SWHEL B cells as in Fig. 3.7. The intact VH10 gene
with the VH36-60 (dark blue), D (light blue) and JH3 segments (dark blue) is depicted together with
the disrupted VH10 gene in four clones showing replacement of VH36-60 by upstream VH (purple)
together with D (green) segments to generate a hybrid VHDDJH3 gene.
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Table 3.1. IgH expression by HEL+ and HEL- B cells.
IgH variable gene expression *
Intact VH10
Disrupted VH10
Non-targeted IgH allele
10/10
0/10
0/10
1/21
9/21
11/21
IgH allotype expression **
Targeted IgHb allotype
Non-targeted IgHa allotype
99.6 ± 0.1%
0.4 ± 0.1%
52.5 ± 1.3%
47.5 ± 1.3%
* IgH variable gene expression was analysed as shown in Fig. 3.8.
** IgH allotype expression was analysed as shown in Fig. 3.9 and Fig. 3.10. The proportion of
HEL+ and HEL- B cells that stained for IgMb or IgMa were calculated separately for each SWHEL
x BALB/c F1 mouse. Percentages represent mean ± S.D. for four mice.
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Fig. 3.8). The remaining clones (11/21) expressed VHDHJH genes derived from
the non-targeted IgH allele as indicated by the presence of either the JH1, JH2 or
JH4 gene segments (that are not present in the targeted IgH allele - Fig. 2.1) or
in the case of the single JH3 containing clone, the presence of additional JH3
sequence absent from VH10 (data not shown). These results are summarised in
Table 3.1.
A similar analysis of Ig κ light chain gene expression resulted in detection
of only intact Vκ10 expression in both HEL+ and HEL- B cells (data not shown).
The failure of HEL- B cells to express anti-HEL BCR therefore appears to be
entirely due to the inactivation of the targeted heavy chain allele by VH gene
replacement.
3.4.4. Allelic exclusion is maintained in SWHEL mice
The analysis of IgH variable region expression described above
indicated that HEL+ B cells expressed only the (intact) targeted heavy chain
allele, whereas HEL- B cells expressed either the targeted allele modified by VH
gene replacement or the non-targeted heavy chain allele. To confirm these
findings and to determine whether allelic exclusion is maintained in the HEL- B
cell population, SWHEL mice (IgHb) were crossed with WT BALB/c mice (IgHa)
and the F1 progeny analysed by FACS® for IgH allotype (Fig. 3.9 and Fig.
3.10). Analysis of the targeted IgDb allotype revealed that virtually all HEL+
(SWHEL × BALB/c) F1 B cells expressed IgDb whereas only half of the HEL- B
cells expressed this allotype (Fig. 3.9 A). On the other hand, while no HEL+ B
cells expressed the non-targeted IgDa allotype almost half of the HEL- B cells
did so (Fig. 3.9 B; Table 3.1). Similar results were obtained for expression of the
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Figure 3.9. Analyis of IgD allotype expression by HEL- B cells. SWHEL (IgHb) mice were crossed
with BALB/c (IgHa) mice and the F1 (SWHEL x BALB/c) progeny analysed by FACS® for surface
expression of B220, IgDa, IgDb and HEL-binding. (A) Expression of the targeted IgDb allele by
SWHEL x BALB/c (top left) B220+ B cells. IgDb expression by WT C57BL/6 (top middle) and WT
BALB/c (top right) B cells is shown for comparison. HEL-binding and IgDb expression by SWHEL
x BALB/c B cells (bottom left). IgDb expression by HEL+ B cells is shown in the upper red box
(bottom middle) and HEL- B cells in the lower blue box (bottom right). HEL+ B cells that are
negative for IgDb all express IgMb (Fig. 3.10 A). Numbers represent the proportion of B cells
expressing IgDb in the gates indicated. (B) Expression of the non-targeted IgDa allele by SWHEL
x BALB/c (top left) B220+ B cells. IgDa expression by WT C57BL/6 (top middle) and WT BALB/c
(top right) B cells is shown for for comparison. HEL-binding and IgDa expression by SWHEL x
BALB/c B cells (bottom left). IgDa expression by HEL+ B cells is shown in the upper red box
(bottom middle) and HEL- B cells in the lower blue box (bottom right). Numbers represent the
proportion of B cells expressing IgDa in the gates shown. Data is representative of four separate
experiments.
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Figure 3.10. Analysis of IgM allotype expression by HEL- B cells. SWHEL (IgHb) mice were
crossed with BALB/c (IgHa) mice and the F1 (SWHEL x BALB/c) progeny analysed by FACS® for
surface expression of B220, IgMa, IgMb and HEL-binding. (A) Expression of the targeted IgMb
allele by SWHEL x BALB/c (top left) B220+ B cells. IgMb expression by WT C57BL/6 (top middle)
and WT BALB/c (top right) B cells is shown for comparison. HEL-binding and IgMb expression
by SWHEL x BALB/c B cells (bottom left). IgMb expression by HEL+ B cells is shown in the upper
red box (bottom middle) and HEL- B cells in the lower blue box (bottom right). The proportion of
B cells expressing IgMb in the gates indicated by the bars are shown. (B) Expression of the non-
targeted IgMa allele by SWHEL x BALB/c (top left) B220+ B cells. IgMa expression by WT
C57BL/6 (top middle) and WT BALB/c (top right) B cells is shown for for comparison. HEL-
binding and IgMa expression by SWHEL x BALB/c B cells (bottom left). IgMa expression by HEL+
B cells is shown in the upper red box (bottom middle) and HEL- B cells in the lower blue box
(bottom right). The proportion of B cells expressing IgMa in the gates indicated are shown. Data
is representative of four separate experiments.
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Figure 3.11. B cell Ig transfer. (A) Transfer of HEL-binding from HEL+ to HEL- SWHEL B cells.
Spleens were harvested from mice of the indicated genotype and stained for cell surface
expression of B220 and HEL-binding. The m.f.i. of HEL- B cells from SWHEL x BALB/c mice was
consistently higher than the m.f.i. of (HEL-) B cells from WT C57BL/6, BALB/c and C57BL/6 x
BALB/c mice. The HEL- population in SWHEL mice has shifted upward as a whole such that a
significant proportion (~20%) lie above the red line. (B) Transfer of IgHb allotype from HEL+ to
HEL- SWHEL B cells. Spleens from (A) were also stained for IgMb and IgMa allotypes. Pseudo-
colour plots show the lack of IgMa staining by WT C57BL/6 cells and lack of IgMb staining by
BALB/c cells. However, staining for both allotypes has shifted in C57BL/6 x BALB/c mice such
that 9.2% of splenocytes now appear to express both IgMb and IgMa. This is most marked in
SWHEL x BALB/c mice (14%) where there is more transfer of IgMb staining because of the high
IgMb expression by HEL+ B cells (Fig. 3.2). Numbers represent the proportion of cells in the
corresponding quadrants. Data is representative of three experiments.
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targeted IgMb allele (Fig. 3.10 A) and non-targeted IgMa allele (Fig. 3.10 B). In
other words, HEL+ B cells almost exclusively expressed IgMb and HEL- B cells
expressed both IgMb (~50%) and IgMa (~50%) (Table 3.1). Finally, double
staining of HEL- B cells for IgHa allotype and IgHb allotype confirmed that these
cells either expressed one allotype or the other but not both (data not shown).
Together these results indicate that HEL- B cells are generated following VH
gene replacement events, with approximately half expressing the targeted
heavy chain allele modified by a functional VH gene replacement. In the case of
the remaining HEL- B cells, VH gene replacement presumably resulted in a non-
functional variable region gene at the targeted allele, thereby providing the
opportunity for productive VHDJH recombination at the non-targeted allele.
3.4.5. B cell membrane transfer - a detour
Careful scrutiny of the HEL- B cell population in SWHEL mice revealed
that, despite their failure to express the intact anti-HEL heavy chain variable
regions, they stained more intensely for HEL-binding than WT B cells (Fig. 3.1).
This phenomenon had been observed previously with MD4 Ig-Tg mice and
ascribed to "cytophilic antibodies" (Mason et al. 1992). A reproducible increase
in m.f.i. was observed for HEL- SWHEL B cells irrespective of the method used to
detect HEL-binding BCRs e.g. HEL directly conjugated to FITC or Alexa Fluor®
647 or HEL plus biotinylated or directly conjugated HyHEL-5 or -9.
To characterise this phenomenon further, SWHEL and WT C57BL/6 mice
were crossed with WT BALB/c mice and the F1 progeny analysed by FACS®
(Fig. 3.11). This revealed that the increase in HEL-binding m.f.i. only occurred
when a population of HEL+ B cells was also present (Fig. 3.11 A). Analysis of
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Figure 3.12. In vitro dose-dependent membrane transfer. Splenocytes from WT C57BL/6-
SJL.Ptprca (left) and MD4 (right) mice were mixed in the ratios indicated and incubated over-
night at 37°C in 96-well round bottom plates at a density of 5 x 106 cells/mL. Cells were then
harvested and stained for expression of B220, HEL-binding and CD45.1. Pseudo-density plots
are gated on B220+ B cells. The m.f.i. of staining for HEL-binding by WT CD45.1+ B cells
(shown in red) increases as the proportion of MD4 B cells increases from left to right. Similarly,
the m.f.i. of staining for CD45.1 (shown in blue) by CD45.1- MD4 B cells increases as the pro-
portion of CD45.1+ WT B cells increases from right to left.
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IgH allotype expression confirmed that the increase in HEL-binding m.f.i.
resulted from transfer of anti-HEL IgMb from HEL+ to HEL- B cells (Fig. 3.11 B).
In fact, there was reciprocal transfer of IgM between IgHa and IgHb allotype cells
in WT C57BL/6 × BALB/c controls (Fig. 3.11 B), although it was less marked
than for SWHEL × BALB/c mice. This difference suggested that the transferred Ig
might be in the membrane rather than the secreted form, since HEL+ B cells
express higher levels of surface IgMb (Fig. 3.2) but contribute relatively little
secreted IgM in unchallenged SWHEL mice (Fig. 3.5). Accordingly, in vivo Ig
transfer was negligible in the BM and peritoneal cavity (data not shown),
suggesting that it required direct physical contact between B cells.
Confirmation that B cells could transfer membrane Ig was shown in vitro
by co-incubating MD4 Ig-Tg with WT CD45.1 congenic B cells in 96-well round
bottom plates (Fig. 3.12). The amount of HEL-binding activity transferred to
CD45.1+ congenic B cells was dependent on the relative proportion of donor
cells (Fig. 3.12) and the overall cell density (data not shown). Under these
circumstances, the CD45.1 congenic marker was also reciprocally transferred to
the CD45.1- MD4 B cells (Fig. 3.12). Membrane transfer could not be inhibited
in vitro by EDTA, blockade with mAbs to CD21/35, CD22, CD62L and CD81, or
treatment with microtubule assembly inhibitors such as colchicine and
cytochalasin D (data not shown). In fact, the only reliable way to prevent
membrane transfer in vitro was by fixation of the cells with paraformaldehyde
prior to co-incubation (data not shown). Although the phenomenon of B cell
membrane transfer was intriguing, its physiological relevance was not
immediately obvious and further investigations were postponed.
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3.5. Discussion
3.5.1. SWHEL B cells and the B1 versus B2 lineage decision
The MD4 Ig-Tg model has been extensively used for more than 15 years
to study the regulation of B cell responses in self-tolerance and immunity. With
the creation of SWHEL mice it is now possible to extend the original observations
to encompass the full range of B cell responses. SWHEL mice, like MD4 Tg mice,
were found to have large numbers of HEL+ B cells (Fig. 3.1). However, unlike
MD4 Tg mice, SWHEL mice also possessed a significant number of HEL- B cells
(Fig. 3.1). These HEL- SWHEL B cells were therefore used as internal controls for
the study of antigen-specific induction of B cell self-tolerance (Chapter 4) and
activation (Chapter 5).
HEL+ SWHEL B cells display a very similar surface phenotype to HEL+ B
cells from MD4 mice. Both populations of B cells express uniformly high levels
of surface IgM (Fig. 3.2) and are restricted to the B2 lineage (Fig. 3.3). The
IgMhi phenotype of HEL+ B cells probably reflects the lack of reactivity of the
monoclonal HyHEL-10 BCR specificity with the endogenous antigenic milieu.
The same lack of significant cross-reactivity with environmental/self-ligands may
also have precluded the positive selection of HEL+ B cells into the B1 cell pool
(Section 1.2.5; and (Hardy and Hayakawa 2001)). As a corollary, expression of
alternate BCR specificities reactive with endogenous antigens by HEL- B cells
resulted in the emergence of IgMlo splenic B2 (Fig. 3.2) as well as peritoneal
cavity B1 cell populations (Fig. 3.3).
Chapter 3. Characterisation of SWHEL mice
80
3.5.2. SWHEL B cells and the Fo versus MZ cell fate decision
The peripheral maturation of SWHEL B cells was normal in that HEL+
SWHEL B cells populated the splenic immature, follicular and MZ B cell
compartments at similar frequencies to HEL- SWHEL and WT B cells (Fig. 3.4).
Thus the normal expression of CD21/35, CD23 and CD24 by HEL+ SWHEL B
cells occurred independently of their IgMhi phenotype and BCR specificity. This
in contrast to VH81x (Chen et al. 1997; Martin and Kearney 2000) and M-167
(Martin and Kearney 2000) Ig-Tg mice, which are characterised by marked
expansion of Ig-Tg B cells in the MZ compartment. Kearney originally
interpreted these data as evidence for positive selection of MZ B cells by self-
ligands in the same manner as for B1 cells (Bendelac et al. 2001; Martin and
Kearney 2001). However, the presence of HEL+ SWHEL B cells in the MZ
compartment contradicts this idea. The normal peripheral maturation of HEL+
SWHEL B cells therefore indicates that the decision between Fo and MZ
pathways is not necessarily dependent on BCR specificity ((Casola et al. 2004);
Section 1.2.5). More importantly, the normal representation of HEL+ B cells in
the peripheral B cell pool allows for more valid comparisons to be made
between the responses of HEL+ Fo and MZ B cells (Chapter 5).
3.5.3. SWHEL B cells and CSR
The previous MD4 model was limited by the fact that the co-integrated
VH10-µδ heavy chain and Vκ10-κ light chain transgenes were not easily
accessible to CSR and SHM. Although MD4 Ig-Tg mice spontaneously secrete
low levels of isotype-switched anti-HEL Igs (Fig. 3.5 A) they could not be
efficiently induced to undergo CSR upon in vitro stimulation (Fig. 3.5 B). In
Chapter 3. Characterisation of SWHEL mice
81
contrast, SWHEL B cells were able to undergo efficient isotype switching and
secretion of anti-HEL Igs upon in vitro stimulation with "TD" and "TI" signals
(Fig. 3.5 B). The demonstration that SWHEL B cells can isotype switch in vitro
validated the targeting strategy used to generate the mice and paved the way
for further in vivo studies of CSR (Chapter 4) and SHM (Chapter 5).
3.5.4. VH gene replacement - a mechanism for antibody diversification?
B cells from SWHEL mice, like those from other Ig gene-targeted mice
(Chen et al. 1995; Cascalho et al. 1996), are susceptible to VH gene
replacement (Fig. 3.6; Fig. 3.7; and Fig. 3.8). VH gene replacement was
originally described in mice carrying targeted insertion of an anti-DNA Ig
variable gene where it may represent a receptor editing mechanism activated in
response to binding of self-antigen (Chen et al. 1995). For this reason it has
also been referred to as "secondary" V(D)J recombination. However, this
mechanism is unlikely to occur in SWHEL mice because HEL+ B cells show no
evidence of self-reactivity in the absence of transgenic expression of HEL and
undergo profound changes in the presence of soluble and membrane-bound
self-antigen as will be shown in Chapter 4. Therefore, VH gene replacement in
SWHEL B cells probably reflects a more general instability of the rearranged
VHDHJH exon during early B cell development before down-regulation of the Rag
recombinases rather than an attempt to escape self-reactivity. Not surprisingly,
deficiency for the rag1 gene abolishes VH gene replacement and only HEL+ B
cells can leave the BM in SWHEL.rag-/- mice (Cook et al. 2003).
A possible function for VH gene replacement during normal B cell
development is to rescue developing B cells with non-productive or non-
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functional V(D)J recombinations. For example, it has been estimated that 2/3 of
the VH → DHJH and VL → JL joints will be out of frame and therefore unable to
encode Ig heavy and light chains, respectively (Zhang et al. 2004). In addition,
the rearranged µ heavy chain may fail to pair with either SLC or a conventional
light chain to generate a functional pre-BCR and BCR, respectively. However,
such a scenario is also unlikely in SWHEL mice given that both the heavy and
light chain exons are already rearranged and are derived from the same
hybridoma expressing the HyHEL-10 specificity.
VH gene replacement appears to be mediated by a cryptic RSS heptamer
embedded at the 3' end of the VH36-60 segment in FR3 (Fig. 3.8 A; and (Chen et
al. 1995)). The cryptic RSS heptamer (TACTGTG) is separated by 23-bp from
an upstream nonamer (ATTCTGTGA) that has some homology (shown in bold;
Fig. 3.8 A) to the consensus RSS heptamer and nonamer in a "two-turn" RSS.
Indeed, the productive in-frame rearrangements in 9/21 clones involved VHDH →
DJH3 replacement events in accordance with the "12/23" rule (Oettinger et al.
1990) that only allows recombination between a "one-turn" RSS (such as those
flanking D gene segments) and a "two-turn" RSS (such as those at the 5' end of
JH segments and the cryptic RSS). As a consequence, VH gene replacement in
the SWHEL mouse results in hybrid VHDHDHJH variable genes whereby the length
of the third complementarity determining region (CDR3) is increased by the
inserted DH segment. In non-Tg B cells, however, VH gene replacement is
unlikely to generate hybrid VHDHDHJH variable genes because of the constraints
imposed by the "12/23" rule. Nevertheless, it is possible that VH gene
replacement is a physiological process that acts to further diversify the B cell
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repertoire, as reported by the Cooper laboratory (Wang et al. 2003; Zhang et al.
2003). Consistent with this possibility, the quasimonoclonal mouse has been
shown to mount protective antiviral antibody responses using BCR specificities
generated by VH gene replacement of the original targeted anti-NP variable
gene (Lopez-Macias et al. 1999). In this respect, VH gene replacement has
evolutionary undertones in the use of pseudogenes and gene conversion to
further diversify the BCR in chickens and sheep.
3.5.5. Final comments
In summary, SWHEL mice possess both HEL+ as well as HEL- B cells
generated by VH gene replacement events that act to diversify the primary B cell
repertoire. The impact of the HEL- B cell population on the induction of B cell
self-tolerance and the regulation of CSR by self-reactive SWHEL B cells
generated in the presence of interclonal competition will be discussed in the
next chapter.
SWHEL MODEL
OF B CELL
SELF-TOLERANCE
Chapter 4
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4.1. Preamble
The development of Ig-Tg mice provided a major catalyst for the understanding
of B cell self-tolerance in the late 1980s. These classical Ig-Tg models provided
not only definitive evidence for the principle mechanisms of self-tolerance such
as clonal deletion, clonal anergy and receptor editing but useful tools for
exploring the underlying molecular basis of these processes as well (Section
1.4). Nevertheless, these models, which have endured for more than 15 years,
do suffer from certain limitations. Firstly, B cells from these Ig-Tg mice do not
undergo efficient CSR because the transgenes used could not encode all the Ig
heavy chain constant regions. Consequently, they only contained the µ heavy
chain alone or in conjunction with the δ heavy chain (Table 1.1). Secondly, the
monoclonal repertoire of these Ig-Tg mice means that any potential impact of
competitor B cells on the development of self-reactive B cell requires the
generation of irradiation BM chimeras. Therefore the SWHEL model, in which
<50% of the B cells are HEL+, provides the opportunity to study the fate of self-
reactive B cells with the potential to undergo CSR within a polyclonal repertoire
in the intact mice. The current chapter describes the re-examination of the
classical models of deletion and anergy in this context.
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Figure 4.1. Deletion of HEL+ self-reactive B cells exposed to high avidity antigen. BM irradiation
chimeras were made with CD45.1+ MD4 and SWHEL donors injected into CD45.1- WT
(C57BL/6) and KLK3 recipients. (A) FACS® analysis of splenocytes from chimeras 2 months
after reconstitution showing expression of B220 and HEL-binding by CD45.1+ donor cells. HEL+
B cells are undetectable in the periphery of KLK3 recipients of both MD4 and SWHEL BM cells
compared to WT recipients. (B) FACS® analysis of BM cells from the same mice for expression
of CD24 and HEL-binding by CD45.1+ B220+ B lineage cells. Mature recirculating B cells are
CD24int and newly-generated immature B cells are CD24hi. HEL+ CD24hi immature B cells are
deleted in the BM of KLK3 but not WT recipients. Numbers indicate the proportion of gated cells
in the boxes shown. Data is representative of two experiments.
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4.2. Self-tolerance to high avidity antigen
4.2.1. HEL+ SWHEL B cells exposed to mHEL are deleted in the BM
B cell self-tolerance to high avidity antigen was studied in BM irradiation
chimeras. SWHEL and MD4 mice were crossed with WT C57BL/6-SJL.Ptprca
mice to generate HEL+ B cells on a CD45.1+ background. BM was then
harvested from the resulting CD45.1+ SWHEL and MD4 mice for transfer into
lethally irradiated KLK3 Tg mice expressing mHEL or WT C57BL/6 recipients.
This allowed the donor CD45.1+ HEL+ B cell population to be unambiguously
distinguished from any mHEL-expressing (CD45.1-) recipient B cells that may
have arisen from endogenous BM reconstitution.
Splenocytes from the resulting BM chimeras were harvested two months
later and analysed by FACS®. This revealed the absence of peripheral self-
reactive HEL+ SWHEL B cells in mHEL-expressing KLK3 Tg recipients (Fig. 4.1
A). This result resembled that observed previously when MD4 B cells were
exposed to high-avidity self-antigen in KLK3 Tg irradiated recipients (Hartley et
al. 1991). As expected, mature recirculating CD24int HEL+ B cells were also
absent from the BM of both the SWHEL→KLK3 and MD4→KLK3 chimeras (Fig.
4.1 B), whereas, immature CD24hi HEL+ B cells were still detectable (Fig. 4.1 B).
However, these newly generated self-reactive B cells expressed low levels of
HEL-binding IgM (Fig. 4.1 B; and data not shown) and failed to emigrate from
the BM (Section 1.2) and subsequent differentiation into mature recirculating
HEL+ B cells (Section 3.1). Thus, HEL+ SWHEL B cells that are capable of CSR
are deleted in the BM when exposed to high-avidity self-antigen.
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FIgure 4.2. SWHEL B cells exposed to low avidity self-antigen are able to exit the BM and enter
the spleen. (A) Splenocytes from WT (data not shown) and Tg mice of the indicated genotypes
were stained for surface expression of B220 and HEL-binding. Numbers indicate the frequency
of HEL+ (upper box) and HEL- (lower box) B cells in the gates shown. (B) HEL+ B220+ B cells
were enumerated as a proportion of total splenocytes using the gates shown in (A). Columns
indicate the mean of individual data points. Data is representative of at least five independent
experiments using 8-14-week-old mice.
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4.3. Self-tolerance to low avidity antigen
4.3.1. HEL+ SWHEL B cells exposed to sHEL populate the spleen but in
reduced numbers
Of more relevance to the regulation of isotype-switched autoantibody
production is the scenario where anergic self-reactive B cell capable of CSR
colonise peripheral lymphoid compartments. To study this, the development
and responsiveness of self-reactive SWHEL and MD4 B cells were compared in
double Tg mice expressing intermediate (ML5) and high (AL3) levels of HEL in
soluble form. These studies were performed on young (<12-week-old) mice and
age-matched littermate controls. As previously shown, HEL+ B cells were not
deleted in MD4 × ML5 or MD4 × AL3 mice but instead emigrated from the BM to
the spleen (Fig. 4.2 A). Similarly, HEL+ B cells were detected in the spleen of
SWHEL × ML5 mice (Fig. 4.2 A). However, the frequency of HEL+ B cells was
markedly reduced when developing SWHEL B cells were exposed to sHEL in
SWHEL × ML5 compared to SWHEL mice (Fig. 4.2 B). In contrast, the presence of
soluble self-antigen did not greatly affect the frequency of self-reactive HEL+
MD4 B cells, even when expressed at high levels (Fig. 4.2 B). These results
suggested that there were fundamental differences in the peripheral fate of self-
reactive SWHEL compared to MD4 B cells.
4.3.2. Self-reactive SWHEL B cells are anergic
To determine whether peripheral self-reactive B cells from SWHEL × ML5
mice were indeed anergic, their phenotype and function was compared to those
in MD4 × ML5 and MD4 × AL3 mice. Self-reactive SWHEL B cells, like MD4 B
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genotypes were stained for expression of B220, IgM, IgD and HEL-binding. Overlay histograms
show surface IgM fluorescence intensity of HEL+ B220+ B cells. (B) Impaired secretion of
serum anti-HEL Igs by self-reactive SWHEL mice. Sera from 8-14-week-old mice of the indicated
genotypes were analysed by ELISA for anti-HEL IgM and total anti-HEL Igs levels using anti-
IgM and anti-Igκ secondary antibodies. Antibody concentrations were then measured against a
HyHEL-10 IgM standard. (C) Inactive BCR signalling by self-reactive SWHEL B cells.
Splenocytes from 8-10-week-old mice of the indicated genotypes were cultured for 24 h in the
presence and absence of 500 ng/mL HEL and then analysed by FACS® for expression of B220,
HEL-binding and CD86. CD86 m.f.i. were obtained by gating either on B220+ B cells (WT) or
HEL+ B220+ B cells (all other mice). Data is representative of three experiments.
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Figure 4.4. Self-reactive SWHEL x ML5 B cells have an immature phenotype. Splenocytes from
9-12-week-old mice of the indicated genotypes were analysed by FACS® for expression of
B220, HEL-binding, CD21/35 and CD23. Pseudo-colour plots are either gated on B220+ B cells
(WT) or HEL+ B220+ B cells (all other mice). Windows indicate immature (CD21/35lo CD23lo),
Fo (CD21/35int CD23hi) and MZ (CD21/35hi CD23lo) phenotype B cells and the corresponding
percentage of the displayed cells within these windows. Data is representative of at least four
mice of each genotype.
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cells, displayed the IgMlo phenotype characteristic of anergic B cells (Fig. 4.3 A;
and (Goodnow et al. 1988)). Moreover, ELISA performed on sera from double
Tg mice revealed that both self-reactive MD4 and SWHEL B cells secreted little if
any anti-HEL Igs of any isotype in vivo (Fig.4.3 B). To confirm that the cells
were anergic, the responsiveness of HEL+ B cells to BCR stimulation was
determined by in vitro culture of splenocytes from MD4 and SWHEL double Tg
mice in the presence and absence of sHEL. Self-reactive B cells from MD4 ×
ML5, MD4 × AL3 and SWHEL × ML5 mice were all shown to be similarly hypo-
responsive to BCR stimulation as indicated by their failure to upregulate CD86,
CD69 or increase FSC following antigenic stimulation (Fig. 4.3 C; and data not
shown). Therefore the ability to undergo CSR did not appear to compromise the
induction of anergy in SWHEL compared to MD4 B cells. In particular, the
reduced numbers of self-reactive HEL+ SWHEL compared to MD4 B cells could
not be explained by differences in the induction of anergy.
4.3.3. Anergic SWHEL B cells have an immature B cell phenotype
The peripheral maturation of anergic MD4 and SWHEL B cells was next
analysed by FACS®. Expression of CD21/35 and CD23 was used to define
immature/transitional (CD21/35lo CD23lo), Fo (CD21/35int CD23hi) and MZ
(CD21/35hi CD23lo) B220+ B cell populations present in the spleen (Oliver et al.
1997). In the absence of self-antigen the proportions of HEL+ MD4 and SWHEL B
cells exhibiting the three B cell phenotypes were comparable to those seen in
non-Tg WT and HEL- SWHEL splenic B cells (Fig. 4.4; and data not shown). As
previously shown for MD4 × ML5 anergic B cells (Mason et al. 1992) SWHEL B
cells failed to develop into the MZ B cell phenotype in the presence of self-
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Figure 4.5. Peripheral self-reactive SWHEL B cells have a reduced lifespan. (A) 9- or 10-week-old
mice of the indicated genotypes were fed BrdU via their drinking water for 72 h. Splenocytes
were stained for B220, CD24, HEL-binding and BrdU-labelling. Pseudo-colour plots are gated
on B220+ B cells. Numbers indicate the percentage of BrdU+ and BrdU- HEL+ B cells in the
gates shown. Data is representative of at least two mice. (B) The proportion of HEL+ B220+ B
cells that labelled with BrdU was calculated with reference to identically stained and analysed
splenocytes from a mouse that had not been fed BrdU. Data points represent individual mice
and the columns represent the mean of the data points. BrdU+ cells were predominantly of the
immature CD24hi B cell phenotype (data not shown).
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antigen (Fig. 4.4). However, anergic SWHEL B cells differed from anergic MD4 B
cells in that the frequency of HEL+ B cells displaying the Fo B cell phenotype
was also markedly reduced (from 70% to 41%; Fig. 4.4). Indeed, even anergic
MD4 B cells exposed to high levels of sHEL in MD4 × AL3 Tg mice were able to
mature normally into Fo phenotype B cells (68% compared to 67% in MD4 Tg
mice; Fig. 4.4). These data underscored the major difference between anergic
MD4 and SWHEL B cells. That is, anergic MD4 B cells conformed to a
predominantly mature Fo B cell phenotype whereas anergic SWHEL B cells
conformed to a predominantly immature (transitional) B cell phenotype.
4.3.4. Anergic SWHEL B cells have a reduced lifespan
The reduced frequency and immature phenotype of anergic SWHEL × ML5
HEL+ B cells suggested that they might have a shortened lifespan relative to
those from MD4 double Tg mice. Therefore, B cell lifespan was measured in
vivo by metabolic labelling with the thymidine analogue BrdU. After 3 days of
BrdU administration >60% of HEL+ SWHEL × ML5 B cells were labelled with BrdU
whereas only 20-30% of HEL+ SWHEL B cells were BrdU+ (Fig. 4.5 A; and B) the
great majority of which was confined to the CD24hi  (HSAhi) immature B cell
compartment (data not shown). Hence, the half-life of self-reactive SWHEL B
cells in the spleen was <3 days which is similar to that immature non-Tg B cells
(Fulcher and Basten 1997). The reduced frequency and immature phenotype of
anergic SWHEL B cells (Fig. 4.2 B) is therefore likely to be a result of their
reduced lifespan. In contrast, the rate of BrdU incorporation into self-reactive B
cells from MD4 × AL3 mice was comparable to that in non-self-reactive B cells
from MD4 and SWHEL mice (Fig. 4.5 A; and B).
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4.3.5. Anergic SWHEL B cells have intermediate levels of BCR occupancy
One explanation for the difference in behaviour of SWHEL and MD4 B
cells when exposed to self-antigen is a difference in BCR occupancy due to the
lower numbers of HEL+ B cells in SWHEL mice (Fig. 3.1). To investigate the
possibility that SWHEL B cells were effectively exposed to greater levels of sHEL,
BCR occupancy by self-antigen was directly measured in the various double Tg
mice. As expected, the proportion of BCRs occupied by endogenous HEL on B
cells from SWHEL × ML5 (70-80%) was greater than those from MD4 × ML5 mice
(40-50%) because of the lower frequency of B cells capable of binding HEL
(Fig. 4.6). On the other hand, the BCR of HEL+ B cells from MD4 × AL3 mice
were almost completely saturated with self-antigen (BCR occupancy = 90-
100%; Fig. 4.6) consistent with the significantly higher levels of sHEL secreted
by AL3 Tg mice. Therefore the level of BCR occupancy by anergic SWHEL B
cells is intermediate between those from MD4 × ML5 and MD4 × AL3 Tg mice.
In other words, the failure of anergic SWHEL B cells to mature and colonise the
primary follicle in the spleen cannot be explained on the basis of greater
interaction with self-antigen.
4.3.6. MD4 and SWHEL B cells acquire the same phenotype under identical
conditions of antigen exposure and interclonal competition
Eliminating the possibility that differences in BCR occupancy accounted
for the disparate phenotype of anergic MD4 and SWHEL B cells suggested that
this may instead be due to intrinsic differences such as the ability of SWHEL but
not MD4 B cells to undergo CSR, or extrinsic factors such as the greater
interclonal competition from the larger pool of HEL- B cells in SWHEL × ML5
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Figure 4.7. Impaired maturation of self-reactive B cells is not due to intrinsic differences
between MD4 and SWHEL B cells. (A) Mixed BM irradiation chimeras were produced to track the
development of self-reactive MD4 and SWHEL B cells under identical conditions of antigenic
exposure and interclonal competition. BM cells were harvested from CD45.1+ SWHEL, CD45.1-
MD4 and CD45.1- WT mice and mixed in a ratio of 75:23:2. Lethally irradiated CD45.1- WT,
ML5 and AL3 Tg mice were reconstituted with mixed donor BM. (B) 2 months later splenocytes
from chimeric mice were stained for B220, CD45.1, CD23 and HEL-binding. After gating on
small lymphocytes to exclude MZ B cells (confirmed by separate CD21/35 stain), CD45.1+
SWHEL (blue circles) and CD45.1- MD4 (red circles) HEL+ B cells were gated separately and the
proportion of immature B cells with a CD23lo phenotype enumerated.
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mice. To distinguish these possibilities, mixed BM irradiation chimeras were
produced to track the development of self-reactive MD4 and SWHEL B cells
under identical conditions of antigenic exposure and interclonal competition
(Fig. 4.7 A). The ratio of donor WT, MD4 and SWHEL BM cells (2:23:75) was
chosen to reconstitute the recipient mice with approximately 50% non-Tg, 25%
MD4-derived HEL+ and 25% SWHEL-derived HEL+ B cells. MD4 and SWHEL
donor cells were distinguished on the basis of expression of the congenic
marker CD45.1 by the latter. In non-Tg WT recipients HEL+ B cells from both
MD4 and SWHEL mice matured normally into Fo and MZ B cells (data not
shown) and contained only low frequencies of immature B cells (Fig. 4.7 B). In
both ML5 and AL3 Tg recipients, however, very few HEL+ MD4 and SWHEL B
cells with a MZ B cell phenotype were detected (data not shown) and the
majority of the self-reactive B cells (40-50%) expressed the immature CD21/35lo
CD23lo phenotype. Thus, self-reactive MD4 B cells also failed to mature in the
presence of competitor B cells, as previously shown by Cyster and Goodnow
(Cyster et al. 1994; Cyster and Goodnow 1995). These data proved that anergic
SWHEL B cells did not undergo greater developmental arrest because of intrinsic
properties such as the ability to isotype switch. Rather the impairment of both
maturation and follicular localisation of anergic SWHEL B cells was due instead to
competition from the greater numbers of HEL- B cells in SWHEL compared to
MD4 mice.
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Figure 4.8. Anatomical localisation of anergic B cells in the spleen of MD4 and SWHEL double Tg
mice. Immunofluorescent staining was performed by Michelle Amesbury on spleen sections
from 9-12-week-old mice of the indicated genotypes. B cells in the primary follicle (Fo) were
stained purple and HEL-binding BCRs stained green. HEL+ B220+ B cells overlay purple and
green and therefore appear cyan. The marginal sinus is stained red to delineate the MZ (bar)
and Fo. The T cell-rich PALS is also indicated. Note the thin MZ in MD4 x ML5 and MD4 x AL3
mice made up of predominantly HEL- B cells and the clustering of immature HEL+ B cells at the
border between the follicle and PALS in SWHEL x ML5 mice. FACS® analysis of the same mice
are shown in Fig. 4.4. Similar data was obtained from independently analysed mice of the same
genotypes.
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4.3.7. Anergic SWHEL B cells fail to colonise the B cell areas of the spleen
Sections of spleens from single and double Tg mice were next analysed
by immunofluorescence microscopy to determine the anatomical localisation of
anergic MD4 and SWHEL B cells. WT, MD4 and SWHEL B cells colonised the
primary B cell follicle and MZ of the spleen with comparable efficiency (Fig. 4.8
A; B; and C). In the presence of sHEL, however, self-reactive HEL+ B cells from
MD4 × ML5, MD4 × AL3 and SWHEL × ML5 were almost completely eliminated
from the MZ compartment (Fig. 4.8 D; E; and F). More importantly, anergic
SWHEL × ML5 B cells also failed to enter the follicle and accumulated near the T-
B border (Fig. 4.8 F). This was not observed for anergic MD4 B cells even when
exposed to high levels of sHEL in MD4 × AL3 mice (Fig. 4.8 E). Moreover,
immunofluorescence microscopy confirmed the reduced frequency and
immature phenotype of anergic compared to non-self-reactive SWHEL B cells
(Fig. 4.8 C; and F) previously observed by FACS® analysis. Thus there were
marked differences in the splenic localisation of anergic SWHEL compared to
MD4 B cells that appeared to depend on the degree of interclonal competition
and not the level of exposure to self-antigen.
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Figure 4.9. Self-reactive SWHEL B cells readily proliferate and secrete IgM autoantibodies in
response to T cell-derived signals. CFSE-labelled small resting B cells purified from WT, MD4,
SWHEL and SWHEL x ML5 mice were stimulated with anti-CD40 mAb plus IL-4 for 4 days. Cells
were fixed, permeabilised and stained for HEL-binding. (A) Pseudo-colour plot of HEL-binding
versus CFSE for mice of the indicated genotypes. (B) Overlays of CFSE cell division profiles
showing the lower proliferative responses of MD4 and HEL+ SWHEL B cells compared to WT and
HEL+ SWHEL x ML5 B cells. HEL- B cells from SWHEL and SWHEL x ML5 mice exhibited similar
CFSE profiles to WT B cells (A; and data not shown). (C) Secretion of anti-HEL IgM antibodies
by WT, MD4, SWHEL and SWHEL x ML5 B cells. ELISA was performed on supernatants from
duplicate cultures. Data is representative of four independent experiments.
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4.4. CSR and Ig secretion by anergic B cells
4.4.1. Proliferation and secretion of IgM autoantibodies
Although immature self-reactive SWHEL B cells are hypo-responsive to
BCR ligation by antigen, their ability to respond to BCR-independent stimulation
remained to be tested. This is particularly relevant to the elucidation of the
mechanisms by which peripheral self-reactive B cells are prevented from
isotype switching and secretion of potentially pathogenic IgG autoantibodies
(Steward and Hay 1976; Papoian et al. 1977; Panosian-Sahakian et al. 1989;
Tillman et al. 1992; Peng et al. 2002). To assess the ability of anergic SWHEL B
cells to respond to BCR-independent stimuli, small resting B cells were purified
from WT, MD4, MD4 × ML5, SWHEL and SWHEL × ML5 mice, CFSE-labelled and
activated with either T cell-derived signals (anti-CD40 mAb plus IL-4) for 4 days
or LPS for 3 days. When the responses to anti-CD40 mAb plus IL-4 were
analysed, HEL+ MD4 and SWHEL B cells were found to have proliferated less
than WT and HEL- SWHEL B cells (Fig. 4.9 A; B; and data not shown). On the
other hand, HEL+ B cells from both SWHEL × ML5 (Fig. 4.9 A; and B) and MD4 ×
ML5 (data not shown) responded better than the corresponding non-self-
reactive B cells, with proliferation being comparable to that of WT B cells. Given
that anergic B cells had developed in the presence of sHEL, this finding
underscored the role of the BCR in modulating responsiveness to a TD
stimulus. ELISA performed on culture supernatant revealed that self-reactive
SWHEL B cells from double Tg mice were not only able to undergo rapid
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Figure 4.10. Self-reactive SWHEL B cells readily proliferate and secrete IgM autoantibodies in
response to LPS. CFSE-labelled small resting B cells purified from WT, MD4, SWHEL and SWHEL
x ML5 mice were stimulated with LPS for 3 days. Cells were fixed, permeabilised and stained for
HEL-binding. (A) Pseudo-colour plot of HEL-binding versus CFSE for mice of the indicated
genotypes. (B) Overlays of CFSE cell division profiles showing the slightly lower proliferative
responses of MD4, HEL+ SWHEL and SWHEL x ML5 B cells compared to WT B cells. HEL- B cells
from SWHEL and SWHEL x ML5 mice exhibited similar CFSE profiles to WT B cells (A; and data
not shown). (C) Secretion of anti-HEL IgM antibodies by WT, MD4, SWHEL and SWHEL x ML5
mice. ELISA was performed on supernatants from duplicate cultures. Data is representative of
four independent experiments.
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proliferation but also to secrete large quantities of anti-HEL IgM autoantibodies
following TD stimulation (Fig. 4.9 C).
By contrast, proliferative responses to the TI stimulus LPS did not vary
greatly between the different B cell populations and were identical for HEL+ B
cells from SWHEL and SWHEL × ML5 mice (Fig. 4.10 A; and B). ELISA performed
on culture supernatants showed that anergic SWHEL B cells secreted as much
anti-HEL IgM autoantibody as did non-self-reactive SWHEL B cells (Fig. 4.10 C).
Thus, proliferation and secretion of IgM autoantibodies were not impaired in
response to these BCR-independent stimuli in immature self-reactive B cells
despite the fact that they were excluded from the primary B cell follicle.
4.4.2. CSR and secretion of IgG autoantibodies
The regulation of CSR by anergic B cells is of more direct relevance to
the pathogenesis of autoantibody-mediated diseases and this was investigated
by analysing the capacity of small resting B cells from WT, MD4, MD4 × ML5,
SWHEL and SWHEL ×  ML5 mice to undergo CSR under the same TD and TI
stimuli in vitro culture conditions as described above. FACS® analysis revealed
that HEL+ B cells from both SWHEL and SWHEL × ML5 mice underwent efficient
isotype switching to IgG1 (Fig. 4.11 A) and IgG3 (Fig. 4.12 A) whereas minimal
switching occurred in MD4 B cells as expected (Fig. 4.11 A; and Fig. 4.12 A).
Back gating and "division-slicing" revealed that the proportion of IgG1+ B cells in
each cell division in response to anti-CD40 mAb plus IL-4 was superimposable
for HEL+ B cells obtained from SWHEL and SWHEL × ML5 mice  (Fig. 4.11 B).
Moreover, the cell division-dependent rate of switching was comparable to that
for WT B cells (Fig. 4.11 B). A similar trend was observed for switching to IgG3
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Figure 4.11. Self-reactive SWHEL B cells readily isotype switch and secrete IgG1 autoantibodies
in response to T cell-derived signals. CFSE-labelled small resting B cells were stimulated in vitro
as in Fig. 4.9 and stained for expression of HEL-binding and IgG1. (A) Pseudo-colour plots of
IgG1 expression versus CFSE for HEL+ and HEL- B cells from the indicated using the regions
shown in Fig. 4.9 A. (B) Analysis of switching per cell division. Gates were drawn around each
CFSE division peak as shown in Fig. 4.9 B and the proportion of IgG1+ cells in each division for
WT and HEL+ MD4, SWHEL and SWHEL x ML5 B cells calculated by backgating. (C) Secretion of
anti-HEL IgG1 antibodies by WT, MD4, SWHEL and SWHEL x ML5 B cells. ELISA was performed
on supernatants from duplicate cultures. Data is representative of four independent experiments.
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Figure 4.12. Self-reactive SWHEL B cells readily isotype switch and secrete IgG3 autoantibodies
in response to LPS. CFSE-labelled small resting B cells were stimulated in vitro as in Fig. 4.10
and stained for expression of HEL-binding and IgG3. (A) Pseudo-colour plots of IgG3 versus
CFSE for HEL+ and HEL- B cells from the indicated using the regions shown in Fig. 4.10 A. (B)
Analysis of switching per cell division. Gates were drawn around each CFSE division peak as
shown in Fig. 4.10 B and the proportion of IgG3+ cells in each division for WT and HEL+ MD4,
SWHEL and SWHEL x ML5 B cells calculated by backgating. (C) Secretion of anti-HEL IgG3 anti-
bodies by WT, MD4, SWHEL and SWHEL x ML5 B cells. ELISA was performed on supernatants
from duplicate cultures. Data is representative of four independent experiments.
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in response to LPS (Fig. 4.12 B). Secretion of anti-HEL IgG1 (Fig. 4.11 C) and
IgG3 (Fig. 4.12 C) mirrored the degree of switching observed by FACS®
analysis. In other words, anergic SWHEL B cells secreted at least as much anti-
HEL IgG antibody as did non-self-reactive SWHEL B cells consistent with the
proposition that anergic B cells have no intrinsic block to CSR or to the
subsequent secretion of potentially pathogenic IgG autoantibodies in response
to BCR-independent stimulation.
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4.5. Discussion
4.5.1. A new model of B cell self-tolerance
The SWHEL model of B cell self-tolerance represents a significant
advance on the original MD4 model that has been used for more than 15 years
to study the regulation of B cell responses. Not only can the development and
fate of self-reactive HEL+ B cells be tracked efficiently in SWHEL mice but the
presence of significant numbers of non-self-reactive HEL- B cells also provided
a useful internal control when analysing the mechanisms of antigen-specific
induction of self-tolerance. More importantly, the diverse polyclonal BCR
repertoire expressed by these HEL- B cells means that the SWHEL model more
closely approximates physiological conditions than the conventional MD4
model. The data presented here demonstrate that the presence of the non-self-
reactive HEL- B cell population is germane to the alternative phenotypes and
peripheral fates of anergic B cells in the two systems.
4.5.2. Phenotype and fate of anergic B cells in the periphery
Both HEL+ MD4 and SWHEL B cells were deleted in the BM on exposure
to high avidity antigen (Fig. 4.1; and (Hartley et al. 1991)). However, the
development of self-reactive MD4 and SWHEL B cells diverged when they were
exposed to lower avidity self-antigen. Under these circumstances, both
populations escaped clonal deletion and emigrated to the spleen (Fig. 4.2)
where they demonstrated the hallmarks of clonal anergy (Fig. 4.3). These
included downmodulation of surface IgM (Fig. 4.3 A), failure to secrete anti-HEL
Igs (Fig. 4.3 B) and hypo-responsiveness to BCR stimulation (Fig. 4.3 C).
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Nevertheless, unlike anergic MD4 B cells, most anergic SWHEL B cells had an
immature (CD21/35lo CD23lo) phenotype (Fig. 4.4) and were arrested in their
migration at the T-B border (Fig. 4.5). As expected for immature B cells, anergic
SWHEL B cells had a reduced lifespan (t1/2 <3 days; Fig. 4.5) and were
consequently found to be present at a reduced in frequency in the spleen (Fig.
4.2). In contrast, anergic MD4 B cells were present at an unaltered frequency
(Fig. 4.2), displayed a predominantly mature (CD21/35int CD23hi) Fo B cell
phenotype (Fig. 4.4), had a normal lifespan (Fig. 4.5) and efficiently colonised
the follicle (Fig. 4.8).
These differences could not be explained by variations in the degree of
interaction with self-antigen because direct measurement of BCR occupancy
clearly showed that the HEL+ SWHEL ×  ML5 B cells had a level of BCR
occupancy intermediate between that of HEL+ B cells from MD4 × ML5 and
MD4 × AL3 double Tg mice (Fig. 4.6). Furthermore, mixed BM irradiation
chimeras established that the impaired maturation of anergic SWHEL B cells was
not due to intrinsic differences between MD4 and SWHEL B cells, but rather was
dependent on the presence of a large pool of competitor HEL- B cells (Fig. 4.7).
This demonstration that the differences in phenotype between the two types of
anergic B cells can be explained solely by interclonal competition has finally
resolved a long-standing controversy surrounding the fate of anergic B cells in
the spleen.
4.5.3. Physiological basis of follicular exclusion
This controversy stemmed from independent studies based on the
original anti-HEL double Tg model that led to two differing theories on the
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mechanism of follicular exclusion. In the presence of interclonal competition, the
failure of self-reactive B cells to enter the follicle was considered to have arisen
as a result of their inability to compete successfully with non-self-reactive B cells
for essential migratory and survival signals (Cyster et al. 1994; Cyster and
Goodnow 1995). The alternative explanation was that the introduction of HEL- B
cells also decreased the pool of HEL+ B cells thereby effectively increasing the
amount of self-antigen available to bind to the BCR (Cook et al. 1997). In other
words, follicular exclusion was not due to active competition from non-self-
reactive B cells but was a passive consequence of higher levels of available
self-antigen due to the presence of HEL- B cells. In support of this interpretation
was the previous demonstration of arrested migration of self-reactive B cells at
the T-B border of some MD4 × AL3 and also MD4 × ML5 double Tg mice
induced with zinc to secrete higher levels of sHEL (Cook et al. 1997).
The simultaneous measurement of competitor HEL- B cell frequency and
BCR occupancy by self-antigen (Fig. 4.6) was combined with analysis of mixed
BM irradiation chimeras (Fig. 4.7) in the current study to show unequivocally
that the impaired migration, maturation and survival of anergic SWHEL B cells
was solely due to competition from HEL- B cells. Critical to this conclusion was
that MD4 × AL3 mice examined for this thesis contained <10% HEL- B cells
(Fig. 4.2 A) and possessed anergic HEL+ B cells that had 90-100% saturation of
their BCRs with self-antigen (Fig. 4.6). In spite of this, anergic B cells from these
mice survived at normal frequencies (Fig. 4.2 B), matured normally to the Fo
stage (Fig. 4.4), had a normal lifespan (Fig. 4.5) and colonised the follicle (Fig.
4.8 E). The discrepancy between the results obtained by Cook and colleagues
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(Cook et al. 1997) and those reported herein almost certainly relates to the
older mice used in their experiments (16- to 36-weeks-old) because HEL- MD4
B cells accumulate with age (Fulcher and Basten 1994) and are clearly present
at high frequencies in the mice used in their experiments (Cook et al. 1997). In
contrast, the mice used for the experiments reported herein were all <12-
weeks-old.
4.5.4. Competitive elimination of peripheral self-reactive B cells
Although the studies reported here and by other groups (Cyster et al.
1994; Cyster and Goodnow 1995; Ekland et al. 2004) show that follicular
exclusion was dependent on the presence of competitor B cells, the mechanism
by which interclonal competition leads to elimination of anergic B cells is still not
completely understood. It was originally proposed that anergic B cells are
indirectly eliminated from the periphery due to their exclusion from access to
survival and maturation signals available in the follicular microenvironment
(Cyster et al. 1994). However, self-reactive CCR7-deficient B cells, although
able to colonise the follicle, still have a shortened lifespan and are eliminated
from the periphery (Ekland et al. 2004). In other words, competitive peripheral
elimination appears to occur independently of follicular exclusion.
This raises the question of what signals anergic and non-self-reactive B
cells may be competing for. One likely candidate may be BAFF as anergic B
cells have recently been reported to be more dependent on BAFF-mediated
signalling for survival than naïve B cells (Lesley et al. 2004). If correct, anergic
B cells should be able to be rescued by increasing the amount of available
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BAFF (e.g. by crossing SWHEL × ML5 with BAFF Tg mice) resulting in their
peripheral maturation and colonisation of the follicle (Thien et al. 2004).
4.5.5. Regulation of CSR by anergic B cells
Given that anergic B cells spontaneously generated within a normal
repertoire are not only capable of CSR but are also likely to be immature, the
availability of anergic SWHEL B cells with a similar immature phenotype in the
current model provided an opportunity to re-evaluate the findings obtained in
the original model using mature self-reactive MD4 B cells. In addition, the fact
that SWHEL B cells have the capacity to Ig isotype switch allowed the regulation
of CSR by anergic B cells to be studied for the first time. This is particularly
relevant because IgG autoantibodies are more pathogenic (Steward and Hay
1976; Papoian et al. 1977; Panosian-Sahakian et al. 1989; Tillman et al. 1992;
Peng et al. 2002) but less prevalent (George and Shoenfeld 1996; Peng et al.
2002) than IgM autoantibodies. For this reason, it was possible that intrinsic
controls over CSR by anergic B cells are required to reinforce peripheral B cell
tolerance and to prevent autoimmunity.
Anergic SWHEL B cells proliferated vigorously in response to BCR-
independent stimulation with anti-CD40 mAb plus IL-4 (Fig. 4.9) or LPS (Fig.
4.10). Moreover, they underwent efficiently isotype switching and secreted anti-
HEL IgG1 (Fig. 4.11) and IgG3 autoantibodies (Fig. 4.12) in response to the
same in vitro stimuli. Thus, whilst anergic B cells are hypo-responsive to BCR
triggering by self-antigen, they retain the capacity to respond to BCR-
independent signals normally.
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The lack of intrinsic controls over CSR and secretion of potentially
pathogenic IgG autoantibodies by anergic B cells points to the need to impose
additional controls on these cells to prevent their inadvertent activation by BCR-
independent signals. In the case of TD signals, the requirement for BCR-
mediated upregulation of CD86 to facilitate delivery of productive T cell help
(Rathmell et al. 1996; Rathmell et al. 1998) and its abrogation in anergic SWHEL
B cells (Fig. 4.3 C) means that they are unlikely to encounter TD signals such
as CD40L plus IL-4. In contrast, access to TI-1 stimuli such as LPS, which
activate B cells in the absence of BCR engagement, must be restricted to
prevent IgG autoantibody secretion. Two ways to achieve this goal were
demonstrated in the SWHEL model of B cell self-tolerance. The first involved
limiting the survival of anergic B cells in the periphery (Fig. 4.8) and the second
involved the restriction of their entry into the follicle and MZ. In the latter case,
the purging of anergic B cells from the MZ is likely to be particularly important
as blood-borne pathogens (such as Gram-negative bacteria bearing LPS) are
directly filtered through the MZ via the marginal sinus (Kraal 1992).
Significantly, inhibition of maturation, survival and follicular homing by anergic B
cells was shown to depend on the presence of competitor B cells, whereas the
purging of anergic B cells from the MZ was not (Fig. 4.5). Therefore this aspect
of anergic B cell regulation could well be fundamental to the induction and
maitenance of peripheral B cell self-tolerance.
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4.5.6. Final comments
These data suggest that acute exposure to LPS may trigger IgG
autoantibody production by anergic B cells despite their restricted lifespan and
migration. Such a conclusion is in agreement with previous studies showing that
LPS administration can result in secretion of pathogenic IgG autoantibodies,
induction of nephritis in normal mice and exacerbation of nephritis in lupus-
prone mice (Hang et al. 1983; Cavallo and Granholm 1990; Granholm and
Cavallo 1992). A similar mechanism may explain the long-recognised
association between systemic infection and clinical relapses of SLE (Wallace
and Dubois 1987). Exposure of anergic B cells to LPS may not only induce
secretion of IgG autoantibodies directly as LPS may upregulate CD86
expression (Hathcock et al. 1994) thereby circumventing the BCR-signalling
defects characteristic of anergic B cells and facilitate their TD activation. As
demonstrated here, activation by CD40L plus IL-4 delivered in this scenario
could also trigger secretion of IgG autoantibodies.
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5.1. Preamble
The study of in vivo B cell activation has been hampered over the years by the
inability to track early events following antigen engagement. With the advent of
Ig-Tg (and TCR-Tg) mice precise tracking of antigen-specific cells became
feasible, thereby providing insight into some of these early events, such as the
visualisation of negative selection within GCs (Shokat and Goodnow 1995) and
the localisation of CD4+ T cell help to the T-B border (Garside et al. 1998).
However, most Ig transgenes only encode the µ and δ heavy chains rendering
them inaccessible to conventional CSR. Moreover, Ig-Tg mice often possess
multiple copies of the Ig transgene making it difficult to track SHM. In contrast,
the targeting of the rearranged VH10 variable gene to the IgH locus in SWHEL
mice made it possible to closely monitor the in vivo responses of HEL+ B cells
which are capable of both CSR and SHM. This chapter describes the response
of adoptively transferred SWHEL B cells to challenge with HEL conjugated to the
carrier SRBC and the requirements for T cell help in this response. It also
describes the use of the SWHEL model to compare the in vivo TD responses of
purified Fo and MZ B cells within an intact immune system.
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5.2. SWHEL response to HEL-SRBC
5.2.1. Rationale for use of SRBCs as a carrier
In order to study TD responses, SWHEL splenocytes (CD45.2+) were
adoptively transferred into WT CD45.1+ congenic recipients together with 2 x
108 HEL-SRBCs. The rationale for using SRBCs as a carrier was to provide a
strong source of primary T cell help to overcome the low-responder I-Ab class II
MHC expressed by C57BL/6 mice for HEL-specific T cell epitopes (Gammon et
al. 1987). The number of transferred cells was limited so as to contain only 1 ×
104 HEL+ B cells for two reasons. The first was to prevent the proportion of
HEL+ B cells from being in too great an excess over the available SRBC-
specific T cell help. The second was to ensure that their frequency (~1 in 104 B
cells assuming that there are 108 B cells in the recipient spleen) approximated
that of antigen-specific B cells in the normal repertoire. For example, the
frequency of anti-phosphorylcholine B cells in mice have been estimated at 2 in
105 B cells (reviewed in (Klinman et al. 1976)) and the frequency of influenza-
specific B cells (Yarchoan et al. 1981; Sigal et al. 1987) and hepatitis B surface
antigen-specific B cells (Shokrgozar and Shokri 2001) in humans have been
estimated to be ~1 in 105 to 1 in 104 B cells. FACS® analysis of splenocytes
from recipient mice allowed precise tracking of the donor cells during the
response by staining for the antigen-specific BCR (HEL-binding) in conjunction
with the CD45 congenic marker (CD45.2).
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Figure 5.1. Visualising the expansion of SWHEL B cells in response to HEL-SRBC. (A) 104 HEL+
B cells were transferred together with either mock-conjugated SRBCs (upper panels) or HEL-
conjugated SRBCs (lower panels). Splenocytes from recipient mice were harvested on day 7
and stained with anti-CD45.2-FITC, anti-IgG1-PE and HEL plus HyHEL-5-A647. Pseudo-colour
plots of FSC and SSC profiles were used to delineate lymphocytes (left panels). Pseudo-colour
plots of FL2 (anti-IgG1-PE) and FL3 (empty channel) were used to identify autofluorescent cells
(mostly granular NK cells). These were dumped and the remaining cells analysed for expression
of CD45.2 and HEL-binding. Note that IgG1+ cells in mice given mock-conjugated SRBCs did
not fluoresce in FL3. In addition, the single colour FL2 compensation control did not fluoresce in
FL3 (data not shown). By contrast, there is a distinct population of IgG1+ cells that fluoresce in
FL3 in mice given HEL-SRBC (red arrow). These IgG1+ cells are all HEL+ CD45.2+ (data not
shown). (B) Splenocytes from (A) were also stained with anti-CD45.2-FITC, anti-syndecan-1-PE
and HEL plus HyHEL-5-A647. Under these circumstances, there is no fluorescence energy
transfer between anti-syndecan-1-PE and HyHEL-5-A647. Numbers indicate the percentage of
cells in the gates shown.
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5.2.2. Visualising the response of SWHEL B cells to HEL-SRBC
To visualise the responses to HEL-SRBC, adoptively transferred SWHEL
B cells were initially analysed using the FACSCalibur™ on day 7 after challenge
(Fig. 5.1). The gating strategy that was used to identify the responding donor B
cells is as follows. Splenocytes were stained with anti-CD45.2-FITC (detected in
the FL1 channel), HEL plus HyHEL-5- Alexa Fluor® 647 (FL4) and either anti-
IgG1-PE or anti-syndecan-1-PE (FL2). The empty FL3 channel was used to
identify autofluorescent cells comprising predominantly granular NK cells.
These cells constituted 1-2% of splenocytes and display low levels of
autofluorescence in all four channels (Fig. 5.1; and data not shown).
Autofluorescent (FL3+) cells in the lymphocyte gate were therefore "dumped" to
allow unequivocal identification of CD45.2+ HEL+ donor B cells (Fig. 5.1).
Splenocytes from mice given SWHEL B cells and mock-conjugated
SRBCs contained a large population of IgG1+ cells (Fig. 5.1 A), which were not
detectable in unimmunised recipients (data not shown) and presumably
represented the endogenous response to SRBCs. In mice given HEL-SRBC
there was an additional population of IgG1+ cells that display high levels of
fluorescence in the FL3 channel (Fig. 5.1 A). This was not a compensation
artefact as the IgG1+ cells in mice given mock-conjugated SRBCs (Fig. 5.1 A)
and single colour compensation control (data not shown) displayed low levels of
fluorescence in FL3. Cells in this IgG1+ FL3+ population were in fact all HEL+
responding donor B cells (data not shown). In contrast, when stained for anti-
syndecan-1-PE, no equivalent population of FL3+ syndecan-1hi responding
donor B cells was observed (Fig. 5.1 B).
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Figure 5.2. Fluorescence energy transfer between anti-IgG1-PE and HyHEL-5-A647 conjugates.
(A) Fluorescence emission spectra of PE fluorochromes overlap with the excitation spectra for
A647. The emission spectra of A647 excited by PE in this way can be detected by the
photomultiplier tubes in FL3. However, the emission spectra of A647 normally excited by the
635 nm laser is not detected in FL3 because of the time-delay in the FACSCalibur™. In fact,
tandem PE-A647 conjugates are available commercially. (B) Mechanism of fluorescence energy
transfer between anti-IgG1-PE bound to surface anti-HEL IgG1 and HyHEL-5-A647 used to
detect HEL-binding BCRs. Since both mAbs are staining the same surface molecule, the short
distance between them allows PE to excite A647. (C) Energy transfer fails to occur between
anti-syndecan-1-PE and HyHEL-5-A647 because they stain two separate surface molecules
that are further apart. Thus, the PE emission has dissipated by the time it reaches the A647
conjugate and therefore is not able to excite it.
The Fluorescence Spectrum Viewer can be downloaded as an applet from the website
http://www.bdbiosciences.com.spectra.
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The explanation for the high FL3 intensity of HEL+ IgG1+ but not HEL+
syndecan-1hi B cells is provided in Fig. 5.2. The FACSCalibur™ utilises a 488nm
Argon laser to excite fluorochromes such as FITC (FL1), PE (FL2) and PerCp,
PE-Cy5 or PI (FL3) in conjunction with a 635 nm Helium-Neon laser for exciting
fluorochromes such as APC and Alexa Fluor®  647 (FL4). To distinguish
between the overlapping emission spectra of fluorochromes such as PerCp in
FL3 and Alexa Fluor® 647 in FL4 (Fig. 5.2 A) there is a time delay between the
photomultiplier tubes (PMTs) used to detect signals elicited by the two lasers
(technical information available from the FACSCalibur™ Operations Manual and
can be downloaded from the BD website http://www.bdbiosciences.com).
However, PE excited by the 488 nm Argon laser has emission spectrum that
overlaps the excitation spectrum for Alexa Fluor® 647 (Fig. 5.2 A) and can
therefore stimulate any Alexa Fluor® 647-conjugated mAbs that happen to bind
to surface molecules in close proximity to it; under these circumstances, the
Alexa Fluor®  647 emission will be detected by PMTs in the FL3 channel
because they are stimulated by the Argon laser and therefore not subject to a
time delay. Fluorescence energy transfer occurs between anti-IgG1-PE and
HyHEL-5-Alexa Fluor® 647 because they are staining the same molecule (one
binds the Fc and the other the Fab portion of the anti-HEL IgG1 molecule; Fig.
5.2 B). In this respect, they are acting in concert as a tandem dye. On the other
hand, no energy transfer occurs between anti-syndecan-1-PE and HyHEL-5-
Alexa Fluor® 647 because they bind different surface molecules that are further
apart (Fig. 5.2 C). Therefore the gating strategy shown in Fig. 5.1 was
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Figure 5.3. Antigen-specific expansion, class switching and plasma cell generation by SWHEL B
cells in adoptive transfer. (A) 104 CD45.2+ HEL+ SWHEL B cells were adoptively transferred
together with mock-conjugated or HEL-conjugated SRBCs. CD45.2- recipients were sacrificed
after 7 days and splenocytes stained for surface expression of CD45.2, HEL-binding and IgG1.
Numbers indicate the percentage of live cells in the gates shown. (B) Pseudo-colour plot of
HEL-binding and IgG1 expression by CD45.2+ donor cells from mice given HEL-SRBC using
the gates shown in (A). Numbers indicate the percentage of CD45.2+ cells in the gate shown.
(C) Identification of ASCs on day 5 of the response. Recipient mice were sacrificed after 5 days
and stained for CD45.2, syndecan-1 and PI. Cells were then sorted by the FACSVantage™ into
CD45.2hi syndecan-1lo PIlo (red) and CD45.2int syndecan-1hi PIlo (blue) cells for ELISPOT assay.
Numbers indicate the percentage of live cells in the gates shown.
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employed to exclude autofluorescent FL3+ cells but retain the IgG1+ HEL+ cells
emitting in FL3 due to fluorescent energy transfer.
5.2.3. SWHEL B cells switch predominantly to IgG1 and rapidly generate
ASCs in response to HEL-SRBC
Using the above gating strategy, expansion of CD45.2+ HEL+ donor B
cells was evident in recipients 7 days after challenge with HEL-SRBC (Fig. 5.3
A). This expansion was antigen-specific since it did not occur in recipients of
SWHEL splenocytes immunised with mock-conjugated SRBCs (Fig. 5.3 A). At
this point of the response, 90-100% of HEL+ CD45.2+ B cells expressed the
activation markers CD95, GL7 and PNA (data not shown), approximately 60%
had undergone CSR to IgG1 (Fig. 5.3 A), and up to 30% had differentiated into
syndecan-1hi cells (Fig. 5.3 B). IgG1 is the predominant isotype in the anti-
SRBC response and is determined primarily by the nature of the T cell help
(Rosenberg and Chiller 1979; Slack et al. 1980; Phillips and Campbell 1982;
Shinall et al. 2000). Therefore it is likely that anti-SRBC T cells also directed
HEL+ SWHEL B cells to switch to IgG1. Expression of syndecan-1 was
associated with increased FSC and downregulation of surface BCR and
CD45.2 expression (Figs. 5.3 B; and data not shown). To identify ASCs, live
cells from the two populations of responding cells were sorted by FACS® and
assayed for secretion of anti-HEL IgG1 by ELISPOT analysis. This showed that
ASCs producing anti-HEL IgG1 antibodies resided almost exclusively in the
CD45.2int syndecan-1hi but not in the CD45.2hi syndecan-1lo compartment (Fig.
5.3 B).
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Figure 5.4. SWHEL B cells make a robust serum anti-HEL antibody response to HEL-SRBC. 104
HEL+ B cells were transferred together with either 2 x 108 HEL-SRBC (red circles) or mock-
conjugated SRBCs (blue circles). Recipient mice were sacrificed on day 7 and sera collected for
measurement of anti-HEL Igs by indirect ELISA. Mice inoculated with HEL-SRBC but not given
HEL+ B cells did not produce any detectable levels of anti-HEL Igs by day 7 (data not shown).
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5.2.4. Secretion of anti-HEL IgG1 in response to HEL-SRBC
By day 7, SWHEL B cells transferred together with HEL-SRBC had made
a robust anti-HEL antibody response (Fig. 5.4). The level of anti-HEL IgG1 was
8-fold higher than that of anti-HEL IgM and accounted for majority of the total
anti-HEL Igκ antibody response. Although both anti-HEL IgG2a and IgG2b
antibodies were detectable, they were only present at very low concentrations
(Fig. 5.4). Therefore, consistent with the FACS® data, the response to HEL-
SRBC is characterised predominantly by isotype switching to IgG1. Production
of anti-HEL antibodies was again antigen-specific since none were detected in
recipients of SWHEL splenocytes challenged with mock-conjugated SRBCs (Fig.
5.4). In addition, no anti-HEL antibodies were detected in mice inoculated with
HEL-SRBC alone (data not shown) indicating that they were produced entirely
by the transferred HEL+ B cells.
5.2.5. Response of SWHEL B cells to HEL-SRBC is T cell-dependent
The murine antibody response to SRBCs are classically considered to be
TD (Miller et al. 1967; Mitchell and Miller 1968). To determine whether this was
also true for the response of SWHEL HEL+ B cells to HEL-SRBC in the current
adoptive transfer system, SWHEL × BALB/c spleen cells were co-transferred with
HEL-SRBC into T cell-deficient nu/nu (athymic) mice or WT syngeneic (BALB/c)
controls. The T cell dependence of the response was confirmed by the 100-fold
lower levels of serum anti-HEL IgG1 and 100-fold fewer splenic IgG1+ HEL+
cells observed in nu/nu recipients (Fig. 5.5 A). The response was also shown to
depend on CD40L-CD40-induced proliferation and survival since the transfer of
SWHEL HEL+ B cells lacking CD40 expression into syngeneic (C57BL/6) WT
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Figure 5.5. The SWHEL response to HEL-SRBC is T cell-dependent and regulated by B cell-
derived CD40 and non-B cell-derived IL-4. (A) 104 HEL+ B cells from a SWHEL mouse on a
BALB/c background were transferred together with either 2 x 108 HEL-SRBC (closed symbols)
or mock-conjugated SRBCs (open symbols) into WT BALB/c (circles) or athymic nu/nu mice
(triangles). (B) 104 HEL+ CD45.2+ B cells from SWHEL x cd40+/- (circles) or SWHEL x cd40-/- mice
(triangles) were transferred and challenged as above. (C) 104 HEL+ CD45.1+ B cells from a
SWHEL x C57BL/6.SJL-Ptprca mouse were transferred into WT (circles) and IL-4-deficient
(triangles) recipients and challenged as above. Sera were collected for measurement of anti-
HEL IgG1 (left panels) and spleens analysed by FACS® to enumerate the expansion of either
(A) IgG1+ HEL+, (B) CD45.2+ HEL+ or (C) CD45.1+ HEL+ donor B cells (right panel) on either
day 7 [(A) and (B)] or day 6 of the response (C). The response in WT and IL-4-deficient recipient
mice was further analysed to determine the proportion of CD45.1+ HEL+ donor B cells that had
isotype switched to IgG1 and differentiated into syndecan-1hi ASCs. Data points represent single
mice and bars indicate the geometric mean of the serum anti-HEL IgG1 levels for each group.
Columns represent the mean of the responding donor cells recovered for each group. Data is
representative of two independent experiments.
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recipients resulted in 16-fold lower levels of serum anti-HEL IgG1 and 600-fold
fewer splenic CD45.2+ HEL+ cells (Fig. 5.5 B). Further, IL-4 was found to be
important for isotype switching to IgG1; thus, serum anti-HEL IgG1 levels were
reduced 5-fold and the proportion of IgG1+ responding B cells was decreased
10-fold from 50% to 5% in il4-/- recipients (Fig. 5.5 C). However, the proportion
of responding cells that differentiated into ASCs was not significantly affected in
the IL-4-deficient recipients  (Fig. 5.3 C).
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Figure 5.6. Purification of Fo and MZ SWHEL B cells. Splenocytes were harvested from SWHEL
mice, red cell lysed and depleted of adherent cells and T cells. Purified B cells were stained with
CD21/35, CD23 and PI. (A) Live Fo (CD21/35int CD23hi PIlo) and MZ B cells (CD21/35hi CD23lo
PIlo) were sorted using the gates shown to >99% purity. (B) Re-analysis showed that the sorted
MZ B cells (bottom panel) had higher FSC than the sorted Fo B cells (top panel). (C) An aliquot
of the sorted populations were additionally stained for B220 and HEL-binding to determine the
proportion of HEL+ B cells and hence the number of sorted cells required to transfer 104 HEL+
Fo and MZ B cells. Numbers indicate the percentage of cells in the gates shown.
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5.3. TD response of Fo versus MZ B cells in vivo
5.3.1. Purification of Fo and MZ SWHEL B cells
To compare the relative abilities of Fo and MZ B cell subsets to mount a
TD immune response, CD21intCD23hi Fo and CD21hiCD23lo MZ B cells were
purified from SWHEL mice by electronic cell sorting (Fig. 5.6 A). The purity of the
sorted populations was reproducibly >98% and their phenotypes conformed to
those typical of Fo and MZ B cells in terms of cell size (FSClo vs FSChi
respectively, Fig. 5.6 B) and CD1d expression (CD1dlo vs CD1dhi respectively,
data not shown). The frequencies of HEL+ B cells in the sorted Fo and MZ
populations were equivalent and mirrored the frequency in unsorted SWHEL B
cells (Fig. 5.6 C; and data not shown). Purified Fo and MZ B cells were then
transferred together with HEL-SRBC into non-irradiated WT CD45.1 congenic
recipients such that each recipient was given 1 × 104 HEL+ B cells. Since donor
B cells were deliberately not sorted on the basis of BCR specificity, recipients
coincidentally received 4-9 × 104 HEL- B cells due to the fact that SWHEL mice
also contained a polyclonal population of HEL- B cells generated by VH gene
replacement (Section 3.3). Thus, HEL+ B cells typically comprised 10-20% of
both the Fo and MZ donor populations used for adoptive transfer (Fig. 5.6 C).
5.3.2. Fo and MZ B cells both make efficient IgM and IgG1 responses to
HEL-SRBC
Analysis of serum antibodies in recipients of the two subsets revealed
that Fo and MZ SWHEL B cells produced anti-HEL IgM and IgG1 with similar
kinetics over a 10-day period (Fig. 5.7). In each case, only anti-HEL IgM was
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Figure 5.7. Secretion of anti-HEL Ig’s by Fo and MZ SWHEL B cells in response to HEL-SRBC.
104 HEL+ Fo and MZ B cells were purified from a SWHEL mouse and adoptively transferred
together with HEL-SRBC into WT recipients and sera collected on day 3, 5, 7 and 10. (A) Serum
anti-HEL IgM response. (B) Serum anti-HEL IgG1 response. Each data point represents single
mice and bars represent the geometric mean of the serum anti-HEL Ig level for each group.
Data is representative of three experiments. Control mice inoculated with HEL-SRBC but not
given any HEL+ B cells did not produce any detectable anti-HEL IgM or IgG1 at any of the time-
points (data not shown).
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detectable on day 3 (Fig. 5.7 A) whereas anti-HEL IgG1 predominated by day 5
and increased further until day 10 of the response (Fig. 5.7 B). The magnitude
of the response in each case was similar with the exception of day 5, where the
production of both IgM (Fig. 5.7 A) and IgG1 (Fig. 5.7 B) by MZ B cells was
lower than that by Fo B cells. Interestingly, no rapid initial burst of anti-HEL IgM
was observed for HEL+ MZ B cells. Furthermore, HEL+ MZ B cells generated an
efficient TD response characterised by isotype switching to IgG1.
5.3.3. MZ B cells do not expand as rapidly as Fo B cells in response to
HEL-SRBC
The slight lag observed in the anti-HEL antibody response of MZ SWHEL
B cells was accompanied by an even more dramatic delay in their cellular
expansion in the spleens of recipient mice. For example, the number of
CD45.2+ HEL+ B cells recovered from recipients of MZ versus Fo B cells was
lower at day 3 (14-fold), day 5 (7-fold) and day 7 (2-fold), and did not reach
parity until after the peak of the response on day 10 (Fig. 5.8 A). In addition, at
the peak of the response on day 7, the number of responding HEL+ MZ B cells
were still 2-fold less than the number of responding HEL+ Fo B cells (Fig. 5.8 A).
This unexpected delay in the in vivo expansion of HEL+ MZ B cells was contrary
to previous in vitro data (Oliver et al. 1997; Oliver et al. 1999) and the similar
rates of Ig secretion by HEL+ Fo and MZ B cells (Fig. 5.7).
5.3.4. MZ as well as Fo B cells switch to IgG1 and differentiate into ASCs
Despite the delayed expansion of the responding HEL+ MZ B cells, their
ability to switch to IgG1 was not compromised compared to Fo B cells. Thus the
proportion of IgG1+ cells within the responding CD45.2+ HEL+ B cell populations
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Figure 5.8. Enumeration of the cellular response by Fo and MZ SWHEL B cells to HEL-SRBC. Fo
and MZ SWHEL B cells were transferred and challenged as for Fig. 5.7 and spleens from the
recipient mice harvested at the indicated time-points. Splenocytes were stained for CD45.2,
HEL-binding and either IgG1 or syndecan-1. (A) Total number of responding CD45.2+ HEL+ B
cells. (B) Proportion of responding CD45.2+ HEL+ B cells that had undergone CSR to IgG1. (C)
Proportion of CD45.2+ HEL+ donor B cells that had differentiated into CD45.2lo syndecan-1hi
ASCs. Columns represent the mean of the data points. Data is representative of three experi-
ments.
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was similar at all time points regardless of the Fo or MZ origin of the donor B
cells (Fig. 5.8 B). On the other hand, the responding MZ B cells contained a
higher proportion of syndecan-1hi cells than that of their Fo counterparts at days
5 and 7 of the response (Fig. 5.8 C). Since this population contains the splenic
ASCs (Fig. 5.3 B), it is likely that the more efficient generation of ASCs by the
responding MZ B cells explains why their antibody secreting potential is similar
to that of Fo B cells (Fig. 5.7) even though their expansion lags significantly
behind (Fig. 5.8 A).
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Figure 5.9. Expression of activation markers by Fo and MZ B cells following in vivo challenge
with HEL-SRBC. Splenocytes from immunised recipient mice were harvested on day 5 and
stained for expression of CD45.2, HEL-binding and either (A) CD95 (Fas), (B) GL7 or (C) PNA.
Splenocytes from an unimmunised SWHEL mouse were also stained for expression of CD21/35,
HEL-binding and the relevant activation marker to determine the baseline level of expression by
HEL+ CD21/35int Fo and HEL+ CD21/35hi MZ B cells. Pseudo-colour plots show expression of
HEL-binding and the relevant activation marker by CD45.2+ HEL+ Fo (left panels) and MZ (right
panels) B cells. Overlay histograms show the baseline expression of the relevant activation
marker by naïve (black histogram) and immunised (coloured histogram) Fo and MZ B cells.
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5.4. Fate of activated Fo versus MZ B cells
5.4.1. Fo and MZ B cells express similar levels of CD95, GL7 and PNA
following in vivo activation with HEL-SRBC
The expression of CD95, GL7 and PNA was analysed to determine if the
delayed expansion of MZ versus Fo HEL+ B cells was due to differences in their
in vivo activation. Naïve HEL+ MZ B cells express slightly higher levels of CD95
than their Fo counterparts (Fig. 5.9 A). However, 5 days after transfer and
challenge with HEL-SRBC, both HEL+ Fo and MZ B cells had upregulated the
level of CD95 expression to similar levels (Fig. 5.9 A). Likewise, expression of
GL7 (Fig. 5.9 B) and PNA (Fig. 5.9 C) was upregulated to the same extent in
HEL+ Fo and MZ B cells. These data therefore did not detect any differences in
the activation signals received by HEL+ Fo and MZ B cells in vivo.
5.4.2. MZ B cells are poorly recruited into the TD response to HEL-SRBC
The basis of the delayed expansion of MZ versus Fo HEL+ B cells was
investigated by comparing the relative abilities of the two subpopulations to
home to the spleen and proliferate in response to HEL-SRBC. To do this, Fo
and MZ B cells were purified from the spleen of SWHEL (CD45.1+ congenic)
mice, labelled with the dye CFSE (Lyons and Parish 1994) and transferred into
WT C57BL/6 (CD45.2+) mice with either HEL-SRBC or mock-conjugated
SRBCs. CD45.1 congenic SWHEL donors were used because of the availability
of the anti-CD45.1-PE mAb made it easy to track CFSE+ CD45.1+ donor B cells.
Splenocytes were harvested from recipient mice 64 hours after transfer, stained
for CD45.1 and HEL-binding and analysed by flow cytometry.
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Figure 5.10. Impaired recruitment of MZ compared to Fo SWHEL B cells in the response to HEL-
SRBC. (A) 2 x 104 HEL+ CD45.1+ Fo and (B) MZ B cells were CFSE-labelled and transferred
together with either 5 x 108 HEL-SRBC or mock-conjugated SRBCs. CD45.1- recipient mice
were sacrificed after 64 hours and splenocytes were stained for CD45.1 and HEL-binding.
Pseudo-colour plots are gated on CD45.1+ lymphocytes. Numbers within the panels indicate the
percentage of CD45.1+ CFSE+ donor cells that are HEL+ (upper box) and HEL- (lower box).
Numbers to the right of the panel indicate the proportion of total splenocytes that are CD45.1+
CFSE+ HEL+ and CD45.1+ CFSE+ HEL-. (C) In vivo proliferation of HEL+ Fo and MZ B cells.
Overlay histogram shows the CFSE profile of CD45.1+ CFSE+ HEL+ Fo (red line) and MZ B
cells (blue line) from (A) and (B), respectively. Numbers represent the percentage of Fo and MZ
B cells that have not diluted their CFSE intensity. Data is representative of three experiments.
(D) In vitro proliferation of Fo and MZ B cells. Fo and MZ B cells were purified from SWHEL mice
as shown in Fig. 5.4 and stimulated in vitro with anti-CD40 mAb plus IL-4. Overlay histogram
shows the CFSE profile of Fo (red line) and MZ B cells (blue line). Data is representative of at
least five experiments.
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The capacity of resting HEL+ compared to HEL- B cells to home to the
spleen was assessed by transferring CFSE-labelled Fo and MZ SWHEL B cells
into recipients given mock-conjugated SRBCs. In this case, the transferred
CD45.1+ B cells did not proliferate, as indicated by the maintenance of high
CFSE fluorescence intensity in both the HEL+ and HEL- B cell populations (Fig.
5.10 A; and B). Significantly, the proportion of HEL+ B cells within the
transferred CFSE+ B cell populations at 64 hours was the same as that within
the input cell inoculum for this experiment (Fig. 5.10 A; B; and data not shown)
indicating that the homing capacity of HEL+ B cells in each case reflected that of
the donor population as a whole irrespective of whether they originated from the
Fo or MZ compartment.
Although transferred HEL+ MZ B cells were able to migrate to the spleen,
it was apparent that they did so less efficiently than Fo B cells. This was
demonstrated by analysing the frequency of HEL- B cells in recipients
challenged with HEL-SRBC. As expected, the CFSE+ HEL- B cells in these mice
did not proliferate, but were present at 2.8-fold lower frequencies in mice that
received MZ compared with Fo donor cells (Fig. 5.10 A; and B). The disparity in
homing was nevertheless insufficient on its own to explain the lesser expansion
of HEL+ MZ B cells, the numbers of which were 14-fold lower than HEL+ Fo B
cells at the same time point (Fig. 5.10 A; and B). Thus, the overall expansion of
MZ HEL+ B cells in response to HEL-SRBC was impaired up to 5-fold relative to
that of Fo HEL+ B cells.
To determine the nature of the impairment in the expansion of MZ HEL+
B cells, the CFSE cell division profiles of HEL+ Fo and MZ B cells were directly
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compared. This revealed that the HEL+ B cells once recruited into the
proliferative response had divided to the same extent regardless of whether
they originated from the Fo or MZ compartment (Fig. 5.10 C). The differential
expansion of the two populations may therefore be explained by more efficient
recruitment of Fo versus MZ B cells into the proliferative response. Consistent
with such a conclusion, the fraction of HEL+ B cells remaining undivided at the
same time point was much greater in MZ than Fo HEL+ B cells (26% versus 7%,
Fig. 5.10 C).
5.4.3. Purified MZ B cells are relatively hyper-responsive to T cell-derived
stimuli in vitro
The relatively poor recruitment of purified MZ B cells into the anti-HEL
response was surprising in light of previous reports that they in fact show
greater responsiveness than Fo B cells to T cell-derived stimuli in vitro (Oliver et
al. 1997; Oliver et al. 1999). To test whether the purification strategy may have
compromised the responsiveness of MZ B cells to such signals, Fo and MZ B
cells were purified as detailed above, labelled with CFSE, and stimulated with
anti-CD40 mAb plus IL-4 in vitro. The in vitro recruitment and subsequent
proliferation of MZ B cells in response to this stimulus was found to be greater
than that of Fo B cells (Fig. 5.10 D) in agreement with previous studies (Oliver
et al. 1997; Oliver et al. 1999). In other words the poor recruitment of MZ B cells
into the TD response to HEL-SRBC in vivo was not due to an intrinsic or
induced hypo-responsiveness to T cell-derived signals. Rather, the ability of MZ
B cells to access T cell help in response to HEL-SRBC in vivo appears to be
limited by physiological factors operant within an intact immune system.
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Figure 5.11. Localisation of HEL+ Fo and MZ B cells 24 hours after challenge with HEL-SRBC.
Splenic sections from (A) control mice given HEL-SRBC without any HEL+ B cells, (B) mice that
received HEL+ Fo B cells together with HEL-SRBC, (C) and (D) mice that received HEL+ MZ B
cells together with HEL-SRBC were stained for B220 (blue) to reveal the primary B cell follicle,
CD4 (red) to reveal the T cell-rich PALS and HEL-binding BCRs (green) to reveal HEL+ B cells
(white arrows). Sections are representative of multiple spleens from at least three independent
experiments.
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5.4.4. MZ B cells do not home efficiently to the T-B border following in
vivo activation with HEL-SRBC
After antigen engagement unfractionated B cells have been shown to
migrate to the border between the PALS and primary follicle (outer PALS) in
search of T cell help, which then initiates the TD immune response (Liu et al.
1988; Cyster and Goodnow 1995; Garside et al. 1998; Reif et al. 2002).
Therefore, it is possible that the poor recruitment of MZ B cells into the anti-HEL
response was due to their inefficient homing to the outer PALS. To test this
hypothesis, we examined the splenic localisation of responding HEL+ Fo and
MZ B cells 24 hours after transfer and activation with HEL-SRBC. HEL+ B cells
could not be detected by histological analysis in the spleens of control mice
given HEL-SRBC but no SWHEL B cells (Fig. 5.11 A). In contrast, HEL+ B cells
were detectable in the spleens of immunised mice given Fo SWHEL B cells the
majority (>90%) of which were localised to the T-B border (Fig. 5.11 B).
However, fewer HEL+ B cells were evident in the spleens of immunised mice
given MZ B cells and these were widely scattered throughout the red pulp (Fig.
5.11 C; and D) with only a minority (<20%) being localised to the T-B border
(Fig. 5.11 D). Thus the immediate homing of MZ B cells to the outer PALS after
antigen engagement was less efficient than that of Fo B cells.
5.4.5. Entry of activated MZ B cells into GCs is delayed compared to Fo B
cells
Differential migration of mature peripheral B cell subsets was also
observed later during the response to HEL-SRBC. By day 3 HEL+ B cells again
could not be detected by histological analysis in the spleens of control mice
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Figure 5.12. Delayed migration of HEL+ MZ B cells into the primary follicle. Splenic sections
from (A) control mice given HEL-SRBC without any HEL+ B cells, (B) mice that received HEL+
Fo B cells together with HEL-SRBC, (C) and (D) mice that received HEL+ MZ B cells together
with HEL-SRBC were stained for B220 (blue) to reveal the primary B cell follicle, CD4 (red) to
reveal the T cell-rich PALS and HEL-binding BCRs (green) to reveal HEL+ B cells (white arrows).
Sections are representative of multiple spleens from at least three independent experiments.
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given HEL-SRBC without SWHEL B cells (Fig. 5.12 A). However, frequent HEL+
Fo B cells could be observed and had migrated away from the T-B border into
the inner regions of the primary follicle (Fig. 5.12 B). In contrast, HEL+ MZ B
cells were still widely scattered around the spleen and could be found in the red
pulp (Fig. 5.12 C), bridging channel and MZ as well as the T-B border (Fig. 5.12
D). By day 5 multiple GCs were established in spleens of mice given Fo B cells
and these were extensively colonised with HEL+ B cells (Fig. 5.13 A left panel).
At the same time-point HEL+ MZ B cells were found mainly in the bridging
channels with only a few having entered the follicle and GCs, which were
present in lower numbers (Fig. 5.13 B right panel). Subsequently, on day 7,
clusters of ASCs with intense cytoplasmic staining for HEL were seen in
recipients of both Fo (Fig. 5.13 B left panel) and MZ B cells (Fig. 5.13 B right
panels). However, the majority (>80%) of HEL+ cells derived from Fo B cells
were localised within GCs (Fig. 5.13 B left panel), whereas ~ 50% of HEL+ cells
derived from MZ B cells resided in proliferative foci in the red pulp (5.13 B right
upper panel) and the bridging channel (Fig. 5.13 B right lower panel). Moreover,
it was not until day 7 that significant numbers of HEL+ GC B cells were seen in
the spleens of mice given MZ B cells and HEL-SRBC (Fig. 5.13 B right lower
panel). Hence, MZ B cells were capable of generating a GC response but this
response lagged significantly behind that of Fo B cells (compare the left panel
of Fig. 5.13 A to the lower right panel Fig. 5.13 B).
5.4.6. Chemokine receptor expression by activated Fo and MZ B cells
The in vivo expression of the chemokine receptors CXCR5, CCR7 and
CXCR4 was analysed to determine the basis of the altered migration and
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Figure 5.13. Delayed migration of HEL+ MZ B cells into the GC in response to HEL-SRBC.
HEL+ Fo and MZ B cells were transferred and challenged with HEL-SRBC. Recipient mice
were sacrificed on (A) day 5 and (B) day 7 and splenic sections stained for expression of B220
(red), PNA (blue) and HEL-binding BCRs (green). GCs are purple due to co-localisation of
B220 and PNA. Note the intense cytoplasmic staining of HEL+ plasma cells compared to the
less intense surface staining of HEL+ GC B cells. Sections are representative of multiple
spleens from at least three independent experiments.
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Fig. 5.14. Expression of chemokine receptors by in vivo activated Fo and MZ SWHEL B cells. 104
HEL+ Fo and MZ B cells were challenged with 2 x 108 HEL-SRBC. Splenocytes were harvested
on day 5 and stained for CD45.2, HEL-binding and either (A) CXCR5, (B) CCR7, or (C) CXCR4.
Pseudo-colour plots on the left are gated on CD45.2+ HEL+ B cells. Overlay histograms on the
right show the baseline level of chemokine receptors expressed by Fo and MZ SWHEL B cells in
naïve (black lines) and immunised mice (blue lines for CD45.2+ HEL+ Fo and red lines for
CD45.2+ HEL+ MZ B cells). Data is representative of three experiments.
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recruitment of MZ compared to Fo B cells. Studies were performed on day 3, 5
and 7 of the immune response. Surprisingly, despite the marked differences in
migration and recruitment, the pattern of chemokine receptor expression did not
significantly differ between populations of responding B cells generated from Fo
and MZ SWHEL B cells (Fig. 5.14; and data not shown). For example, although
basal expression of CXCR5 was 2-fold higher on MZ than Fo B cells, both
expressed similar levels of CXCR5 on day 5 following challenge with HEL-
SRBC (Fig. 5.14 A). On the other hand, expression of CCR7 was 1.5-fold
higher for Fo compared to MZ B cells at baseline but by day 5 was equivalent
between the two populations (Fig. 5.14 B). Finally, while MZ B cells expressed
5-fold higher levels of CXCR4 than Fo B cells, this difference had again
disappeared by day 5 of the response (Fig. 5.14 C). The similar changes in
patterns of CXCR5, CCR7 and CXCR4 expression suggest that other
chemotactic factors may be involved in the trafficking of Fo and MZ B cells
following in vivo activation.
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Figure 5.15. Delayed onset of SHM in MZ B cells in response to HEL-SRBC. The VH10 Ig heavy
chain variable gene was PCR amplified and individual amplicons cloned and sequenced. The
DNA sequences obtained were then aligned with the original VH10 gene in the targeting con-
struct to determine the mutation frequency. (A) Background PCR error rate was determined by
cloning the VH10 gene from genomic DNA isolated from the brain of a SWHEL mouse. (B)
Baseline mutations due to pre-immune diversification of the BCR were determined by cloning
the VH10 gene from sorted unimmunised HEL+ Fo and MZ B cells. The frequency of antigen-
induced SHM of Fo and MZ B cells was determined by cloning the VH10 gene from CD45.2+
HEL+ cells sorted from mice given either Fo or MZ SWHEL B cells on (C) day 6 and (D) day 7
after challenge with HEL-SRBC. For each pie chart n equals the number of clones isolated and
the individual segments represent the proportion of clones with the corresponding number of
mutations per clone.
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5.5. SHM of Fo versus MZ B cells
5.5.1. Naïve HEL+ SWHEL B cells mice exhibit limited SHM of the VH10 gene
The next step was to determine the potential impact of the delayed entry
of MZ B cells into GCs on their ability to undergo SHM compared to Fo B cells.
To do this, the targeted VH10 heavy chain variable region gene was first PCR
amplified from naïve HEL+ B cells and individual amplicons cloned and
sequenced. The sequences obtained were then compared with the original
VH10 variable gene in the targeting construct. The rate of PCR-introduced errors
was established using DNA isolated from the brain of a SWHEL mouse which
revealed a background rate of 2 mutations per 104 bp (Fig. 5.15 A) that was
significantly lower than the mutation rates observed in resting peripheral HEL+
Fo and MZ B cells (8 and 6 mutations per 104 bp, respectively; Fig. 5.15 B). Of
the 16 mutations identified in these naïve HEL+ B cells, 62.5% were in
hypermutation hotspots (in or adjoining an RGYW motif (Rogozin and
Kolchanov 1992)) and 62.5% were silent mutations (data not shown). Thus it
was possible that these mutations were not antigen-selected but had arisen via
the recently identified mechanism of T cell-independent SHM that occurs during
immature B cell development (Mao et al. 2004). From this limited analysis,
however, there was no indication that this mechanism is deployed differentially
during the development of Fo versus MZ B cells.
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Figure 5.16. Altered pattern of SHM in MZ B cells in response to HEL-SRBC. The DNA
sequences obtained in Fig. 5.15 were translated and aligned with the original HyHEL-10
sequence (numbered according to Kabat et al. 1991) to determine the position and significance
of mutations. (A) Pattern of SHM by HEL+ Fo B cells on day 6. Mutations in FRs (yellow
regions) are shown in grey and mutations in CDRs (blue regions) are highlighted in green. The
residues S52 and S56 in contact with HEL are shown. (B) Pattern of SHM by HEL+ MZ B cells
on day 6.
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5.5.2. SHM is delayed in the response of MZ versus Fo B cells
To examine SHM during a TD response, CD45.2+ HEL+ responding B
cells were purified by electronic cell sorting from recipients of Fo and MZ SWHEL
B cells on days 6 and 7 following challenge with HEL-SRBC. On day 6, the
rates of SHM in the heavy chain variable gene of responding HEL+ Fo and MZ
B cells had both increased significantly above those present in the
corresponding naïve B cell population (Fig. 5.15 B; and C), but were twice as
prevalent in the responding Fo than in the MZ population (58 versus 29 per 104
bp; Fig. 5.15 C). Moreover, 52% of the Fo clones contained multiple (>1)
mutations compared to only 21% of the MZ clones (Fig. 5.15 C). By day 7, the
mutation rates of clones derived from HEL+ Fo and MZ B cells were similar and
both contained clones that had acquired multiple mutations (Fig. 5.15 D). Thus,
in contrast to the rapid isotype switching of the response to IgG1, the onset of
SHM was delayed in MZ compared to Fo B cells, in parallel with their delayed
entry into GCs.
5.5.3. MZ and Fo B cells have distinct patterns of SHM
In addition to the slower onset of SHM during the response of MZ B cells,
a difference was observed in the nature of the mutations that accumulated in
responding MZ and Fo B cells. Thus, the early (day 6) mutations present in the
Fo but not MZ responders were heavily biased towards CDR2, in particular the
HEL contact residues S52 and S56 (Fig. 5.16). In addition, by day 7, the MZ but
not the Fo responders had accumulated multiple mutations in the Y47 and
especially the E46 residues within FR2 (Fig. 5.17). All the E46 mutations
observed in the day 7 MZ response occurred in independent clones since the
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Figure 5.17. Altered pattern of SHM in MZ B cells in response to HEL-SRBC. The DNA
sequences obtained in Fig. 5.13 were translated and aligned with the original HyHEL-10
sequence (numbered according to Kabat et al. 1991) to determine the position and significance
of mutations. (A) Pattern of SHM by HEL+ Fo B cells on day 7. Mutations in FRs (yellow
regions) are shown in grey and mutations in CDRs (blue regions) are highlighted in green. (B)
Pattern of SHM by HEL+ MZ B cells on day 6. The residues E46 and Y47 in FR2 just proximal to
CDR2 are highlighted in red.
V24 G26 D32 S35 N43 E46 V51 S52 T57
WT gtc ggc gat agc aat gag gta agc acg
23 ... .c. ... ... ... ..a ... ... g..
45 ... ... ..c ... ... ..a a.. ... ...
7 ... ... ... ..t ... t.t ... ... ...
38 .c. ... ... ... .c. t.t ... ... ...
8 ... ... ... ... ... c.a ... .c. ...
37 ... ... ... ... ... ..c ... ... ...
Table 5.1. Sequence from 6 independent clones that had mutated residue E46.
Sequences derived from responding MZ B cells on day 7 of the response that had
mutated E46 (highlighted in green) are shown along with the original sequence derived
from the HyHEL-10 hybridoma used in the targeting construct (designated as WT).
ResidueClone
Chapter 5. SWHEL model of in vivo B cell activation
120
E46 codon was mutated in four different ways in the 6 clones studied and each
clone carried independent mutations in other variable region residues (Table
5.1). Thus, there was not only a delayed onset of SHM but also an alteration to
the intrinsic pattern of SHM associated with clones of Fo and MZ B cell origin.
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5.6. Discussion
5.6.1. A new model for studying in vivo B cell activation
The experimental system reported here has several advantages over
previously published models used for analysing in vivo TD B cell responses.
Firstly, the responses take place in non-irradiated wild-type mice, thereby
allowing the normal navigation of responding lymphocytes to occur through
intact secondary lymphoid structures. Importantly, this approach avoids the
potential problems associated with the use of lymphopaenic recipients such as
Rag-2-/- and scid/scid mice to visualise donor B cells (Song and Cerny 2003;
Vinuesa et al. 2003). Moreover, it means that the B cell-specific functions of
candidate immunoregulatory molecules can be interrogated by using B cells
from SWHEL Ig-Tg mice crossed onto different genetically manipulated
backgrounds. This is demonstrated in the experiment shown in Fig. 5.5 where
the requirement for B cell expression of CD40 in TD responses was confirmed
with B cells derived from SWHEL × cd40-/- donor mice. Secondly, the response is
generated from only a small number (1 to 2 × 104) of antigen-specific B cells, a
situation that more closely reflects the frequency of such cells in the normal B
cell repertoire and results in a large proportion of the inoculum of transferred
HEL+ B cells being recruited into the response (Fig. 5.10). Thus the potential
artefacts associated with having a heterogeneous population of responding and
non-responding antigen-specific B cells in recipient mice are avoided. Such a
situation typically occurs when large numbers (105-107) of HEL+ B cells are used
(data not shown) or in other models in which the numbers of antigen-specific
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donor B cells greatly exceed the amount of antigen and T cell help available
(Garside et al. 1998; Pape et al. 2003; Attanavanich and Kearney 2004).
Thirdly, the fact that the SWHEL B cells are capable of both CSR and SHM
means that the regulation of these critical components of TD responses can be
analysed while still maintaining the advantages of using a Tg system for
tracking antigen-specific cells in vivo. Indeed, since the variable gene
sequences of the primary responding (HEL+) B cells are known, the process of
SHM can be monitored with precision during the induction phase of the
response (Figs. 5.15; 5.16; and 5.17) in contrast to previously reported
experimental systems (Jacob et al. 1993; Song and Cerny 2003). Finally,
simultaneous staining for BCR specificity (HEL-binding) and donor CD45
allotype in this model provides a unique window into the earliest stages of the B
cell response by using a combination of flow cytometry and histological
analysis.
5.6.2. MZ versus Fo B cell response to HEL-SRBC
Comparison of the responses of CD21int CD23hi Fo and CD21hi CD23lo MZ
B cells to HEL-SRBC confirmed several findings observed in a recent study in
which TD responses were analysed in scid/scid recipient mice (Song and Cerny
2003). Thus both Fo and MZ B cells secreted IgM and IgG antibodies (Fig. 5.7),
participated in GC reactions (Fig. 5.13) and underwent SHM (Fig. 5.15). In the
study by Song and Cerny, however, MZ but not Fo B cells produced large
amounts of specific IgM antibody early in the response, a difference that was
not observed here (Fig. 5.7). Although this disparity between the two systems
can be explained by differences in the antigen used and/or its route of
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administration, it may also have been due to the fact that B cells transferred into
a lymphopaenic environment do not face the physiological obstacles to locating
T cell help which are associated with intact secondary lymphoid tissues. Since
the data presented here indicate that MZ B cells do not efficiently locate and
respond to T cell help under such circumstances, it is possible that the TD
response of MZ B cells in a lymphopaenic environment may simply reflect their
known hyper-responsiveness to T cell-derived signals (as shown in Fig. 5.10 D;
and reported previously in (Oliver et al. 1997; Oliver et al. 1999)) rather than
any intrinsic ability to mediate a TD response within a normal immune system.
5.6.3. CD95, GL7 and PNA identify activated and not GC B cells
Interestingly, the activation markers CD95, GL7 and PNA were
upregulated to similar levels on both Fo and MZ B cells at day 5 of the response
(Fig. 5.9). Although upregulated expression of CD95 (Daniel and Krammer
1994; Lagresle et al. 1995), GL7 (Laszlo et al. 1993) and PNA (Rose et al.
1980; Butcher et al. 1982) has been described in human and murine GC B
cells, they are more correctly considered as activation markers. For example,
CD95 can be induced by BCR triggering alone (Lagresle et al. 1995) and
anergic B cells that reside outside the follicle and GCs also express high levels
of CD95 (Rathmell et al. 1995). Furthermore, GL7 can be induced by in vitro
polyclonal stimulation with LPS (Laszlo et al. 1993), which is not classically
associated with GC formation. The fact that these markers are present on GC B
cells is therefore coincident on their activated state rather than contingent on
their localisation within GCs. In support of this, the majority of activated HEL+
MZ B cells were found to reside outside GCs on day 5 (Fig. 5.13 A) despite the
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fact that they nevertheless almost uniformly expressed high levels of CD95 (Fig.
5.9 A), GL7 (Fig. 5.9 B) and PNA (Fig. 5.9 C).
5.6.4. Chemokine receptor expression by Fo versus MZ B cells
To explain the poor recruitment of MZ B cells into the TD response
against HEL-SRBC the relative performance of Fo and MZ HEL+ B cells was
examined during the earliest stages of the response. After 24h, before any
proliferation of either subset of HEL+ B cells had occurred (data not shown), the
migration of MZ B cells to the T-B border was found to be less efficient than that
of Fo B cells (Fig. 5.11). Migration to the outer PALS at this early stage of the
response is thought to be primarily dependent on BCR-mediated upregulation
of CCR7 (Reif et al. 2002). In the SWHEL model, however, no evidence for
differential expression of CCR7 between Fo and MZ B cells was demonstrable
early in the response (Fig. 5.14; and data not shown). CCR7 may therefore
deliver quantitatively or qualitatively distinct signals to MZ versus Fo B cells.
Alternatively, Fo and MZ B cells may migrate differently due to differential
expression of other homing receptors such as S1P1 (Cinamon et al. 2004).
Irrespective of the precise mechanism, the impaired ability of MZ B cells to
migrate to the outer PALS is provides a plausible explanation of their limited
recruitment into TD responses that occurs within intact secondary lymphoid
tissues.
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5.6.5. Altered rate and pattern of SHM by MZ versus Fo B cells
Despite a lower level of recruitment into the TD response against HEL-
SRBC, the MZ B cells that were recruited underwent CSR to IgG1 as efficiently
as Fo B cells (Figs. 5.7; and 5.8). Strikingly, however, the onset of SHM was
significantly delayed in MZ relative to Fo B cells (Fig. 5.15). Since both CSR
and SHM are dependent on the inducible modifier AID (Muramatsu et al. 2000;
Revy et al. 2000), AID expression is unlikely to be differentially induced in
responding Fo and MZ B cells. Rather, the uncoupling of these two AID-
dependent events in MZ B cells would suggest that some additional signal
required for SHM but not CSR may be delayed in responding MZ B cells. The
fact that the entry of MZ B cells into GCs lags behind Fo B cells (Fig. 5.13) and
coincides with the onset of SHM in these cells (Fig. 5.15), points to a
requirement for a GC-specific signal for the onset of SHM but not CSR. Such a
scenario is consistent with the recent finding of an association of AID with
replication protein A during the induction of SHM but not CSR (Chaudhuri et al.
2004).
5.6.6. Final comments
Overall, MZ B cells proved to be significantly less efficient than Fo B cells
at mediating a TD response within an intact immune system despite their
inherent hyper-responsiveness to T cell-derived stimuli (Fig. 5.10; and (Oliver et
al. 1997; Oliver et al. 1999)). This result is consistent with the concept of a
"division of labour", in the sense that Fo B cells are specialised to deal with TD
antigen and MZ B cells with TI-2 antigen (Martin et al. 2001). Interestingly, it
was observed that responding MZ B cells exhibited a distinct pattern of SHM
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compared to Fo B cells (Fig. 5.17). In particular, clones derived from MZ B cells
mutated E46 and Y47 in FR2 just proximal to CDR2 much more frequently than
did Fo B cells. This unconventional mutation pattern may conceivably diversify
the BCR in such a way as to generate alternative specificities to those induced
by conventional targeting of CDRs. Such a difference may arise either due to
differential recruitment of co-factors to the AID-mutator complex (McBride et al.
2004; Shinkura et al. 2004) or to differential antigenic selection of these cells
(William et al. 2002). Either way, these data point to the possibility that TD
responses from MZ B cells may contribute BCR specificities complementary to
those generated from the predominant Fo response. Thus although Fo B cells
may be programmed to respond more efficiently to TD antigen, there may be
circumstances when their response is inadequate to deal with the pathogen. In
such a situation, a delayed synergistic response by MZ B cells generated via an
alternative pathway may prove useful in eliminating that pathogen.
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Conclusions
The work described within this thesis provides a substantial basis upon
which to advance the current understanding of B cell biology. The SWHEL model
has several advantages over the traditional Ig-Tg models that have been used
extensively over the last 15 years to characterise B cell responses. In particular,
the capacity of SWHEL B cells to undergo CSR and SHM has the potential to add
greatly to the original observations made using the MD4 Tg mice. For example,
it was possible to show for the first time in the SWHEL model that anergic B cells
lacked any intrinsic controls over CSR and the secretion of isotype-switched
autoantibodies. The fact that BCR-independent signals such as LPS could
bypass the normal controls that prevent inadvertent activation of anergic B cells
reinforces the need for extrinsic controls over the migration and survival of
anergic B cells in the periphery. The access of anergic B cells to these BCR-
independent signals is therefore restricted by excluding them from splenic
microenvironments such as the follicle and MZ and by shortening their lifespan.
The fact that these controls are provided by interclonal competition from non-
self-reactive (HEL-) B cells demonstrates the robustness of the immune system,
given that self-reactive B cells would normally arise within a diverse polyclonal
repertoire. Although the actual nature of the signals for which anergic B cells
compete remains to be fully characterised, the role of candidate molecules such
as BAFF can be easily tested in the SWHEL model.
In addition to B cell self-tolerance, the MD4 Tg line also enabled
investigators to observe negative selection within GCs and the initial site of T-B
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collaboration at the border between the follicle and PALS in the context of a TD
immune response. However, the inability of MD4 Tg B cells to undergo CSR
and SHM made it difficult to study these key aspects of TD antibody responses.
As shown in the response to HEL-SRBC, both these aspects can be tracked
with precision in the SWHEL model. Application of the model to study the in vivo
responses of Fo and MZ B cells demonstrated subtle differences in the
recruitment and migration of these mature peripheral B cell subsets that
translated into significant differences in the rate and pattern of SHM. These
differences were not demonstrable in a previous comparison of in vivo TD
responses by Fo and MZ B cells that involved their adoptive transfer into
lymphopaenic recipients. Work is currently underway to conjugate HEL directly
to the polymer Ficoll to create a TI-2 antigen. In this way, the responses of HEL+
Fo and MZ B cells to TI-2 antigen can be directly compared. This will
complement the comparison of the TD responses described in this thesis and
provide a comprehensive picture of the relative response capabilities of Fo and
MZ B cells in vivo. Finally, and most excitingly, the amino acid residues in HEL
directly in contact with HyHEL-10 have been mutated by Didrik Paus to
generate mutant HEL proteins that retain lysozyme activity but are recognised
by HEL+ SWHEL B cells with significantly lower affinities. These mutant proteins
can be conjugated to SRBCs to directly study the impact of BCR affinity on the
immune response, with particular interest in the generation of plasma cells and
memory B cells.
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